0001877322-24-000088.txt : 20240501 0001877322-24-000088.hdr.sgml : 20240501 20240501063255 ACCESSION NUMBER: 0001877322-24-000088 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 84 CONFORMED PERIOD OF REPORT: 20240329 FILED AS OF DATE: 20240501 DATE AS OF CHANGE: 20240501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ESAB Corp CENTRAL INDEX KEY: 0001877322 STANDARD INDUSTRIAL CLASSIFICATION: GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC [3569] ORGANIZATION NAME: 06 Technology IRS NUMBER: 870923837 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41297 FILM NUMBER: 24899961 BUSINESS ADDRESS: STREET 1: 909 ROSE AVENUE STREET 2: 8TH FLOOR CITY: NORTH BETHESDA STATE: MD ZIP: 20852 BUSINESS PHONE: (302) 252-9160 MAIL ADDRESS: STREET 1: 909 ROSE AVENUE STREET 2: 8TH FLOOR CITY: NORTH BETHESDA STATE: MD ZIP: 20852 10-Q 1 esab-20240329.htm 10-Q esab-20240329
0001877322--12-31falseQ12024http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherAssetsCurrenthttp://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherAssetsCurrent00018773222024-01-012024-03-2900018773222024-04-22xbrli:sharesiso4217:USD00018773222023-01-012023-03-31iso4217:USDxbrli:shares00018773222024-03-2900018773222023-12-310001877322us-gaap:CommonStockMember2023-12-310001877322us-gaap:AdditionalPaidInCapitalMember2023-12-310001877322us-gaap:RetainedEarningsMember2023-12-310001877322us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001877322us-gaap:NoncontrollingInterestMember2023-12-310001877322us-gaap:RetainedEarningsMember2024-01-012024-03-290001877322us-gaap:NoncontrollingInterestMember2024-01-012024-03-290001877322us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-290001877322us-gaap:CommonStockMember2024-01-012024-03-290001877322us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-290001877322us-gaap:CommonStockMember2024-03-290001877322us-gaap:AdditionalPaidInCapitalMember2024-03-290001877322us-gaap:RetainedEarningsMember2024-03-290001877322us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-290001877322us-gaap:NoncontrollingInterestMember2024-03-290001877322us-gaap:CommonStockMember2022-12-310001877322us-gaap:AdditionalPaidInCapitalMember2022-12-310001877322us-gaap:RetainedEarningsMember2022-12-310001877322us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001877322us-gaap:NoncontrollingInterestMember2022-12-3100018773222022-12-310001877322us-gaap:RetainedEarningsMember2023-01-012023-03-310001877322us-gaap:NoncontrollingInterestMember2023-01-012023-03-310001877322us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001877322us-gaap:CommonStockMember2023-01-012023-03-310001877322us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001877322us-gaap:CommonStockMember2023-03-310001877322us-gaap:AdditionalPaidInCapitalMember2023-03-310001877322us-gaap:RetainedEarningsMember2023-03-310001877322us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001877322us-gaap:NoncontrollingInterestMember2023-03-3100018773222023-03-31esab:segment0001877322us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMembercountry:RU2024-01-012024-03-29xbrli:pure0001877322country:RU2024-01-012024-03-290001877322us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMembercountry:RU2024-01-012024-03-290001877322us-gaap:AccumulatedTranslationAdjustmentMember2024-03-290001877322esab:AsbestosRelatedActivityMember2024-01-012024-03-290001877322esab:AsbestosRelatedActivityMember2023-01-012023-03-310001877322esab:SagerS.A.Member2024-02-262024-02-260001877322esab:TherapyEquipmentLimitedMember2023-01-112023-01-110001877322esab:EquipmentProductsMember2024-01-012024-03-290001877322esab:EquipmentProductsMember2023-01-012023-03-310001877322esab:ConsumableProductsMember2024-01-012024-03-290001877322esab:ConsumableProductsMember2023-01-012023-03-310001877322us-gaap:EmployeeSeveranceMember2023-12-310001877322us-gaap:EmployeeSeveranceMember2024-01-012024-03-290001877322us-gaap:EmployeeSeveranceMember2024-03-290001877322us-gaap:FacilityClosingMember2023-12-310001877322us-gaap:FacilityClosingMember2024-01-012024-03-290001877322us-gaap:FacilityClosingMember2024-03-290001877322esab:TheCreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMember2024-03-290001877322esab:TheCreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMember2023-12-310001877322esab:TheCreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-03-290001877322esab:TheCreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2023-12-310001877322esab:TheCreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2022-04-040001877322esab:TheCreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMember2022-04-040001877322us-gaap:SeniorNotesMemberesab:TheCreditAgreementMemberus-gaap:SecuredDebtMember2022-04-040001877322us-gaap:SeniorNotesMemberesab:TheCreditAgreementMemberus-gaap:SecuredDebtMember2022-04-042022-04-040001877322esab:TheCreditAgreementMemberus-gaap:LetterOfCreditMemberus-gaap:LineOfCreditMember2022-04-040001877322us-gaap:BridgeLoanMemberesab:TheCreditAgreementMemberus-gaap:LineOfCreditMember2022-04-040001877322esab:TheCreditAgreementMember2022-04-042022-04-040001877322esab:TheCreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2022-04-042022-04-040001877322esab:TheCreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMember2022-04-042022-04-040001877322esab:EnovisCorporationMember2022-04-042022-04-040001877322us-gaap:SeniorNotesMemberesab:TheCreditAgreementMemberus-gaap:SecuredDebtMember2022-06-280001877322us-gaap:SeniorNotesMemberesab:TheCreditAgreementMemberus-gaap:SecuredDebtMember2024-03-290001877322esab:TheCreditAgreementMemberus-gaap:LineOfCreditMember2024-03-290001877322esab:TheCreditAgreementMemberus-gaap:LineOfCreditMember2023-06-300001877322srt:ScenarioForecastMemberesab:TheCreditAgreementMemberus-gaap:LineOfCreditMember2024-06-300001877322us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberesab:TheCreditAgreementMembersrt:MinimumMember2022-04-042022-04-040001877322us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberesab:TheCreditAgreementMembersrt:MaximumMember2022-04-042022-04-040001877322us-gaap:BaseRateMemberesab:TheCreditAgreementMembersrt:MinimumMember2022-04-042022-04-040001877322us-gaap:BaseRateMemberesab:TheCreditAgreementMembersrt:MaximumMember2022-04-042022-04-040001877322esab:TheCreditAgreementMember2024-03-290001877322esab:UncommittedCreditLineMemberus-gaap:LetterOfCreditMember2024-03-290001877322us-gaap:LetterOfCreditMember2024-03-290001877322us-gaap:OtherAssetsMember2024-03-290001877322us-gaap:LongTermDebtMember2024-03-290001877322us-gaap:InterestRateSwapMember2022-07-14esab:agreement0001877322us-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-07-140001877322us-gaap:CashFlowHedgingMembersrt:MinimumMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-07-140001877322us-gaap:CashFlowHedgingMembersrt:MaximumMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-07-140001877322us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2024-01-012024-03-290001877322us-gaap:SeniorNotesMemberus-gaap:SubsequentEventMemberesab:SeniorNoteOfferingMember2024-04-090001877322us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2024-03-290001877322srt:ScenarioForecastMemberus-gaap:InterestRateSwapMember2024-04-010001877322us-gaap:InterestRateSwapMember2024-03-290001877322us-gaap:InterestRateSwapMember2024-01-012024-03-290001877322us-gaap:InterestRateSwapMemberesab:InterestExpenseIncomeAndOtherNetMember2024-01-012024-03-290001877322us-gaap:InterestRateSwapMemberesab:InterestExpenseIncomeAndOtherNetMember2023-01-012023-03-310001877322us-gaap:ForeignExchangeContractMember2022-07-220001877322us-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-07-22iso4217:EUR0001877322us-gaap:InterestRateSwapMember2023-01-012023-03-310001877322us-gaap:ForeignExchangeContractMember2024-03-290001877322us-gaap:ForeignExchangeContractMember2023-12-310001877322us-gaap:InterestRateSwapMember2023-12-310001877322us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-03-290001877322us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-12-310001877322us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-01-012024-03-290001877322us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-01-012023-03-310001877322us-gaap:FairValueInputsLevel1Member2024-03-290001877322us-gaap:FairValueInputsLevel2Member2024-03-290001877322us-gaap:FairValueInputsLevel3Member2024-03-290001877322us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:FairValueInputsLevel1Member2024-03-290001877322us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:FairValueInputsLevel2Member2024-03-290001877322us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:FairValueInputsLevel3Member2024-03-290001877322us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel1Member2024-03-290001877322us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMember2024-03-290001877322us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMember2024-03-290001877322us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel1Member2024-03-290001877322us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMember2024-03-290001877322us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DesignatedAsHedgingInstrumentMember2024-03-290001877322us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-03-290001877322us-gaap:FairValueInputsLevel1Member2023-12-310001877322us-gaap:FairValueInputsLevel2Member2023-12-310001877322us-gaap:FairValueInputsLevel3Member2023-12-310001877322us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:FairValueInputsLevel1Member2023-12-310001877322us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:FairValueInputsLevel2Member2023-12-310001877322us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:FairValueInputsLevel3Member2023-12-310001877322us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel1Member2023-12-310001877322us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMember2023-12-310001877322us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMember2023-12-310001877322us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel1Member2023-12-310001877322us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001877322us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001877322us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001877322us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310001877322us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001877322esab:AccumulatedGainLossNetInvestmentHedgesParentMember2023-12-310001877322us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310001877322us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-03-290001877322us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-03-290001877322esab:AccumulatedGainLossNetInvestmentHedgesParentMember2024-01-012024-03-290001877322us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-03-290001877322us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-03-290001877322esab:AccumulatedGainLossNetInvestmentHedgesParentMember2024-03-290001877322us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-03-290001877322us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001877322us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001877322esab:AccumulatedGainLossNetInvestmentHedgesParentMember2022-12-310001877322us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310001877322us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-03-310001877322us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310001877322esab:AccumulatedGainLossNetInvestmentHedgesParentMember2023-01-012023-03-310001877322us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-03-310001877322us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-03-310001877322us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310001877322esab:AccumulatedGainLossNetInvestmentHedgesParentMember2023-03-310001877322us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-31esab:claim0001877322esab:AmericasSegmentMember2024-01-012024-03-290001877322esab:AmericasSegmentMember2023-01-012023-03-310001877322esab:EMEAAndAPACSegmentMember2024-01-012024-03-290001877322esab:EMEAAndAPACSegmentMember2023-01-012023-03-310001877322us-gaap:SeniorNotesMemberesab:TheCreditAgreementMemberus-gaap:SubsequentEventMemberus-gaap:SecuredDebtMember2024-04-092024-04-090001877322us-gaap:SubsequentEventMemberesab:SUMIGSolucoesParaSoldaLtdaMember2024-04-302024-04-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended March 29, 2024
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                     
Commission file number - 001-41297
ESAB Corporation
(Exact name of registrant as specified in its charter)
 
Delaware 87-0923837
(State or other jurisdiction of
incorporation or organization)		 (I.R.S. Employer
Identification Number)
909 Rose Avenue, 8th Floor
 
North Bethesda, Maryland
20852
(Address of principal executive offices) (Zip Code)
(301)323-9099
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.001 per shareESABNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes   ☑   No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes   ☑  No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☑     Accelerated filer ☐        Non-accelerated filer ☐
Smaller reporting company ☐    Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☑
As of April 22, 2024, there were 60,424,421 shares of the registrant’s common stock, par value $0.001 per share, outstanding.


TABLE OF CONTENTS
 Page
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
Consolidated and Condensed Statements of Operations
Consolidated and Condensed Statements of Comprehensive Income
Consolidated and Condensed Balance Sheets
Consolidated and Condensed Statements of Equity
Consolidated and Condensed Statements of Cash Flows
Notes to Consolidated and Condensed Financial Statements
Note 1. Organization and Basis of Presentation
Note 2. Discontinued Operations
Note 3. Acquisitions
Note 4. Revenue
Note 5. Earnings Per Share from Continuing Operations
Note 6. Income Taxes
Note 7. Inventories, Net
Note 8. Accrued and Other Liabilities
Note 9. Benefit Plans
Note 10. Debt
Note 11. Derivatives
Note 12. Financial Instruments and Fair Value Measurements
Note 13. Equity
Note 14. Commitments and Contingencies
Note 15. Segment Information
Note 16. Subsequent Events
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Mine Safety Disclosures
Item 5. Other Information
Item 6. Exhibits
SIGNATURES
1

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

ESAB CORPORATION
CONSOLIDATED AND CONDENSED STATEMENTS OF OPERATIONS
Dollars in thousands, except per share amounts
(Unaudited)
Three Months Ended
March 29, 2024March 31, 2023
Net sales$689,744 $684,000 
Cost of sales434,717 436,611 
Gross profit255,027 247,389 
Selling, general and administrative expense142,450 147,282 
Restructuring and other related charges1,924 9,444 
Operating income110,653 90,663 
Pension settlement loss12,155 — 
Interest expense and other, net17,091 19,510 
Income from continuing operations before income taxes81,407 71,153 
Income tax expense18,504 37,024 
Net income from continuing operations62,903 34,129 
Loss from discontinued operations, net of taxes(1,309)(913)
Net income61,594 33,216 
Income attributable to noncontrolling interest, net of taxes(1,643)(1,313)
Net income attributable to ESAB Corporation$59,951 $31,903 
Earnings (loss) per share – basic
Income from continuing operations$1.01 $0.54 
Loss on discontinued operations$(0.02)$(0.02)
Net income per share$0.99 $0.52 
Earnings (loss) per share – diluted
Income from continuing operations$1.00 $0.54 
Loss on discontinued operations$(0.02)$(0.02)
Net income per share – diluted$0.98 $0.52 
    

See Notes to Consolidated and Condensed Financial Statements.

2

ESAB CORPORATION
CONSOLIDATED AND CONDENSED STATEMENTS OF COMPREHENSIVE INCOME
Dollars in thousands
(Unaudited)
Three Months Ended
March 29, 2024March 31, 2023
Net income$61,594 $33,216 
Other comprehensive (loss) income:
Foreign currency translation, net of tax expense of $1,531 and $45
(25,354)42,084 
Unrealized income (loss) on derivatives designated and qualifying as cash flow hedges, net of tax expense (benefit) of $295 and $(1,045)
1,013 (3,581)
Defined benefit pension and other post-retirement plan activity, net of tax expense of $203 and $66
629 277 
Other comprehensive (loss) income(23,712)38,780 
Comprehensive income37,882 71,996 
Comprehensive income attributable to noncontrolling interest(1,320)(1,814)
Comprehensive income attributable to ESAB Corporation $36,562 $70,182 


See Notes to Consolidated and Condensed Financial Statements.

3

ESAB CORPORATION
CONSOLIDATED AND CONDENSED BALANCE SHEETS
Dollars in thousands, except share and per share amounts
(Unaudited)
March 29, 2024December 31, 2023
ASSETS
CURRENT ASSETS:
Cash and cash equivalents$76,495 $102,003 
Trade receivables, less allowance for credit losses of $25,424 and $25,477
430,149 385,198 
Inventories, net405,601 392,858 
Prepaid expenses60,415 61,771 
Other current assets70,088 55,890 
Total current assets1,042,748 997,720 
Property, plant and equipment, net290,431 294,305 
Goodwill1,586,943 1,588,331 
Intangible assets, net484,219 499,535 
Lease assets - right of use94,162 95,607 
Other assets328,986 353,131 
Total assets$3,827,489 $3,828,629 
LIABILITIES AND EQUITY
CURRENT LIABILITIES:
Accounts payable$338,399 $306,593 
Accrued liabilities292,903 313,489 
Total current liabilities631,302 620,082 
Long-term debt992,798 1,018,057 
Other liabilities521,011 542,833 
Total liabilities2,145,111 2,180,972 
Equity:
Common stock - $0.001 par value - 600,000,000 shares authorized, 60,424,421 and 60,295,634 shares outstanding as of March 29, 2024 and December 31, 2023, respectively
60 60
Additional paid-in capital1,881,534 1,881,054
Retained earnings406,867 350,557
Accumulated other comprehensive loss(647,661)(624,272)
Total ESAB Corporation equity1,640,800 1,607,399
Noncontrolling interest41,578 40,258
Total equity1,682,378 1,647,657
Total liabilities and equity$3,827,489 $3,828,629 


See Notes to Consolidated and Condensed Financial Statements.

4

ESAB CORPORATION
CONSOLIDATED AND CONDENSED STATEMENTS OF EQUITY
Dollars in thousands, except share and per share amounts
(Unaudited)
Common StockAdditional Paid in Capital Retained EarningsAccumulated Other Comprehensive LossNoncontrolling InterestTotal
SharesAmount
Balance at December 31, 2023
60,295,634 $60 $1,881,054 $350,557 $(624,272)$40,258 $1,647,657 
Net income— — — 59,951 — 1,643 61,594 
Dividends declared ($0.06 per share)
— — — (3,641)— — (3,641)
Other comprehensive loss, net of tax expense of $2,029
— — — — (23,389)(323)(23,712)
Common stock-based award activity128,787 — 480 — — — 480 
Balance at March 29, 2024
60,424,421 $60 $1,881,534 $406,867 $(647,661)$41,578 $1,682,378 
Common StockAdditional Paid in CapitalRetained EarningsAccumulated Other Comprehensive LossNoncontrolling InterestTotal
SharesAmount
Balance at December 31, 2022
60,094,725 $60 $1,865,904 $159,231 $(674,988)$38,251 $1,388,458 
Net income— — — 31,903 — 1,313 33,216 
Dividends declared ($0.05 per share)
— — — (3,033)— — (3,033)
Distributions to noncontrolling owners— — — — — (1,359)(1,359)
Other comprehensive gain, net of tax benefit of $934
— — — — 38,279 501 38,780 
Common stock-based award activity127,538 — 2,229 — — — 2,229 
Balance at March 31, 2023
60,222,263 $60 $1,868,133 $188,101 $(636,709)$38,706 $1,458,291 


See Notes to Consolidated and Condensed Financial Statements.
5

ESAB CORPORATION
CONSOLIDATED AND CONDENSED STATEMENTS OF CASH FLOWS
Dollars in thousands
(Unaudited)
Three Months Ended
March 29, 2024March 31, 2023
Cash flows from operating activities:
Net income$61,594 $33,216 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization, and other impairment charges16,387 21,871 
Stock-based compensation expense4,133 2,994 
Deferred income tax(638)2,290 
Non-cash interest expense1,062 299 
Pension settlement loss12,155 — 
Changes in operating assets and liabilities:
Trade receivables, net(48,946)(21,048)
Inventories, net(16,078)(21,611)
Accounts payable36,196 28,480 
Other operating assets and liabilities(21,398)(8,424)
Net cash provided by operating activities44,467 38,067 
Cash flows from investing activities:
Purchases of property, plant and equipment(7,414)(7,709)
Proceeds from sale of property, plant and equipment368 681 
Acquisition, net of cash received(18,067)(18,721)
Other(1,501)— 
Net cash used in investing activities(26,614)(25,749)
Cash flows from financing activities:
Proceeds from borrowings on revolving credit facility115,000 187,000 
Repayments of borrowings on term credit facility(6,250)— 
Repayments of borrowings on revolving credit facility and other(139,035)(189,765)
Payment of dividends(3,635)(3,033)
Distributions to noncontrolling interest holders— (1,249)
Net cash used in financing activities(33,920)(7,047)
Effect of foreign exchange rates on Cash and cash equivalents(9,441)4,769 
(Decrease) increase in Cash and cash equivalents (25,508)10,040 
Cash and cash equivalents, beginning of period102,003 72,024 
Cash and cash equivalents, end of period$76,495 $82,064 


See Notes to Consolidated and Condensed Financial Statements.
6
ESAB CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS
(Unaudited)


1. Organization and Basis of Presentation

Founded in 1904, ESAB Corporation (“ESAB” or the “Company”) is a focused premier industrial compounder. ESAB provides its partners with fabrication technology advanced equipment, consumables, gas control equipment, robotics, and digital solutions. The Company’s rich history of innovative products and workflow solutions and its business system ESAB Business Excellence (“EBX”) enables the Company’s purpose of Shaping the world we imagineTM. The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America, and “EMEA & APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific. On April 4, 2022, ESAB Corporation completed its spin-off from Colfax Corporation (“Colfax,” “Enovis” or “Former Parent”) and became an independent, public-traded company (the “Separation”).

The Company’s fiscal year ends December 31. The Company’s first quarter ends on the last business day of the 13th week after the end of the prior quarter. As used herein, the first quarter results for 2024 and 2023 refer to the 13-week periods ended March 29, 2024 and March 31, 2023, respectively.

Russia and Ukraine Conflict

The invasion of Ukraine by Russia and the sanctions imposed in response have increased the level of economic and political uncertainty. While ESAB continues to closely monitor the situation and evaluate options, the Company is meeting current contractual obligations while addressing applicable laws and regulations. For the three months ended March 29, 2024, Russia represented approximately 5% of the Company’s total revenue, and approximately $4 million of its Net income. Russia also has approximately 3% of the Company’s total net assets excluding any goodwill allocation as of March 29, 2024. In case of a disposition of the Russia business, a portion of goodwill would need to be allocated and disposed of at the relative fair value attributable to the Russia business. Russia has a cumulative translation loss of approximately $118 million as of March 29, 2024, which could be realized upon a transition out. The Company is closely monitoring developments in Ukraine and Russia. Changes in laws and regulations or other factors impacting the Company’s ability to fulfill contractual obligations could have an adverse effect on the results of operations.

Basis of Presentation

The Consolidated and Condensed Financial Statements included herein have been prepared by the Company pursuant to the rules and regulations of the Security and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in the financial statements prepared in accordance with the accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted pursuant to SEC rules and regulations; however the Company believes that the disclosures are adequate to make the information presented not misleading.

The Consolidated and Condensed Financial Statements reflect, in the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Intercompany transactions and accounts are eliminated in consolidation.

In the normal course of business, the Company incurs research and development costs related to new product development, which are expensed as incurred and included in Selling, general and administrative expenses on the Company’s Consolidated and Condensed Statements of Operations. Research and development costs were $10.1 million and $9.6 million during the three months ended March 29, 2024 and March 31, 2023, respectively. These amounts do not include development and application engineering costs incurred in conjunction with fulfilling customer orders and executing customer projects, nor do they include costs related to securing third party product rights. The Company expects to continue making significant expenditures for research and development to maintain and improve its competitive positions.

The accompanying interim Consolidated and Condensed Financial Statements and the related notes should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”), filed with the SEC on February 29, 2024.




7
ESAB CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

2. Discontinued Operations

The Company holds certain asbestos-related contingencies and insurance coverages from divested businesses for which it does not have an interest in the ongoing operations. The Company has classified asbestos-related activity in its Consolidated and Condensed Statements of Operations as part of Loss from discontinued operations, net of taxes. This activity consists primarily of expected settlements, legal and administrative expenses associated with the above liabilities.

For the three months ended March 29, 2024 and March 31, 2023, respectively, loss from discontinued operations, net of taxes was $1.3 million and $0.9 million. See Note 14, “Commitments and Contingencies” for further information.

Cash used in operating activities related to discontinued operations for the three months ended March 29, 2024 and March 31, 2023 was $3.7 million and $5.4 million, respectively.

3. Acquisitions

On February 26, 2024, the Company completed the acquisition of Sager S.A., a welding repair and maintenance product and service leader in South America, for $18.1 million, net of cash received.

On January 11, 2023, the Company completed the acquisition of Therapy Equipment Limited, a regional leader in oxygen regulators, for $18.7 million, net of cash received.

4. Revenue

The Company provides fabrication technology advanced equipment, consumables, gas control equipment, robotics and digital solutions. The Company’s products are utilized to solve challenges in a wide range of industries. Substantially all revenue is recognized at a point in time. The Company disaggregates its revenue into the following product groups:
Three Months Ended
March 29, 2024March 31, 2023
(In thousands)
Equipment$214,860 $200,219 
Consumables474,884 483,781 
Total$689,744 $684,000 

The sales mix in the above table is relatively consistent across both reportable segments. The consumables product grouping generally has less production complexity and shorter production cycles than equipment products.

Given the nature of the business, the total amount of unsatisfied performance obligations with an original contract duration of greater than one year as of March 29, 2024 is immaterial. In some circumstances, customers are billed in advance of revenue recognition, resulting in contract liabilities. As of December 31, 2023 and December 31, 2022, total contract liabilities were $31.2 million and $25.9 million, respectively, and were included in Accrued liabilities on the Consolidated and Condensed Balance Sheets. During the three months ended March 29, 2024 and March 31, 2023, revenue recognized that was included in the contract liabilities balance at the beginning of the year was $16.2 million and $11.1 million, respectively. As of March 29, 2024 and March 31, 2023, total contract liabilities were $29.5 million and $28.3 million, respectively, and were included in Accrued liabilities on the Company’s Consolidated and Condensed Balance Sheets.










8
ESAB CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

Allowance for Credit Losses

A summary of the activity in the Company’s allowance for credit losses included within Trade receivables in the Consolidated and Condensed Balance Sheets is as follows:
Three Months Ended March 29, 2024
Balance at
Beginning
of Period		Charged to Expense, netWrite-Offs and DeductionsForeign
Currency
Translation		Balance at
End of
Period
(In thousands)
Allowance for credit losses$25,477 $651 $(439)$(265)$25,424 

5. Earnings per Share from Continuing Operations

The Company has unvested share-based payment awards with a right to receive non-forfeitable dividends, which are considered participating securities. The Company allocates earnings to participating securities and computed earnings per share using the two-class method as follows:
Three Months Ended
March 29, 2024March 31, 2023
(In thousands, except share and per share data)
Computation of earnings per share from continuing operations – basic:
Income from continuing operations attributable to ESAB Corporation(1)
$61,260 $32,816 
Less: distributed and undistributed earnings allocated to nonvested shares(365)(237)
Income from continuing operations attributable to common stockholders$60,895 $32,579 
Weighted-average shares of Common stock outstanding – basic60,346,121 60,146,348 
Income per share from continuing operations – basic$1.01 $0.54 
Computation of earnings per share from continuing operations – diluted:
Income from continuing operations attributable to common stockholders$60,895 $32,579 
Weighted-average shares of Common stock outstanding – basic60,346,121 60,146,348 
Net effect of potentially dilutive securities(2)
641,836 339,878 
Weighted-average shares of Common stock outstanding – dilution60,987,957 60,486,226 
Net income per share from continuing operations – diluted$1.00 $0.54 
(1) Net income from continuing operations attributable to ESAB Corporation for the respective periods is calculated using Net income from continuing operations, less Income attributable to noncontrolling interest, net of taxes, of $1.6 million for the three months ended March 29, 2024 and $1.3 million for the three months ended March 31, 2023.
(2) Potentially dilutive securities include stock options, performance-based restricted stock units and non-performance-based restricted stock units.

6. Income Taxes

During the three months ended March 29, 2024, Income from continuing operations before income taxes was $81.4 million, while Income tax expense was $18.5 million. The effective tax rate was 22.7% for the three months ended March 29, 2024. The effective tax rate differed from the 2024 U.S. federal statutory rate of 21.0% primarily due to withholding taxes.

During the three months ended March 31, 2023, Income from continuing operations before income taxes was $71.2 million, while Income tax expense was $37.0 million. The effective tax rate was 52.0% for the three months ended March 31, 2023. The effective tax rate differed from the 2023 U.S. federal statutory rate of 21.0% primarily due to discrete tax expenses in 2023 for dividend withholding taxes and an increase in the liability for uncertain tax positions as discussed below, that do not recur in 2024.

9
ESAB CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

During the three months ended March 31, 2023, the Company changed its indefinite reinvestment assertion on certain undistributed earnings of the Company’s foreign subsidiaries, resulting in a total tax expense of $10.9 million, as of March 31, 2023 on such earnings that have not been indefinitely reinvested.

The Company records a liability for certain unrecognized income tax benefits for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority (“uncertain tax positions”). During the three months ended March 31, 2023, due to an adverse court ruling in a tax case in a foreign jurisdiction, the Company increased the related liability for uncertain tax positions by $9.4 million partially offset by changes in other positions.

7. Inventories, Net

Inventories, net consisted of the following:
March 29, 2024
December 31, 2023
(In thousands)
Raw materials$153,072 $156,583 
Work in process48,627 43,561 
Finished goods253,643 244,580 
455,342 444,724 
LIFO reserve(4,980)(4,279)
Allowance for excess, slow-moving and obsolete inventory(44,761)(47,587)
$405,601 $392,858 

At March 29, 2024 and December 31, 2023, 26.0% and 27.4% of total inventories, respectively, were valued using the LIFO method.

8. Accrued and Other Liabilities

Accrued and Other liabilities in the Consolidated and Condensed Balance Sheets consisted of the following:
March 29, 2024December 31, 2023
CurrentNoncurrentCurrentNoncurrent
(In thousands)
Accrued taxes and deferred tax liabilities$44,727 $144,214 $45,681 $144,662 
Compensation and related benefits75,906 50,750 97,052 52,589 
Asbestos liability34,111 223,829 32,908 234,796 
Contract liabilities29,548 — 31,248 — 
Lease liabilities22,936 73,995 22,794 76,609 
Warranty liability12,936 — 12,606 — 
Third-party commissions11,224 — 18,711 — 
Restructuring liability4,045 256 5,345 354 
Other57,470 27,967 47,144 33,823 
$292,903 $521,011 $313,489 $542,833 

10
ESAB CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

Accrued Warranty Liability
A summary of the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated and Condensed Balance Sheets is as follows:
Three Months Ended
March 29, 2024March 31, 2023
(In thousands)
Warranty liability, beginning of period$12,606 $12,946 
Accrued warranty expense2,457 1,393 
Changes in estimates related to pre-existing warranties727 672 
Cost of warranty service work performed(2,647)(2,678)
Foreign exchange translation effect(207)964 
Warranty liability, end of period$12,936 $13,297 

Accrued Restructuring Liability

The Company’s restructuring programs include a series of actions to reduce the structural costs of the Company. A summary of the activity in the Company’s restructuring liability included in Accrued and Other liabilities in the Consolidated and Condensed Balance Sheets is as follows:
Three Months Ended March 29, 2024
Balance at Beginning of PeriodChargesPaymentsForeign Currency TranslationBalance at End of Period
(In thousands)
Restructuring and other related charges:
Termination benefits(1)
$4,595 $1,320 $(1,507)$(352)$4,056 
Facility closure costs and other(2)
1,104604 (1,404)(59)245 
Total$5,699 $1,924 $(2,911)$(411)$4,301 
(1) Includes severance and other termination benefits, including outplacement services.
(2) Includes the cost of relocating associates, relocating equipment, lease termination expense and other costs in connection with the closure and optimization of facilities and product lines.

9. Benefit Plans

The Company sponsors various defined benefit plans and other post-retirement benefits plans, including health and life insurance, for certain eligible employees or former employees.

During the three months ended March 29, 2024, the Company recognized a non-cash pension settlement loss of $12.2 million related to the transfer of plan assets to a third party as part of externalizing the risk associated with a foreign defined benefit plan. This amount is reflected in Pension settlement loss in the Consolidated and Condensed Statements of Operations.

10. Debt

Long-term debt consisted of the following:
March 29, 2024December 31, 2023
(In thousands)
Term loans$981,250 $987,500 
Revolving credit facilities12,000 32,000 
Total debt993,250 1,019,500 
Unamortized deferred financing fees(452)(1,443)
Long-term debt$992,798 $1,018,057 
11
ESAB CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

Term Loans and Revolving Credit Facility

On April 4, 2022, the Company entered into a credit agreement (as amended and restated from time-to-time, the “Credit Agreement”) in connection with the Separation. The Credit Agreement initially consisted of the following facilities:

•A $750 million revolving credit facility (the “Revolving Facility”) with a maturity date of April 4, 2027;

•A Term A-1 loan with an initial aggregate principal amount of $400 million (the “Term Loan A-1 Facility”), with a maturity date of April 4, 2027; and

•A $600 million 364-day senior term loan facility (the “Term Loan A-2 Facility”) with a maturity date of April 3, 2023.

The Revolving Facility contains a $300 million foreign currency sublimit and a $50 million swing line loan sub-facility.

On April 4, 2022, the Company drew down $1.2 billion available under the credit facilities consisting of (i) $200 million under the Revolving Facility, (ii) $400 million under the Term Loan A-1 Facility and (iii) $600 million under the Term Loan A-2 Facility. The Company used these proceeds to make payments to Enovis of $1.2 billion, which was used as part of the consideration for the contribution of certain assets and liabilities to the Company by Enovis in connection with the Separation.

On June 28, 2022, the Company amended and restated the Credit Agreement by entering into Amendment No. 2 to Credit Agreement (“Credit Agreement Amendment”). The Credit Agreement Amendment provides for a $600 million term loan facility (the “Term Loan A-3 Facility” and, together with the Term Loan A-1 Facility, the “Term Facilities”, and together with the Revolving Facility, the “Facilities”) with a maturity date of April 3, 2025 to refinance the Company’s existing Term Loan A-2 Facility. Also on June 28, 2022, the Company borrowed the entire $600 million under Term Loan A-3 Facility to fund the repayment of the Term Loan A-2 Facility.

As March 29, 2024, the Credit Agreement consisted of the following facilities:

•A $750 million revolving credit facility (the “Revolving Facility”) with a maturity date of April 4, 2027, of which $12 million was drawn;

•A Term A-1 loan with an aggregate principal amount of $393 million (the “Term Loan A-1 Facility”) with a maturity date of April 4, 2027; and

• A Term A-3 loan with an aggregate principal amount of $589 million (the “Term Loan A-3 Facility”) with a maturity date of April 3, 2025. Refer to Note 16, “Subsequent Events” for further information.

The draw-down and repayment related to these term facilities are presented net within the Consolidated and Condensed Statements of Cash Flows.

The Credit Agreement contains customary covenants limiting the ability of the Company and its subsidiaries to, among other things, incur debt or liens, merge or consolidate with others, dispose of assets, make investments or pay dividends. In addition, the Credit Agreement contains financial covenants requiring the Company to maintain (i) a maximum total leverage ratio of not more than 4.00:1.00, with step-downs to, commencing with the fiscal quarter ending June 30, 2023, 3.75:1.00, and commencing with the fiscal quarter ending June 30, 2024, 3.50:1.00, and (ii) a minimum interest coverage ratio of 3.00:1.00. The Credit Agreement contains various events of default (including failure to comply with the covenants under the Credit Agreement and related agreements) and upon an event of default the lenders may, subject to various customary cure rights, require the immediate payment of all amounts outstanding under the Term Facilities and the Revolving Facility. Certain United States subsidiaries of the Company have agreed to guarantee the obligations of the Company under the Credit Agreement.

Loans made under the Term Facilities will bear interest, at the election of the Company, at either the base rate (as defined in the Credit Agreement) or at the term Secured Overnight Financing Rate (“SOFR”) rate plus an adjustment (as defined in the Credit Agreement), in each case, plus the applicable interest rate margin. Loans made under the Revolving Facility will bear interest, at the election of the Company, at either the base rate or, (i) in the case of loans denominated in dollars, the term SOFR rate plus an adjustment or the daily simple SOFR plus an adjustment, (ii) in the case of loans denominated in euros, the adjusted Euro Interbank Offered Rate (“EURIBOR”) rate and, (iii) in the case of loans denominated in sterling, Sterling Overnight Index
12
ESAB CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

Average (“SONIA”) plus an adjustment (as all such rates are defined in the Credit Agreement Amendment), in each case, plus the applicable interest rate margin. The applicable interest rate margin changes based upon the Company’s total leverage ratio (consolidated total debt divided by EBITDA, as defined in the credit agreement and ranging from 1.125% to 1.750% or in the case of the base rate margin, 0.125% to 0.750%). Each swing line loan denominated in dollars will bear interest at the base rate plus the applicable interest rate margin.

To manage exposures to currency exchange rates and interest rates arising in Long-term debt, the Company entered into interest rate and cross currency swap agreements during the year ended December 31, 2022. Refer to Note 11, “Derivatives” for additional information.

As of March 29, 2024, the weighted-average interest rate of borrowings under the Credit Agreement was 5.09%, including the net impact from the interest rate and cross currency swaps and excluding accretion of deferred financing fees, and there was $738 million of borrowing capacity available under the Revolving Facility, subject to meeting financial covenants and other requirements.

Other Indebtedness

In addition to the debt agreements discussed above, the Company also has the ability to incur approximately $77 million of indebtedness pursuant to certain uncommitted credit lines, consisting of an uncommitted credit line that the Company has used from time to time in the past for short-term working capital needs.

The Company is party to letter of credit facilities with an aggregate capacity of $109.0 million. Total letters of credit of $28.3 million were outstanding as of March 29, 2024.

Deferred Financing Fees

The Company had total deferred financing fees of $1.3 million included in its Consolidated Balance Sheet as of March 29, 2024, which will be charged to Interest expense and other, net, using the straight-line method. The costs associated with the Term Facilities will be amortized over the contractual term of the Term Facilities and the costs associated with the Revolving Facility will be amortized over the life of the Credit Agreement. Of the $1.3 million, $0.8 million of deferred financing fees relating to the Revolving Facility are included in Other assets and $0.5 million of deferred financing fees relating to the Term Facilities are recorded as a contra-liability within Long-term debt.

11. Derivatives

The Company uses derivative instruments to manage exposures to currency exchange rates and interest rates arising in connection with Long-term debt and the normal course of business. The Company has established policies and procedures that govern the risk management of these exposures. Both at inception and on an ongoing basis, the derivative instruments that qualify for hedge accounting are assessed as to their effectiveness, when applicable.

The Company is subject to the credit risk of counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. None of the concentrations of risk with an individual counterparty was considered significant as of March 29, 2024. The Company does not expect any counterparties to fail to meet their obligations. The Company records derivatives in the Consolidated and Condensed Balance Sheets at fair value.

Cash Flow Hedges

On July 14, 2022, the Company entered into two interest rate swap agreements to manage interest rate risk exposure. The aggregate notional amount of these contracts is $600 million and they mature in April 2025. These interest rate swap agreements utilized by the Company effectively modify the Company’s exposure to interest rate risk by converting a portion of the Company’s floating-rate debt to a fixed rate of 3.293%, plus a spread, thus reducing the impact of interest-rate changes on future interest expense. The applicable spread may vary between 1.125% to 1.750%, depending on the total leverage ratio of the Company.

In March 2024, the Company received $5.5 million to settle one of the interest rate swaps associated with the Company’s floating-rate debt. The termination of the interest rate swap related to the anticipated repayment of the Term A-3 Facility when
13
ESAB CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

completed in April with the proceeds of the April 2024 $700 million Senior Note Offering. Refer to Note 16, “Subsequent Events” for further information. As this interest rate swap was designated as a cash flow hedge, $5.5 million was deferred in accumulated other comprehensive income (loss) (“AOCI”) and will be recognized in earnings over the period the originally forecasted hedged transaction impacts earnings. The remaining $300 million swap will continue to be hedged against the remaining floating-rate debt.

For the remaining swap, the spread was 1.250% as of March 29, 2024. This agreement involves the receipt of floating-rate amounts in exchange for fixed-rate interest payments over the life of the agreement without an exchange of the underlying principal amount. This interest rate swap agreement is designated and qualifies as a cash flow hedge and as such, the gain or loss on the derivative instrument due to the change in fair value is reported as a component of AOCI and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is deemed to be ineffective, the change in fair value of the derivative is recognized directly in earnings. The Company did not have any ineffectiveness related to the cash flow hedges during the three months ended March 29, 2024.

The cash inflows and outflows associated with the Company’s interest rate swap agreement designated as cash flow hedges are classified in cash flows from operating activities in the accompanying Consolidated and Condensed Statements of Cash Flows.

The Company expects a gain of $4.0 million, net of tax, related to interest rate swap agreements to be reclassified from AOCI to earnings over the next 12 months as the hedged transactions are realized. The expected gain to be reclassified is based on current forward rates in active markets as of March 29, 2024.

The effects of designated cash flow hedges on the Company’s Consolidated and Condensed Statements of Operations consisted of the following:
Three Months Ended
Derivative type(Gain) recognized in the Consolidated and Condensed Statements of Operations:March 29, 2024March 31, 2023
(In thousands)
Interest rate swap agreementsInterest expense and other, net$(2,722)$(1,977)

Net Investment Hedges

On July 22, 2022, the Company entered into two cross-currency swap agreements to partially hedge its net investment in its Euro-denominated subsidiaries against adverse movements in exchange rates between the U.S. Dollar and the Euro. In addition, the cross-currency swap agreements include provisions to exchange fixed-rate payments in U.S. Dollar for fixed-rate payments in Euro and are designated and qualify as a net investment hedge. These contracts have a Euro aggregate notional amount of approximately €270 million and a U.S. Dollar aggregate notional amount of $275 million at March 29, 2024, and they mature in April 2025.

The changes in the spot rate of these instruments are recorded in AOCI in equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCI. The Company uses the spot method of assessing hedge effectiveness and as such, the initial value of the hedge components excluded from the assessment of effectiveness is recognized in the Interest expense and other, net line item in the Consolidated and Condensed Statement of Operations under a systematic and rational method over the life of the cross-currency swap agreements. Any ineffective portions of net investment hedges are reclassified from AOCI into earnings during the period of change. The Company did not have any ineffectiveness related to net investment hedges during the three months ended March 29, 2024.

The cash inflows and outflows associated with the excluded components of the Company’s cross-currency swap agreements designated as net investment hedges are classified in operating activities in the accompanying Consolidated and Condensed Statements of Cash Flows.





14
ESAB CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

The effects of the excluded components of designated net investment hedges on the Company’s Consolidated and Condensed Statements of Operations consisted of the following:
Three Months Ended
Derivative type(Gain) recognized in the Consolidated and Condensed Statements of Operations:March 29, 2024March 31, 2023
(In thousands)
Cross currency swap agreementsInterest expense and other, net$(1,179)$(1,201)

The table below shows the fair value of the derivatives recognized in the Consolidated Balance Sheet:
March 29, 2024December 31, 2023
Designated as hedging instrumentsOther LiabilitiesOther AssetsOther LiabilitiesOther Assets
(In thousands)
Cross currency swap agreements$15,783 $— $22,232 $— 
Interest rate swap agreements— 5,174 — 9,522 
Total $15,783 $5,174 $22,232 $9,522 

Derivatives Not Designated as Hedging Instruments

The Company has certain foreign currency contracts that are not designated as hedges. As of March 29, 2024 and December 31, 2023, the Company had foreign currency contracts related to purchases and sales with notional values of $267.2 million and $232.5 million, respectively.

The table below shows the fair value of derivative instruments not designated in a hedging relationship recognized in the Consolidated Balance Sheet:
March 29, 2024December 31, 2023
Not designated as hedging instrumentsAccrued LiabilitiesOther Current AssetsAccrued LiabilitiesOther Current Assets
(In thousands)
Foreign currency contracts$431 $874 $596 $1,088 

The amounts in the table above as of March 29, 2024 reflect the fair value of the Company’s foreign currency contracts on a net basis where allowable under master netting agreements. Had these amounts been recognized on a gross basis, the impact would have been a $0.6 million increase in Other current assets with a corresponding increase in Accrued liabilities.

The Company recognized the following in its Consolidated and Condensed Financial Statements related to its derivative instruments not designated in a hedging relationship:
Three Months Ended
Foreign currency contractsMarch 29, 2024March 31, 2023
(In thousands)
Change in unrealized gains (losses)$(49)$143 
Realized gains (losses)(394)1,027 

The above gains or losses on foreign currency contracts are usually offset by foreign exchange exposure on cash and intercompany positions, all of which are recognized in Interest expense and other, net, in the Consolidated and Condensed Statements of Operations.

12. Fair Value Measurements

The carrying values of financial instruments, including Trade receivables and Accounts payable, approximate their fair values due to their short-term maturities. The estimated fair values may not represent actual values of the financial instruments that could be realized as of the balance sheet date or that will be realized in the future.

15
ESAB CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS — (Continued)
(Unaudited)
A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is as follows:
March 29, 2024
Level
One		Level
Two		Level
Three		Total
(In thousands)
Assets:
Cash equivalents$2,968 $— $— $2,968 
Foreign currency contracts - not designated as hedges— 1,457 — 1,457 
Interest rate swap agreements— 5,174 — 5,174 
Deferred compensation plans— 4,281 — 4,281 
$2,968 $10,912 $— $13,880 
Liabilities:
Foreign currency contracts - not designated as hedges$— $1,014 $— $1,014 
Cross currency swap agreements— 15,783 — 15,783 
Deferred compensation plans— 4,281 — 4,281 
$— $21,078 $— $21,078 

December 31, 2023
Level
One		Level
Two		Level
Three		Total
(In thousands)
Assets:
Cash equivalents$6,027 $— $— $6,027 
Foreign currency contracts - not designated as hedges— 2,261 — 2,261 
Interest rate swap agreements— 9,522 — 9,522 
Deferred compensation plans— 3,488 — 3,488 
$6,027 $15,271 $— $21,298 
Liabilities:
Foreign currency contracts - not designated as hedges$— $1,769 $— $1,769 
Cross currency swap agreements — 22,232 — 22,232 
Deferred compensation plans— 3,488 — 3,488 
$— $27,489 $— $27,489 

The Company measures the fair value of foreign currency contracts, cross currency swap agreements and interest rate swap agreements using Level Two inputs based on observable spot and forward rates in active markets. Additionally, the fair value of derivatives designated in hedging relationships includes a credit valuation adjustment to appropriately incorporate nonperformance risk for the Company and the respective counterparty. For the three months ended March 29, 2024, the impact of the credit valuation adjustment on the Company’s derivatives is immaterial. Refer to Note 11, “Derivatives” for additional information.

There were no transfers in or out of Level One, Two or Three during the three months ended March 29, 2024.
16
ESAB CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS — (Continued)
(Unaudited)
13. Equity

Accumulated Other Comprehensive Loss

The following tables present the changes in the balances of each component of AOCI including reclassifications out of AOCI for the three months ended March 29, 2024 and March 31, 2023. All amounts are net of tax and noncontrolling interest, if any.
Accumulated Other Comprehensive Loss Components
Net Unrecognized Pension and Other Post-Retirement Benefit CostForeign Currency Translation AdjustmentNet Investment HedgesCash Flow HedgesTotal
(In thousands)
Balance at December 31, 2023
$(59,805)$(554,622)$(17,215)$7,370 $(624,272)
Other comprehensive income (loss) before reclassifications:
Foreign currency translation adjustment243 (38,265)4,995 — (33,027)
Gain on long-term intra-entity foreign currency transactions— 7,996 — — 7,996 
Unrealized loss on cash flow hedges— — — 3,920 3,920 
Other comprehensive income (loss) before reclassifications243 (30,269)4,995 3,920 (21,111)
Amounts reclassified from Accumulated other comprehensive loss(1)(2)
629 — — (2,907)(2,278)
Net current period Other comprehensive income (loss)872 (30,269)4,995 1,013 (23,389)
Balance at March 29, 2024
$(58,933)$(584,891)$(12,220)$8,383 $(647,661)
(1) The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost.
(2) During the three months ended March 29, 2024, the amount within Cash Flow Hedges is a component of Interest expense and other, net. See Note 11, “Derivatives” for additional details.
Accumulated Other Comprehensive Loss Components
Net Unrecognized Pension and Other Post-Retirement Benefit CostForeign Currency Translation AdjustmentNet Investment HedgesCash Flow HedgesTotal
(In thousands)
Balance at December 31, 2022
$(63,847)$(613,907)$(8,336)$11,102 $(674,988)
Other comprehensive income (loss) before reclassifications:
Net actuarial loss(2)— — — (2)
Foreign currency translation adjustment(108)31,276 (2,086)— 29,082 
Gain on long-term intra-entity foreign currency transactions— 12,501 — — 12,501 
Unrealized loss on cash flow hedges— — — (2,051)(2,051)
Other comprehensive (loss) income before reclassifications(110)43,777 (2,086)(2,051)39,530 
Amounts reclassified from Accumulated other comprehensive loss(1)(2)
279 — — (1,530)(1,251)
Net current period Other comprehensive (loss) income169 43,777 (2,086)(3,581)38,279 
Balance at March 31, 2023
$(63,678)$(570,130)$(10,422)$7,521 $(636,709)
(1) The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost.
(2) During the three months ended March 31, 2023, the amount within Cash Flow Hedges is a component of Interest expense and other, net. See Note 11, “Derivatives” for additional details.
17
ESAB CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS — (Continued)
(Unaudited)
14. Commitments and Contingencies

Asbestos Contingencies

Certain entities that became subsidiaries of ESAB Corporation in connection with the Separation are the legal obligor, or owner, for certain asbestos obligations including long-term asbestos insurance assets, long-term asbestos insurance receivables, accrued asbestos liabilities, long-term asbestos liabilities, asbestos indemnity expenses, asbestos-related defense costs and asbestos insurance recoveries related to the asbestos obligations from the Former Parent’s other legacy industrial businesses. As a result, the Company holds certain asbestos-related contingencies and insurance coverages.

These subsidiaries are each one of many defendants in a large number of lawsuits that claim personal injury as a result of exposure to asbestos from products manufactured or used with components that are alleged to have contained asbestos. Such components were acquired from third-party suppliers, and were not manufactured by any of the Company’s, or Former Parent’s, subsidiaries, nor were the subsidiaries, producers or direct suppliers of asbestos. The manufactured products that are alleged to have contained or used asbestos generally were provided to meet the specifications of the subsidiaries’ customers, including the U.S. Navy. The subsidiaries settle asbestos claims for amounts the Company considers reasonable given the facts and circumstances of each claim. The annual average settlement payment per asbestos claimant has fluctuated during the past several years while the number of cases has steadily declined. The Company expects such settlement value fluctuations to continue in the future based upon, among other things, the number and type of claims settled in a particular period and the jurisdictions in which such claims arise. To date, the majority of settled claims have been dismissed for no payment to plaintiffs.

The Company has classified asbestos-related activity in Loss from discontinued operations, net of taxes in the Consolidated and Condensed Statements of Operations. This is consistent with the Former Parent’s classification on the basis that, pursuant to the purchase agreement from the Former Parent’s Fluid Handling business divestiture, the Former Parent retained its asbestos-related contingencies and insurance coverages. However, as the Former Parent did not retain an interest in the ongoing operations of the business subject to the contingencies, asbestos-related activity was classified as part of Loss from discontinued operations, net of taxes in the Condensed Consolidated Statements of Operations of the Former Parent.

The Company has projected each subsidiary’s future asbestos-related liability costs with regard to pending and future unasserted claims based upon the Nicholson methodology. The Nicholson methodology is a standard approach used by experts and has been accepted by numerous courts. Consistent with the Former Parent, it is ESAB’s policy to record a liability for asbestos-related liability costs for the longest period of time that ESAB management can reasonably estimate.

The Company believes that it can reasonably estimate the asbestos-related liability for pending and future claims that will be resolved in the next 15 years and has recorded that liability as its best estimate. While it is reasonably possible that the subsidiaries will incur costs after this period, the Company does not believe the reasonably possible loss or a range of reasonably possible losses is estimable at the current time. Accordingly, no accrual has been recorded for any costs that may be paid after the next 15 years. Defense costs associated with asbestos-related liabilities as well as costs incurred related to efforts to recover insurance from the subsidiaries’ insurers are expensed as incurred.

Each subsidiary has separate insurance coverage acquired prior to Company ownership. The Company estimates the insurance assets for each subsidiary based upon the applicable policy language, expected recoveries and allocation methodologies, and law pertaining to the affected subsidiary’s insurance policies.

18
ESAB CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS — (Continued)
(Unaudited)
Asbestos-related claims activity since December 31 is as follows:
Three Months Ended
March 29, 2024March 31, 2023
(Number of claims)
Claims unresolved, beginning of period13,648 14,106 
Claims filed(1)
1,297 986 
Claims resolved(2)
(714)(749)
Claims unresolved, end of period14,231 14,343 
(1) Claims filed include all asbestos claims for which notification have been received or a file has been opened.
(2) Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants.

The Company’s Consolidated Balance Sheet included the following amounts related to asbestos-related litigation:
March 29, 2024December 31, 2023
(In thousands)
Long-term asbestos insurance asset(1)
$213,323 $221,489 
Long-term asbestos insurance receivable(1)
18,306 17,868 
Accrued asbestos liability(2)
34,111 32,908 
Long-term asbestos liability(3)
223,829 234,796 
(1) Included in Other assets in the Consolidated Balance Sheets.
(2) Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay, and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Consolidated Balance Sheets.
(3) Included in Other liabilities in the Consolidated Balance Sheets.

Management’s analyses are based on currently known facts and assumptions. Projecting future events, such as new claims to be filed each year, the average cost of resolving each claim, coverage issues among layers of insurers, the method in which losses will be allocated to the various insurance policies, interpretation of the effect on coverage of various policy terms and limits and their interrelationships, the continuing solvency of various insurance companies, the amount of remaining insurance available, as well as the numerous uncertainties inherent in asbestos litigation could cause the actual liabilities and insurance recoveries to be higher or lower than those projected or recorded that could materially affect the Company’s financial condition, results of operations or cash flow.

General Litigation

The Company is involved in various pending legal proceedings arising out of the ordinary course of the Company’s business. None of these legal proceedings is expected to have a material adverse effect on the financial condition, results of operations or cash flow of the Company. With respect to these proceedings, and the litigation and claims described in the preceding paragraphs, management of the Company believes that it will either prevail, has adequate insurance coverage or has established appropriate accruals to cover potential liabilities. Legal costs related to proceedings or claims are recorded when incurred. Other costs that management estimates may be paid related to the claims are accrued when the liability is considered probable and the amount can be reasonably estimated. There can be no assurance, however, as to the ultimate outcome of any of these matters, and if all or substantially all of these legal proceedings were to be determined adverse to the Company, there could be a material adverse effect on the financial condition, results of operations or cash flow of the Company.

15. Segment Information

ESAB is a focused premier industrial compounder. ESAB provides its partners with fabrication technology, advanced equipment, consumables, gas control equipment, welding robotics and digital solutions.

The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America, and “EMEA & APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific.
19
ESAB CORPORATION
NOTES TO CONSOLIDATED AND CONDENSED FINANCIAL STATEMENTS — (Continued)
(Unaudited)
The Company’s management evaluates the operating results of each of its reportable segments based upon Net sales and Adjusted EBITDA, which represents Net income from continuing operations excluding the impact of Income tax expense, Interest expense and other, net, Pension settlement (loss), Restructuring and other related charges, acquisition - amortization and other related charges and depreciation and other amortization.

The Company’s segment results were as follows:
Three Months Ended
March 29, 2024March 31, 2023
(In thousands)
Net sales:
Americas$296,047 $291,569 
EMEA & APAC393,697 392,431 
$689,744 $684,000 
Adjusted EBITDA(1):
Americas$54,098 $49,442 
EMEA & APAC75,039 68,547 
$129,137 $117,989 
(1) The following is a reconciliation of Net income from continuing operations to Adjusted EBITDA.
Three Months Ended
March 29, 2024March 31, 2023
(In thousands)
Net income from continuing operations$62,903 $34,129 
Income tax expense 18,504 37,024 
Interest expense and other, net(1)
17,091 19,510 
Pension settlement loss12,155 — 
Restructuring and other related charges1,924 9,444 
Acquisition - amortization and other related charges(2)
7,777 9,289 
Depreciation and other amortization8,783 8,593 
Adjusted EBITDA$129,137 $117,989 
(1) Relates to removal of interest expense, net included within the Interest expense and other, net line within the Consolidated and Condensed Statements of Operations.
(2) Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.

16. Subsequent Events

On April 9, 2024, the Company completed a $700.0 million Senior Note Offering (“the Offering”). The Offering has a contractual interest rate of 6.25% and expected maturity date of April 15, 2029. The Company used the net proceeds from the Offering to repay $588.8 million of borrowings under its Term Loan A-3 Facility and pay fees associated with the Offering. The Company intends to use the remaining proceeds received to repay borrowings under its Revolving Facility and other general corporate purposes. The Offering did not have any material changes to the required financial covenants for the Company.

The dividend of $3.6 million included in Accrued liabilities in the Consolidated Balance Sheet at March 29, 2024 was paid on April 12, 2024 to stockholders of record as of March 29, 2024.

On April 30, 2024, the Company reached an agreement to acquire SUMIG Soluções para Solda e Corte Ltda, a South American light automation and equipment business for approximately $74 million of cash consideration. This acquisition is expected to be completed during the second half of 2024, subject to the receipt of applicable regulatory approvals and customary closing conditions.
20

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion of the financial condition and results of operations of ESAB Corporation (“ESAB,” the “Company,” “we,” “our” and “us”) should be read in conjunction with the Consolidated and Condensed Financial Statements and related footnotes included in Part I. Item 1. “Financial Statements” of this Quarterly Report on Form 10-Q for the quarterly period ended March 29, 2024 (this “Form 10-Q”) and the Consolidated and Financial Statements and related footnotes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “2023 Form 10-K”). You should review the discussion titled “Special Note Regarding Forward-Looking Statements” for a discussion of forward-looking statements. Our actual results could differ materially from those discussed in the forward looking statements.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

Some of the statements contained in this Form 10-Q that are not historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Exchange Act. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date this Form 10-Q is filed with the SEC. All statements other than statements of historical fact are statements that could be deemed to be forward-looking statements, including statements regarding: the impact of the war in Ukraine and the resulting escalating geopolitical tensions on our business; projections of revenue, profit margins, expenses, tax provisions and tax rates, earnings or losses from operations, impact of foreign exchange rates, cash flows, pension and benefit obligations and funding requirements, synergies or other financial items; plans, strategies and objectives of our management for future operations, including statements relating to potential acquisitions, compensation plans or purchase commitments; developments, performance or industry or market rankings relating to products or services; future economic conditions or performance, including the impact of inflationary pressures; the outcome of outstanding claims or legal proceedings, including asbestos-related liabilities and insurance coverage litigation; potential gains and recoveries of costs; assumptions underlying any of the foregoing; and any other statements that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. Forward-looking statements may be, but not always, characterized by terminology such as “believe,” “anticipate,” “should,” “would,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy,” “targets,” “aims,” “seeks,” “sees,” and similar expressions. These statements are based on assumptions and assessments made by our management as of the filing date of this Form 10-Q in light of their experience and perception of historical trends, current conditions, expected future developments and other factors we believe to be appropriate. These forward-looking statements are subject to a number of risks and uncertainties and actual results or outcomes could differ materially due to numerous factors, including but not limited to the following:

•the wars in Ukraine and the Middle East, escalating geopolitical tensions and the related impact on energy supplies and prices;

•changes in the general economy, including disruptions caused by geopolitical conflicts, as well as the cyclical nature of the markets we serve;

•supply chain constraints and backlogs, including risks affecting raw material, part and component availability, labor shortages and inefficiencies, freight and logistical challenges and inflation in raw material, part, component, freight and delivery costs and our ability to increase our prices to account for increased costs;

•volatility in the commodity markets and certain commodity prices, including oil and steel;

•our ability to identify, finance, acquire and successfully integrate attractive acquisition targets;

•our exposure to unanticipated liabilities resulting from acquisitions;

•significant movements in foreign currency exchange rates or inflation rates;

21

•the impact of natural or man-made disasters, adverse weather events or conditions, epidemics, pandemics and other global health events;

•our ability and the ability of our customers to access required capital at a reasonable cost;

•our ability to accurately estimate the cost of or realize savings from our restructuring programs;

•the amount of, and our ability to estimate and manage, our asbestos-related liabilities;

•the solvency of our insurers and the likelihood of their payment for asbestos-related costs;

•material disruptions at any of our manufacturing facilities;

•noncompliance with various laws and regulations associated with our international operations, including anti-bribery laws, export control regulations and sanctions and embargoes;

•risks associated with our international operations, including risks from trade protection measures and other changes in trade relations;

•risks associated with the representation of our employees by trade unions and works councils;

•our exposure to product liability claims;

•potential costs and liabilities associated with environmental, health and safety laws and regulations;

•failure to maintain, protect and defend our intellectual property rights;

•our ability to attract and retain our employees, including the loss of key members of our leadership team;

•restrictions in our financing arrangements that may limit our flexibility in operating our business;

•impairment in the value of intangible assets;

•the funding requirements or obligations of our defined benefit pension plans and other postretirement benefit plans;

•new regulations and customer preferences reflecting an increased focus on environmental, social and governance issues, including regulations related to climate change and the use of conflict minerals;

•service interruptions, data corruption, cyber-based attacks or network security breaches affecting our electronic information systems;

•risks arising from changes in technology;

•the competitive environment in our industries;

•changes in our tax rates, realizability of deferred tax assets, or exposure to additional income tax liabilities;

•our ability to manage and grow our business and execution of our business and growth strategies;

•the level of capital investment and expenditures by our customers in our strategic markets;

•our financial performance;

•difficulties and delays in integrating or fully realizing projected cost savings and benefits of our acquisitions; and

•other risks and factors set forth under Item 1A. “Risk Factors” in Part I in our 2023 Form 10-K.
22

See Part I. Item 1.A. “Risk Factors” in our 2023 Form 10-K and Part II. Item 1.A “Risk Factors” in this Form 10-Q for a further discussion regarding reasons that actual results and outcomes may differ materially from the results, developments and business decisions contemplated by our forward-looking statements. Forward-looking statements speak only as of the date of the report, document, press release, webcast, call materials or other communication in which they are made. We do not assume any obligation to update or revise any forward-looking statement, whether because of new information, future events and developments or otherwise.

Overview

Please see Part I. Item 1. “Business” in our 2023 Form 10-K, for a discussion of ESAB’s objectives and methodologies for delivering stockholder value.

General

We are a focused premier industrial compounder. Our rich history of innovative products, workflow solutions and our business system, ESAB Business Excellence (“EBX”), enables our purpose of Shaping the world we imagineTM.

We conduct our operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America, and “EMEA & APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific. We serve a global customer base across multiple markets through a combination of direct sales and third-party distribution channels. Our customer base is highly diversified in the industrial end markets.

Integral to our operations is EBX, our business management system. EBX is our culture and includes our values, a comprehensive set of tools, and repeatable, teachable processes that we use to drive continuous improvement and create superior value for our customers, stockholders and associates. We believe that our management team’s access to, and experience in, the application of the EBX methodology is one of our primary competitive strengths.

Outlook

We believe that we are well positioned to grow our businesses organically over the long term by enhancing our product offerings and expanding our customer base. We believe our business mix is well balanced between sales in emerging and developed markets, and equipment and consumables. We intend to continue to utilize our strong global presence and worldwide network of salespeople and distributors to capitalize on growth opportunities by selling regionally-developed and/or marketed products and solutions throughout our served markets. We believe our geographic and end market diversity helps mitigate the effects from cyclical industrial market exposures. Given this balance, management does not use indices other than general economic trends and business initiatives to predict the overall outlook for the Company. Instead, our individual businesses monitor key competitors and customers, including to the extent possible their sales, to gauge relative performance and outlook for the future.

We expect strategic acquisitions to contribute to our growth. We believe that the extensive experience of our leadership team in acquiring and effectively integrating acquisition targets should enable us to capitalize on future opportunities. We believe that the recent acquisitions of Sager S.A. on February 26, 2024 and Therapy Equipment Limited (“Therapy Equipment”) on January 11, 2023 are aligned with this strategic direction. Refer to Note 3, “Acquisitions” in the accompanying Notes contained elsewhere in this Form 10-Q for additional information.

The discussion that follows includes a comparison of our results of operations and liquidity and capital resources for the three months ended March 29, 2024 and March 31, 2023.
23

Results of Operations

The following discussion of Results of Operations addresses the comparison of the periods presented. Our management evaluates the operating results of each of its reportable segments based upon Net sales, Adjusted EBITDA and Core adjusted EBITDA as defined in the “Non-GAAP Measures” section.

Items Affecting Comparability of Reported Results

The comparability of our operating results for the three months ended March 29, 2024 and March 31, 2023 is affected by the following additional significant items:

Russia and Ukraine conflict

The invasion of Ukraine by Russia and the sanctions and other actions taken by governments in response to this crisis have increased the level of economic and political uncertainty. Refer to Note 1, “Organization and Basis of Presentation” in the accompanying Notes contained elsewhere in this Form 10-Q as well as Part I. Item 1.A. “Risk Factors” section of the 2023 Form 10-K for additional information.

Acquisitions

We complement our organic growth with acquisitions and other investments. Acquisitions can significantly affect our reported results, and we report the change in our Net sales between periods both from existing and acquired businesses. The change in Net sales due to acquisitions for the periods presented in this filing represents the incremental sales as a result of acquisitions.

On February 26, 2024, the Company completed the acquisition of Sager S.A., a welding repair and maintenance product and service leader in South America. For additional information on this acquisition, refer to Note 3, “Acquisitions” in the accompanying Notes contained elsewhere in this Form 10-Q.

During the first quarter of 2023, we completed the acquisition of Therapy Equipment, a regional leader in oxygen regulators. For additional information on this acquisition, refer to Note 3, “Acquisitions” in the accompanying Notes contained elsewhere in this Form 10-Q.

Foreign Currency Fluctuations

A significant portion of our Net sales, 78%, for the three months ended March 29, 2024 are outside the United States, with the majority of those sales denominated in currencies other than the U.S. Dollar. Because much of our manufacturing and employee costs are outside the United States, a significant portion of our costs are also denominated in currencies other than the U.S. Dollar. Changes in foreign exchange rates can impact our results of operations and are quantified when significant.

For the three months ended March 29, 2024 compared to the three months ended March 31, 2023, fluctuations in foreign currencies reduced Net sales by 1.7% and Gross profit by 1.7% and increased Selling, general and administrative expenses by 0.1%.

Seasonality

Our European operations typically experience a slowdown during the July and August vacation seasons.










24

Non-GAAP Measures

Adjusted EBITDA is a non-GAAP performance measure that we include in this report because it is a key metric used by our management to assess our operating performance. ESAB presents this non-GAAP financial measure including and excluding Russia due to economic and political volatility caused by the Russia and Ukraine conflict, which we believe results in enhanced investor interest in these alternative presentations. Adjusted EBITDA excludes from Net income from continuing operations the effect of Income tax expense, Interest expense and other, net, Pension settlement (loss), Restructuring and other related charges, acquisition-amortization and other related charges and depreciation and other amortization. We also present Adjusted EBITDA margin, which is subject to the same adjustments as Adjusted EBITDA. Further, we present these non-GAAP performance measures on a segment basis, where we exclude the impact of Restructuring and other related charges, acquisition-amortization and other related charges and depreciation and other amortization from operating income. We also present Core adjusted EBITDA and Core adjusted EBITDA margins, which are subject to the same adjustments as Adjusted EBITDA and Adjusted EBITDA margins, respectively, and which removes the impact of Russia for three months ended March 29, 2024 and March 31, 2023. Adjusted EBITDA and Core adjusted EBITDA assist management in comparing our operating performance over time because certain items may obscure underlying business trends and make comparisons of long-term performance difficult, as they are of a nature and/or size that occur with inconsistent frequency or relate to unusual events or discrete restructuring plans and other initiatives that are fundamentally different from our ongoing productivity and core business. Management also believes that presenting these measures allows investors to view our performance using the same measures that we use in evaluating our financial and business performance and trends.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with U.S. GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable U.S. GAAP financial measures.

The following tables set forth a reconciliation of Net income from continuing operations, the most directly comparable GAAP financial measure, to Adjusted EBITDA, Adjusted EBITDA margin, Core adjusted EBITDA and Core adjusted EBITDA margin by segment for the three months ended March 29, 2024 and March 31, 2023.

Three Months Ended March 29, 2024
AmericasEMEA & APACTotal
(Dollars in millions)(1)
Net income from continuing operations (GAAP)$62.9 
Income tax expense18.5 
Interest expense and other, net17.1 
Pension settlement loss12.2 
Operating income (GAAP)46.0 64.7 110.7 
Adjusted to add:
Restructuring and other related charges(2)
0.2 1.7 1.9 
Acquisition-amortization and other related charges(3)
4.4 3.3 7.7 
Depreciation and other amortization3.5 5.3 8.8 
Adjusted EBITDA (non-GAAP)$54.1 $75.0 $129.1 
Adjusted EBITDA attributable to Russia (non-GAAP)(4)
— 5.9 5.9 
Core adjusted EBITDA (non-GAAP)$54.1 $69.1 $123.2 
Adjusted EBITDA margin (non-GAAP)18.3 %19.1 %18.7 %
Core adjusted EBITDA margin (non-GAAP)(5)
18.3 %19.2 %18.8 %
(1) Numbers may not sum due to rounding.
(2) Includes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expenses, impairment of long-lived assets and other costs in connection with the closure and optimization of facilities and product lines.
25

(3) Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.
(4) Numbers calculated following the same definition as Adjusted EBITDA for total Company.
(5) Net sales were $33.6 million relating to Russia for the three months ended March 29, 2024.

Three Months Ended March 31, 2023
AmericasEMEA & APACTotal
(Dollars in millions)(1)
Net income from continuing operations (GAAP)$34.1 
Income tax expense37.0 
Interest expense and other, net19.5 
Operating income (GAAP)39.9 50.8 90.7 
Adjusted to add:
Restructuring and other related charges(2)
0.9 8.5 9.4 
Acquisition-amortization and other related charges(3)
5.3 4.0 9.3 
Depreciation and other amortization3.3 5.3 8.6 
Adjusted EBITDA (non-GAAP)$49.4 $68.5 $118.0 
Adjusted EBITDA attributable to Russia (non-GAAP)(4)
— 5.3 5.3 
Core adjusted EBITDA (non-GAAP)$49.4 $63.2 $112.7 
Adjusted EBITDA margin (non-GAAP)17.0 %17.5 %17.2 %
Core adjusted EBITDA margin (non-GAAP)(5)
17.0 %17.8 %17.4 %
(1) Numbers may not sum due to rounding.
(2) Includes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expenses, impairment of long-lived assets and other costs in connection with the closure and optimization of facilities and product lines.
(3) Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.
(4) Numbers calculated following the same definition as Adjusted EBITDA for total Company.
(5) Net sales were $37.1 million relating to Russia for the three months ended March 31, 2023.

Total Company

Sales

Net sales increased for the three months ended March 29, 2024 as compared with the three months ended March 31, 2023. The following table presents the components of changes in our consolidated and condensed Net sales.
Three Months Ended
Net Sales Change %
(Dollars in millions)
For the three months ended March 31, 2023
$684.0 
Components of Change:
Existing businesses (organic sales growth)(1)
16.6 2.4 %
Acquisitions(2)
1.0 0.1 %
Foreign currency translation(3)
(11.9)(1.7)%
Total sales growth 5.7 0.8 %
For the three months ended March 29, 2024
$689.7 
(1) Excludes the impact of acquisitions and foreign exchange rate fluctuations, thus providing a measure of change due to organic growth factors such as price, product mix and volume.
(2) Represents the incremental sales in comparison to the portion of the prior period during which we did not own the business.
(3) Represents the difference between prior year sales valued at the actual prior year foreign exchange rates and prior year sales valued at current year foreign exchange rates.

26

Net sales from existing businesses increased $16.6 million during the three months ended March 29, 2024, compared to the prior year period, due to an increase in sales volumes of $8.2 million and customer pricing increases of $8.4 million. During the three months ended March 29, 2024, net sales from acquisitions were attributable to Therapy Equipment and Sager S.A. The strengthening of the U.S. Dollar relative to other currencies caused a $11.9 million unfavorable currency translation impact during the three months ended March 29, 2024.

Sales excluding Russia

Sales excluding Russia (“Core Sales”) increased for the three months ended March 29, 2024 as compared with the three months ended March 31, 2023. The following table presents the components of changes in our consolidated and condensed Net sales.
Three Months Ended
Core Sales(1)(5)
 Change %
(Dollars in millions)
For the three months ended March 31, 2023
$646.9 
Components of Change:
Existing businesses (core organic sales growth)(2)
13.0 2.0 %
Acquisitions(3)
1.0 0.2 %
Foreign currency translation(4)
(4.8)(0.7)%
Total core sales growth9.2 1.4 %
For the three months ended March 29, 2024
$656.1 
(1) Numbers may not sum due to rounding.
(2) Excludes the impact of acquisitions and foreign exchange rate fluctuations, thus providing a measure of change due to organic growth factors such as price, product mix and volume.
(3) Represents the incremental sales in comparison to the portion of the prior period during which we did not own the business.
(4) Represents the difference between prior year sales valued at the actual prior year foreign exchange rates and prior year sales valued at current year foreign exchange rates.
(5) Net sales relating to Russia were $33.6 million for the three months ended March 29, 2024, and $37.1 million for the three months ended March 31, 2023.

Core Sales from existing businesses for ESAB increased $13.0 million during the three months ended March 29, 2024, compared to the prior year period primarily due to customer pricing increases of $5.3 million and an increase in sales volume of $7.7 million during the three months ended March 29, 2024. During the three months ended March 29, 2024, net sales from acquisitions were attributed to Therapy Equipment and Sager S.A. The changes in foreign exchange rates caused a $4.8 million unfavorable currency translation impact during the three months ended March 29, 2024.


27

Operating Results
The following table summarizes our results for the comparable periods.
Three Months Ended
March 29, 2024March 31, 2023
(Dollars in millions)
Gross profit$255.0 $247.4 
Gross profit margin37.0 %36.2 %
Selling, general and administrative expense$142.5 $147.3 
Net income from continuing operations$62.9 $34.1 
Net income margin from continuing operations9.1 %5.0 %
Adjusted EBITDA (non-GAAP)$129.1 $118.0 
Adjusted EBITDA margin (non-GAAP)18.7 %17.2 %
Core adjusted EBITDA (non-GAAP)$123.2 $112.7 
Core adjusted EBITDA margin (non-GAAP)18.8 %17.4 %
Items excluded from Adjusted EBITDA:
Restructuring and other related charges(1)
$1.9 $9.4 
Acquisition-amortization and other related charges(2)
$7.7 $9.3 
Interest expense and other, net$17.1 $19.5 
Income tax expense$18.5 $37.0 
Pension settlement loss$12.2 $— 
Depreciation and other amortization$8.8 $8.6 
Items excluded from Core adjusted EBITDA:
Adjusted EBITDA attributable to Russia (non-GAAP)(3)
$5.9 $5.3 
(1) Includes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating
equipment, lease termination, impairment of long-lived assets and other costs in connection with the closure of and optimization of facilities and product lines.
(2) Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.
(3) Numbers calculated following the same definition as Adjusted EBITDA for total Company.

First Quarter of 2024 Compared to First Quarter of 2023

Gross profit increased $7.6 million in the first quarter of 2024, which resulted in the gross profit margin expanding 80 basis points to 37.0% compared with the prior year period. This increase was primarily attributable to benefits from price and product mix, partially offset by unfavorable currency translation.

Selling, general and administrative expense decreased $4.8 million in the first quarter of 2024, compared to the prior year period. This decrease is primarily driven by savings from restructuring initiatives.

The effective tax rate of 22.7% for the quarter ended March 29, 2024 differed from the effective tax rate of 52.0% for the same period ending March 31, 2023 due to discrete tax adjustments in 2023 for dividend withholding taxes and an increase in unrecognized tax benefits due to an adverse court ruling in a tax case in a foreign jurisdiction that do not recur in 2024.

Net income from continuing operations increased $28.8 million in the first quarter of 2024, compared with the prior year period primarily due to lower restructuring charges, interest expenses and other, net and tax expense partially off set by a pension settlement loss. Net income margin from continuing operations increased due to the items discussed above.

In the first quarter of 2024, Adjusted EBITDA increased $11.1 million and Adjusted EBITDA margin increased by 150 basis points compared to the same period in 2023 benefiting from higher Gross profit and lower Selling, general and administrative expense. Core adjusted EBITDA increased from $112.7 million to $123.2 million, and Core adjusted EBITDA margins expanded 140 basis points from 17.4% to 18.8%.


28

Business Segments

We formulate, develop, manufacture, and supply consumable products and equipment, including cutting, joining, and welding robotics, as well as gas control equipment. Our products are marketed under several brand names, most notably ESAB, providing a wide range of products with innovative technologies to solve challenges in virtually any industry. ESAB’s comprehensive range of welding consumables includes electrodes, cored and solid wires, and fluxes using a wide range of specialty and other materials, and cutting consumables including electrodes, nozzles, shields, and tips. ESAB’s equipment ranges from portable welding machines, gas control equipment and customized automated cutting and welding systems. ESAB also offers a range of software and digital solutions to help its customers increase their productivity, remotely monitor their welding operations, and digitize their documentation. Products are sold into a wide range of end markets, including general industry, infrastructure, renewable energy, medical and life sciences, transportation, construction and energy.

We report results in two reportable segments: Americas and EMEA & APAC.

Americas

The following table summarizes selected financial data for our Americas segment:
Three Months Ended
March 29, 2024March 31, 2023
(Dollars in millions)
Net sales$296.0 $291.6 
Gross profit$111.1 $105.7 
Gross profit margin37.5 %36.3 %
Selling, general and administrative expense$64.8 $64.9 
Adjusted EBITDA (non-GAAP)$54.1 $49.4 
Adjusted EBITDA margin (non-GAAP)18.3 %17.0 %
Items excluded from Adjusted EBITDA:
Restructuring and other related charges$0.2 $0.9 
Acquisition- amortization and other related charges$4.4 $5.3 
Depreciation and other amortization$3.5 $3.3 

First Quarter of 2024 Compared to First Quarter of 2023

Net sales in our Americas segment increased $4.4 million in the first quarter of 2024, compared with the prior year period. Net sales from existing business increased $8.9 million partially offset by $5.3 million in unfavorable currency translation. The increase in Net sales from existing business was mainly due to pricing increases partially offset by a decrease in sales volumes due to fewer trading days from adverse weather in January in North America and the timing of Easter holidays versus the prior year. The acquisition of Sager S.A. contributed to $0.9 million of the overall sales increase. Gross profit increased $5.4 million due to price increases, partially offset by inflation-related cost increases and an unfavorable currency impact. Gross profit margin expanded 120 basis points to 37.5%, due to price increases, partially offset by inflation. Adjusted EBITDA increased $4.7 million to $54.1 million and margins expanded 130 basis points to 18.3% primarily because of the aforementioned factors.














29

EMEA & APAC

The following table summarizes the selected financial data for our EMEA & APAC segment:
Three Months Ended
March 29, 2024March 31, 2023
(Dollars in millions)
Net sales$393.7 $392.4 
Gross profit$144.0 $141.7 
Gross profit margin36.6 %36.1 %
Selling, general and administrative expense$77.7 $82.4 
Adjusted EBITDA (non-GAAP)$75.0 $68.5 
Adjusted EBITDA margin (non-GAAP)19.1 %17.5 %
Core adjusted EBITDA (non-GAAP)$69.1 $63.2 
Core adjusted EBITDA margin (non-GAAP)19.2 %17.8 %
Items excluded from Adjusted EBITDA:
Restructuring and other related charges$1.7 $8.5 
Acquisition- amortization and other related charges$3.3 $4.0 
Pension settlement loss$12.2 $— 
Depreciation and other amortization$5.3 $5.3 
Items excluded from Core adjusted EBITDA:
Adjusted EBITDA attributable to Russia (non-GAAP)$5.9 $5.3 

First Quarter of 2024 Compared to First Quarter of 2023

Net sales increased for our EMEA & APAC segment by $1.3 million in the first quarter of 2024, compared with the prior year period. Net sales from existing business increased $7.7 million offset by $6.6 million in unfavorable currency translation. The increase in Net sales from existing business was primarily due to an increase in sales volumes. Gross profit increased $2.3 million in the first quarter of 2024 compared with the prior year period primarily due to an increase in sales volumes and improved product mix. Gross profit margin expanded 50 basis points compared to the same period in 2023 due to the increase in sales as mentioned above. Selling, general and administrative expense decreased compared to the same period in 2023 due to savings from restructuring initiatives. Core adjusted EBITDA increased from $63.2 million to $69.1 million and the related Core adjusted EBITDA margins expanded 140 basis points from 17.8% to 19.2% primarily because of the aforementioned factors.

30

Liquidity and Capital Resources

Overview

We expect to finance our working capital requirements through cash flows from operating activities. We expect that our primary ongoing requirements for cash will be for working capital, funding of acquisitions, capital expenditures and restructuring related cash outflows, asbestos-related cash outflows, and debt service and required amortization of principal and, pending Board approval, payment of cash dividends.

In conjunction with the Separation on April 4, 2022, we drew down $1.2 billion under the Credit Agreement and used these proceeds to make payments to Enovis of $1.2 billion, which was used as part of the consideration for the contribution of certain assets and liabilities to us by Enovis in connection with the Separation.

On June 28, 2022, we amended and restated the Credit Agreement by entering into Amendment No. 2 to Credit Agreement (“Credit Agreement Amendment”). The Credit Agreement Amendment provides for a $600 million Term Loan A-3 Facility with a maturity date of April 3, 2025 to refinance our existing Term Loan A-2 Facility (the “Term Loan A-3 Facility” and together with the Term Loan A-1 Facility, the “Term Loans”). Also on June 28, 2022, we borrowed the entire $600 million under the Term Loan A-3 Facility to fund the repayment of the Term Loan A-2 Facility. The Company’s total borrowing capacity under the Credit Agreement remained unchanged.

As of March 29, 2024, we were in compliance with the covenants under the Credit Agreement. As of March 29, 2024, the weighted average interest rate of borrowings under the Credit Agreement was 5.09%, excluding accretion of deferred financing fees. Refer to Note 11, “Derivatives” in the accompanying Notes contained elsewhere in this Form 10-Q for more information related to swap agreements.

After the quarter ended March 29, 2024, on April 9, 2024, the Company completed a $700.0 million Senior Note Offering (the “Offering”). The Offering has a contractual interest rate of 6.25% and expected maturity date of April 15, 2029. The Company used the net proceeds from the Offering to repay $588.8 million of borrowings under its Term Loan A-3 Facility, representing all outstanding borrowings under the Term Loan A-3 Facility, and pay fees associated with the Offering. The Company intends to use the remaining proceeds received to repay borrowings under its Revolving Facility and other general corporate purposes.

As of the end of the first quarter, we had the capacity for additional indebtedness of up to $738 million available on the Revolving Facility, subject to meeting financial covenants and other requirements. Additionally, we have the ability to incur $77 million of indebtedness pursuant to certain uncommitted credit lines, consisting of an uncommitted credit line that we currently have in place, which we have used from time to time in the past for short-term working capital needs. Refer to Note 10, “Debt” in the accompanying Notes contained elsewhere in this Form 10-Q for more information related to the Facilities. We believe that we could raise additional funds in the form of debt or equity if it were determined to be appropriate for strategic acquisitions or other corporate purposes. We believe that our sources of liquidity between debt and cash flows from operating activities are adequate to fund our operations for the next twelve months and thereafter.

31

Cash Flows

As of March 29, 2024, we had $76.5 million of Cash and cash equivalents, a decrease of $25.5 million from the balance of $102.0 million as of December 31, 2023.

The following table summarizes the change in Cash and cash equivalents during periods indicated:
Three Months Ended
March 29, 2024March 31, 2023
(Dollars in Millions)(1)
Net cash provided by operating activities$44.5 $38.1 
Purchases of property, plant and equipment(7.4)(7.7)
Proceeds from sale of property, plant and equipment0.4 0.7 
Acquisition, net of cash received(18.1)(18.7)
Other(1.5)— 
Net cash used in investing activities(26.6)(25.7)
Proceeds from borrowings on revolving credit facility and other115.0 187.0 
Repayments of borrowings on term credit facility(6.3)— 
Repayments of borrowings on revolving credit facility and other(139.0)(189.8)
Payment of dividends(3.6)(3.0)
Distributions to noncontrolling interest holders— (1.2)
Net cash used in financing activities(33.9)(7.0)
Effect of foreign exchange rates on Cash and cash equivalents(9.4)4.8 
(Decrease) increase in Cash and cash equivalents$(25.5)$10.0 
(1) Numbers may not sum due to rounding.

Cash flows from operating activities can fluctuate significantly from period to period due to changes in working capital and the timing of payments for items such as pension funding, asbestos-related costs and restructuring program funding. Changes in significant operating cash flow items are discussed below.

•Operating cash flow was positively impacted by increased operating income for the three months ended March 29, 2024, partly offset by higher working capital to support growth.

•Discontinued operations for the three months ended March 29, 2024 and March 31, 2023 included outflows of $3.7 million and $5.4 million, respectively, which were mainly asbestos-related.

•Restructuring initiative payments were $2.9 million for the three months ended March 29, 2024 and $4.2 million for the three months ended March 31, 2023, which includes severance and other termination benefits including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expense, and other costs in connection with the closure and optimization of facilities and product lines.

Cash flows used in investing activities include $18.1 million of cash used primarily for the acquisition of Sager S.A. during the three months ended March 29, 2024.

Cash outflows used in financing activities of $33.9 million during the three months ended March 29, 2024 was primarily driven by net repayment of borrowings on the Revolving Facility of $20.0 million, repayment of $6.3 million on the term credit facility and cash dividends of $3.6 million.

Our Cash and cash equivalents as of March 29, 2024 include $69.5 million held in jurisdictions outside the United States. Cash repatriation of non-United States cash into the United States may be subject to withholding taxes, other local statutory restrictions and minority owner distributions.

32

Critical Accounting Policies

The methods, estimates and judgments that we use in applying our critical accounting policies have a significant impact on our results of operations and financial position. We evaluate our estimates and judgments on an ongoing basis. Our estimates are based upon our historical experience, our evaluation of business and macroeconomic trends and information from other outside sources, as appropriate. Our experience and assumptions form the basis for our judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may vary from what our management anticipates, and different assumptions or estimates about the future could have a material impact on our results of operations and financial position.

There have been no other significant additions or changes to the methods, estimates and judgments included in “Management’s Discussion and Analysis of Financial Condition and Results of Operations-Critical Accounting Policies” in the 2023 Form 10-K.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risk from changes in foreign currency exchange rates and commodity prices that could impact our results of operations and financial condition. We address our exposure to these risks through our normal operating and financing activities. We do not enter into derivative contracts for trading purposes.

Interest Rate Risk

We entered into certain Term Loans and a Revolving Facility pursuant to the terms of the Credit Agreement. Please refer to Note 10, “Debt” in the accompanying Notes contained elsewhere in this Form 10-Q for additional information regarding our Facilities. We are exposed to interest rate risk on the variable-rate term loans under these Facilities. To mitigate our interest risk, in July 2022, we entered into two interest rate swaps to hedge approximately $600 million of our floating-rate debt. In March 2024, the Company priced a Senior Note Offering, the proceeds of which are intended to pay off the Term A-3 Facility balance once completed in April 2024. As a result, the Company terminated one of the two $300 million swaps during March 2024 and the other $300 million swap will continue to be hedged against our floating-rate debt as of the period ended March 29, 2024. See Note 11, “Derivatives” and Note 16, “Subsequent Events” in our Notes contained elsewhere in this Form 10-Q for additional information. A hypothetical increase in interest rates of 1% during the three months ended March 29, 2024 would have increased interest expense by approximately $6.9 million.

Exchange Rate Risk

We have manufacturing sites throughout the world and sell our products globally. As a result, we are exposed to movements in the exchange rates of various currencies against the U.S. Dollar and against the currencies of other countries in which we manufacture and sell products and services. During the three months ended March 29, 2024, approximately 78% of our sales were derived from operations outside the United States. We have significant manufacturing operations in European countries that are not part of the Eurozone. Sales are more highly weighted toward the Euro and U.S. Dollar. We also have significant contractual obligations in U.S. Dollars that are met with cash flows in other currencies as well as U.S. Dollars. To better match revenue and expense as well as cash needs from contractual liabilities, we regularly enter into currency swaps and forward contracts.

We also face exchange rate risk from our investments in subsidiaries owned and operated in foreign countries. The effect of a change in currency exchange rates on our net investment in international subsidiaries is reflected in the AOCI component of Equity. A 10% depreciation in major currencies relative to the U.S. Dollar as of March 29, 2024 would result in a reduction in Equity of approximately $176 million. In 2022, we entered into two fixed-to-fixed cross-currency swaps, which will provide a hedge to a portion of our European net asset position.

We also face exchange rate risk from intercompany transactions between affiliates. Although we use the U.S. Dollar as our functional currency for reporting purposes, we have manufacturing sites throughout the world, and a substantial portion of our costs are incurred and sales are generated in foreign currencies. Costs incurred and sales recorded by subsidiaries operating outside of the United States are translated into U.S. Dollars using exchange rates effective during the respective period. As a result, we are exposed to movements in the exchange rates of various currencies against the U.S. Dollar. Similarly, tax costs may increase or decrease as local currencies strengthen or weaken against the U.S. Dollar.
33

Commodity Price Risk

We are exposed to changes in the prices of raw materials used in our production processes. To manage commodity price risk, we periodically enter into fixed price contracts directly with suppliers.

34

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of March 29, 2024. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective in providing reasonable assurance that the information required to be disclosed in this report on Form 10-Q has been recorded, processed, summarized and reported as of the end of the period covered by this report on Form 10-Q.
Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f)) identified in connection with the evaluation required by Rule 13a-15(d) of the Exchange Act that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.



35

PART II - OTHER INFORMATION
Item 1. Legal Proceedings

Discussion of legal proceedings is incorporated by reference to Note 14, “Commitments and Contingencies,” in the Notes included in Part I. Item 1. “Financial Statements” of this Form 10-Q.

Item 1A. Risk Factors

In addition to the information set forth in this quarterly report on Form 10-Q, including in “Management Discussion and Analysis of Financial Condition and Results of Operations - Special Note Regarding Forward Looking Statements,” in Part I of this Form 10-Q, you should carefully consider the factors discussed in the “Risk Factors” section of the Company’s 2023 Form 10-K filed with the SEC on February 29, 2024. There were no material changes during the three months ended March 29, 2024 to the risk factors reported in the “Risk Factors” section of the Company’s 2023 Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

During the three months ended March 29, 2024, none of our directors or officers adopted or terminated a Rule 10b5-1 or non-Rule 10b-5 trading arrangement as defined in Item 408 of Regulation S-K.




36

Item 6. Exhibits
Exhibit No.Exhibit Description
Indenture, dated as of April 9, 2024, by and among ESAB Corporation, as issuer, the guarantors named therein, and U.S. Bank Trust Company, National Association, as trustee.(incorporated by reference to Exhibit 4.1 to ESAB Corporation’s Form 8-K (File No. 001-41297) as filed with the SEC on April 9, 2024).
Form of Global Note (included in Exhibit 4.1) (incorporated by reference to Exhibit 4.2 to ESAB Corporation’s Form 8-K (File No. 001-41297) as filed with the SEC on April 9, 2024).
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INSInline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema Document.
101.CALInline XBRL Extension Calculation Linkbase Document.
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.
104
Cover Page Interactive Data File - The cover page from this Quarterly Report on Form 10-Q for the quarter ended March 29, 2024 is formatted in Inline XBRL (included as Exhibit 101).


37

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Registrant: ESAB Corporation

By:

/s/ Shyam P. KambeyandaPresident and Chief Executive Officer
Shyam P. Kambeyanda(Principal Executive Officer)May 1, 2024
/s/ Kevin JohnsonChief Financial Officer
Kevin Johnson(Principal Financial Officer)May 1, 2024
/s/ Renato NegroController and Chief Accounting Officer
Renato Negro(Principal Accounting Officer)May 1, 2024
38
 EX-31.1 2 exhibit311ceocertification.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATIONS
I, Shyam P. Kambeyanda, certify that:
1.I have reviewed this quarterly report on Form 10-Q of ESAB Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 (a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 (b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 (c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 (d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 (a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 (b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: May 1, 2024
/s/ Shyam P. Kambeyanda
Shyam P. Kambeyanda
President and Chief Executive Officer
(Principal Executive Officer)

 EX-31.2 3 exhibit312cfocertification.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATIONS
I, Kevin Johnson, certify that:
1.I have reviewed this quarterly report on Form 10-Q of ESAB Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 (a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 (b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 (c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 (d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 (a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 (b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: May 1, 2024
/s/ Kevin Johnson
Kevin Johnson
Chief Financial Officer
(Principal Financial Officer)


 EX-32.1 4 exhibit321ceocertification.htm EX-32.1 Document

Exhibit 32.1

Certification Pursuant to 18 U.S.C. Section 1350
(as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002)

I, Shyam P. Kambeyanda, as President and Chief Executive Officer of ESAB Corporation (the “Company”), certify, pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), that to my knowledge:

1.the quarterly report on Form 10-Q of the Company for the period ended March 29, 2024 (the "Report"), filed with the U.S. Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 1, 2024
/s/ Shyam P. Kambeyanda
Shyam P. Kambeyanda
President and Chief Executive Officer
(Principal Executive Officer)


 EX-32.2 5 exhibit322cfocertification.htm EX-32.2 Document

Exhibit 32.2

Certification Pursuant to 18 U.S.C. Section 1350
(as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002)
I, Kevin Johnson, as Executive Vice President, Finance, Chief Financial Officer of ESAB Corporation (the “Company”), certify, pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), that to my knowledge:

1.the quarterly report on Form 10-Q of the Company for the period ended March 29, 2024 (the "Report"), filed with the U.S. Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 1, 2024
/s/ Kevin Johnson
Kevin Johnson
Chief Financial Officer
(Principal Financial Officer)


 EX-101.SCH 6 esab-20240329.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - COVER PAGE link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONSOLIDATED AND COMBINED CONDENSED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONSOLIDATED AND COMBINED CONDENSED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF EQUITY link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000009 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Organization and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Acquisition link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Earnings per Share from Continuing Operations link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Inventories, Net link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Accrued and Other Liabilities link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Benefit Plans link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Derivatives link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Organization and Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Earnings per Share from Continuing Operations (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Inventories, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Accrued and Other Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Derivatives (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Organization and Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Discontinued Operations (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Discontinued Operations (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Acquisition (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Revenue - Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Revenue - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Revenue - Allowance for Credit Loss Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Earnings per Share from Continuing Operations (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Inventories, Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Accrued and Other Liabilities - Current and Noncurrent (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Accrued and Other Liabilities - Warranty Liability Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Accrued and Other Liabilities - Restructuring Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Benefit Plans (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Debt - Schedule of Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Debt - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Derivatives - Narratives (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Derivatives - Schedule of Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Derivatives - Derivatives Not Designated as Hedging Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Derivatives - Schedule of Fair Values of Derivative Instruments in the Financial Statements (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Fair Value Measurements - Fair Value Hierarchy (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Equity (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Commitments and Contingencies - Asbestos-Related Claims Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Commitments and Contingencies - Asbestos Litigation (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - Segment Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - Segment Information - Segment Results (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 esab-20240329_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 esab-20240329_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 esab-20240329_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Deferred income tax Deferred Income Taxes and Tax Credits Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Variable Rate [Domain] Variable Rate [Domain] Income attributable to noncontrolling interest, net of taxes Net Income (Loss) Attributable to Noncontrolling Interest Pay vs Performance Disclosure [Line Items] Financing Receivable, Allowance for Credit Loss [Roll Forward] Financing Receivable, Allowance for Credit Loss [Roll Forward] Schedule of Accrued and Other Liabilities Schedule of Accrued Liabilities [Table Text Block] Accrued liabilities Total accrued and other liabilities, Current Accrued Liabilities, Current Statistical Measurement [Domain] Statistical Measurement [Domain] Allowance for excess, slow-moving and obsolete inventory Inventory Valuation Reserves Aggregate principal amount Line of Credit Facility, Maximum Borrowing Capacity Research and development expense Research and Development Expense Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent All Award Types Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Investment, Name [Domain] Investment, Name [Domain] Debt Debt Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Cash consideration Payments to Acquire Businesses, Gross Revolving credit facilities Revolving Credit Facility [Member] Effect of foreign exchange rates on Cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Accrued taxes and deferred tax liabilities Deferred Income Tax Liabilities, Net MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Segment Reporting [Abstract] Segment Reporting [Abstract] Accounts payable Accounts Payable, Current Discontinued Operations and Disposal Groups [Abstract] Discontinued Operations and Disposal Groups [Abstract] Restatement Determination Date: Restatement Determination Date [Axis] Investment, Name [Axis] Investment, Name [Axis] Derivatives Not Designated as Hedging Instruments Derivatives Not Designated as Hedging Instruments [Table Text Block] Foreign currency translation, tax expense (benefit) Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax Claims unresolved, beginning of period Claims unresolved, end of period Loss Contingency, Pending Claims, Number Insider Trading Policies and Procedures [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Derivative asset, current Derivative Asset, Current Foreign Currency Translation Restructuring Reserve, Foreign Currency Translation Gain (Loss) Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Uncommitted Credit Line Uncommitted Credit Line [Member] Uncommitted Credit Line Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Geographical [Axis] Geographical [Axis] Income Taxes Income Tax Disclosure [Text Block] Cost of warranty service work performed Standard and Extended Product Warranty Accrual, Decrease for Payments Other Other Accrued Liabilities, Noncurrent Accrued warranty expense Standard and Extended Product Warranty Accrual, Increase for Warranties Issued Concentration Risk [Line Items] Concentration Risk [Line Items] CURRENT LIABILITIES: Current Liabilities, Current [Abstract] Business Acquisition [Line Items] Business Acquisition [Line Items] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Adjusted EBITA Adjusted Earnings Before Interest, Taxes And Amortization Adjusted Earnings Before Interest, Taxes And Amortization Net income per share - diluted (in dollars per share) Earnings Per Share, Diluted Derivative liabilities Derivative Liability, Subject to Master Netting Arrangement, before Offset Enovis Corporation Enovis Corporation [Member] Enovis Corporation PEO Total Compensation Amount PEO Total Compensation Amount Hedging Relationship [Axis] Hedging Relationship [Axis] Trade receivables, less allowance for credit losses of $25,424 and $25,477 Accounts Receivable, after Allowance for Credit Loss, Current Maximum total leverage ratio Debt Instrument, Covenant, Leverage Ratio, Maximum Debt Instrument, Covenant, Leverage Ratio, Maximum Unrealized gain on cash flow hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent Senior Note Offering Senior Note Offering [Member] Senior Note Offering Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Level Three Fair Value, Inputs, Level 3 [Member] Line of Credit Line of Credit [Member] Trading Symbol Trading Symbol Letters of credit outstanding Letters of Credit Outstanding, Amount Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Schedule of Allowance for Credit Losses Financing Receivable, Allowance for Credit Loss [Table Text Block] Other comprehensive income (loss), tax expense (benefit) Other Comprehensive Income (Loss), Tax Net income attributable to ESAB Corporation Net income Net Income (Loss) Total current liabilities Liabilities, Current SOFR Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] Derivative Contract [Domain] Derivative Contract [Domain] Fair Value Disclosures [Abstract] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Amounts reclassified from Accumulated other comprehensive loss Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Contract liability Contract with Customer, Liability Consumables Consumable Products [Member] Consumable Products [Member] Inventories, gross Inventory, Gross Schedule of Earnings Per Share from Continuing Operations Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Cost of sales Cost of Goods and Services Sold Executive Category: Executive Category [Axis] Schedule of Loss Contingencies by Number of Claims Schedule Of Loss Contingencies By Claims Quantities [Table Text Block] Tabular disclosure of the rollforward of asbestos claims activity during the year, including claims filed and resolved. Cross currency swap agreements Foreign currency contracts Foreign Exchange Contract [Member] Net actuarial loss Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent Level One Fair Value, Inputs, Level 1 [Member] Name Measure Name Name Forgone Recovery, Individual Name Goodwill Goodwill Equity Components Equity Components [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Hedging Relationship [Domain] Hedging Relationship [Domain] LIFO reserve Inventory, LIFO Reserve Underlying Securities Award Underlying Securities Amount Entity Small Business Entity Small Business Local Phone Number Local Phone Number Trade receivables, net Increase (Decrease) in Accounts Receivable Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Scenario, Forecast Forecast [Member] Letter of Credit Letter of Credit [Member] Notional amount Derivative, Notional Amount Changes in estimates related to pre-existing warranties Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties Quarterly cash dividend declared (in dollars per share) Dividends on common stock (in dollars per share) Common Stock, Dividends, Per Share, Declared Lease liabilities Operating Lease, Liability, Noncurrent Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Debt term Debt Instrument, Term Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Accrued taxes and deferred tax liabilities Accrued Taxes and Deferred Income Tax Liabilities, Current Accrued Taxes and Deferred Income Tax Liabilities, Current Income Statement Location [Axis] Income Statement Location [Axis] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Net effect of potentially dilutive securities (in shares) Weighted Average Number of Shares Outstanding, Diluted, Adjustment Net sales Revenues Product and Service [Domain] Product and Service [Domain] Other Performance Measure, Amount Other Performance Measure, Amount Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Inventories, net Increase (Decrease) in Inventories Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Balance at Beginning of Period Balance at End of Period Restructuring Reserve Award Type Award Type [Axis] Derivative Instruments and Hedging Activities Disclosure [Abstract] Document Quarterly Report Document Quarterly Report Restructuring liability Restructuring Reserve, Noncurrent Dividends declared Dividends, Common Stock Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Hedging Designation [Axis] Hedging Designation [Axis] Trading Arrangement: Trading Arrangement [Axis] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity File Number Entity File Number Lease liabilities Operating Lease, Liability, Current Prepaid expenses Prepaid Expense, Current Warranty liability Product Warranty Accrual, Current Entity Shell Company Entity Shell Company Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Other comprehensive income (loss) before reclassifications OCI, before Reclassifications, Net of Tax, Attributable to Parent Restatement Determination Date Restatement Determination Date Minimum interest coverage ratio Debt Instrument, Covenant, Interest Coverage Ratio, Minimum Debt Instrument, Covenant, Interest Coverage Ratio, Minimum Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Americas Segment Americas Segment [Member] Americas Segment Consideration transferred for acquisition Purchase price for business combination agreement Business Combination, Consideration Transferred Gross profit Gross Profit SUMIG Soluções para Solda Ltda SUMIG Soluções para Solda Ltda [Member] SUMIG Soluções para Solda Ltda Contract liabilities Contract with Customer, Liability, Current Security Exchange Name Security Exchange Name Total assets at fair value Assets, Fair Value Disclosure Long-term Debt Long-Term Debt Selling, general and administrative expense Selling, General and Administrative Expense Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Employee Stock Option Employee Stock Option [Member] Foreign Currency Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Derivatives Derivative Instruments and Hedging Activities Disclosure [Text Block] Loss Contingency, Receivable, Noncurrent Loss Contingency, Receivable, Noncurrent Pension settlement loss Pension settlement loss Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Maximum Maximum [Member] Comprehensive income attributable to ESAB Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive Income (Loss), Net of Tax, Attributable to Parent Document Type Document Type Future claims period Future Claims Period Period for which the Company believes it can reasonably estimate the asbestos-related liability for pending and future claims that will be resolved. Geographic Concentration Risk Geographic Concentration Risk [Member] Tabular List, Table Tabular List [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Subsequent Event [Table] Subsequent Event [Table] Derivative liability, current Derivative Liability, Current Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Interest expense and other, net Interest Expense (Income) and Other, Net Interest Expense (Income) and Other, Net Business Acquisition [Axis] Business Acquisition [Axis] Trade receivables, allowance for doubtful accounts Balance at Beginning of Period Balance at End of Period Accounts Receivable, Allowance for Credit Loss, Current Subsequent Event Subsequent Event [Member] Third-party commissions Accrued Third-Party Commisions, Noncurrent Accrued Third-Party Commisions, Noncurrent Derivative [Table] Derivative [Table] Variable Rate [Axis] Variable Rate [Axis] Asbestos Related Activity Asbestos Related Activity [Member] Asbestos Related Activity Income Statement [Abstract] Income Statement [Abstract] Accrued and Other Liabilities Accrued and Other Liabilities Disclosure [Text Block] The entire disclosure for the accrued and other liabilities during the reporting period. Title of 12(b) Security Title of 12(b) Security Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Schedule of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Acquisition Business Combination Disclosure [Text Block] Derivative liabilities Derivative Liability Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Dividends payable included in accrued liabilities Dividends Payable, Current Common stock-based award activity Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Other current assets Other Assets, Current Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Distributions to noncontrolling interest holders Payments to Noncontrolling Interests Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Earnings (loss) per share – diluted Computation of earnings per share from continuing operations – diluted: Earnings Per Share, Diluted [Abstract] Fair Value Measurements Financial Instruments Disclosure [Text Block] Entity Tax Identification Number Entity Tax Identification Number Inventories, net Inventories, net Inventory, Net EMEA and APAC Segment EMEA and APAC Segment [Member] EMEA and APAC Segment Statistical Measurement [Axis] Statistical Measurement [Axis] Asbestos liability Long-term asbestos liability Asbestos Liability Noncurrent Asbestos liability noncurrent. Sager S.A. Sager S.A. [Member] Sager S.A. Balance Sheet Location [Domain] Balance Sheet Location [Domain] Discontinued Operations Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Entity Interactive Data Current Entity Interactive Data Current Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Increase in derivative assets and liabilities Increase (Decrease) in Derivative Assets and Liabilities Total Shareholder Return Amount Total Shareholder Return Amount Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Income from continuing operations attributable to ESAB Corporation Net Income (Loss) from Continuing Operations Attributable to Parent Net Income from continuing operations attributable to Parent: Net income from continuing operations attributable to parent for the respective periods is calculated using Net income from continuing operations less the income attributable to noncontrolling interest, net of taxes. Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Other Liabilities Other Assets [Member] Defined benefit pension and other post-retirement plan activity, tax expense Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax Segments [Domain] Segments [Domain] Deferred compensation plans Deferred Compensation Plan Assets Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Retained earnings Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Principal amount Outstanding borrowings Debt Instrument, Face Amount Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code CURRENT ASSETS: Assets, Current [Abstract] Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Income from continuing operations (in dollars per share) Income per share from continuing operations – basic (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Undistributed foreign earnings, tax expense Undistributed Foreign Earnings, Tax Expense Undistributed Foreign Earnings, Tax Expense Disposal Group Name [Domain] Disposal Group Name [Domain] Earnings (loss) per share – basic Earnings Per Share, Basic [Abstract] PEO PEO [Member] Benefit Plans Retirement Benefits [Text Block] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] Net income from continuing operations Net income from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Derivative assets Derivative Asset, Subject to Master Netting Arrangement, before Offset Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Gain on long-term intra-entity foreign currency transactions Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Class of Stock [Domain] Class of Stock [Domain] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Net Income (Loss) Available to Common Stockholders Net Income (Loss) Available to Common Stockholders, Basic Schedule of Inventory, Net Schedule of Inventory, Current [Table Text Block] Interest rate swap agreements Interest Rate Swap [Member] Debt Instrument [Axis] Debt Instrument [Axis] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Effective tax rate (as a percent) Effective Income Tax Rate Reconciliation, Percent Credit Facility [Axis] Credit Facility [Axis] Unrealized gain on hedging activities, tax expense Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax Total liabilities Liabilities Organization and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Equity Shareholders' Equity and Share-Based Payments [Text Block] Accumulated Other Comprehensive Loss Total AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount All Executive Categories All Executive Categories [Member] Contract liabilities Contract with Customer, Liability, Noncurrent Repayments of borrowings on revolving credit facility and other Repayments of Long-Term Lines of Credit Noncurrent Liabilities, Noncurrent [Abstract] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Net Unrecognized Pension and Other Post-Retirement Benefit Cost Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Number of reportable segments Number of Reportable Segments Earnings Per Share [Abstract] Earnings Per Share [Abstract] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Subsequent Event [Line Items] Subsequent Event [Line Items] Common stock - $0.001 par value - 600,000,000 shares authorized, $60,424,421 and 60,295,634 shares outstanding as of March 29, 2024 and December 31, 2023, respectively Common Stock, Value, Issued Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Loss Contingency, Accrual, Current Loss Contingency, Accrual, Current Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Senior Notes Senior Notes [Member] Total current assets Assets, Current Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] All Individuals All Individuals [Member] Entity Filer Category Entity Filer Category Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] Restructuring Cost and Reserve [Axis] Restructuring Type [Axis] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Short-Term Debt, Type [Domain] Short-Term Debt, Type [Domain] Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] PEO Name PEO Name Concentration risk (as a percent) Concentration Risk, Percentage Schedule of Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Base Rate Base Rate [Member] Loss Contingency Accrual [Roll Forward] Loss Contingency Accrual [Roll Forward] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Class of Stock [Axis] Class of Stock [Axis] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Other Other Accrued Liabilities, Current Other operating assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Contractual interest rate Debt Instrument, Interest Rate, Stated Percentage Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Warranty liability, beginning of period Warranty liability, end of period Standard and Extended Product Warranty Accrual Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Total ESAB Corporation equity Cumulative translation loss Equity, Attributable to Parent Revenue recognized, contract liability Contract with Customer, Liability, Revenue Recognized Foreign currency translation, net of tax expense of $1,531 and $45 Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Cash Flow Hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Subsequent Events [Abstract] Subsequent Events [Abstract] Income from continuing operations before income taxes Income from continuing operations before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Third-party commissions Accrued Sales Commission, Current Basis spread on variable rate (as a percent) Derivative, Basis Spread on Variable Rate Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Percentage of inventory valued at LIFO Percentage of LIFO Inventory Depreciation, amortization, and other impairment charges Depreciation, Depletion and Amortization, Nonproduction Claims filed Loss Contingency, New Claims Filed, Number Hedging Designation [Domain] Hedging Designation [Domain] Level Two Fair Value, Inputs, Level 2 [Member] Entity Emerging Growth Company Entity Emerging Growth Company Deferred financing fees Debt Issuance Costs, Net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Proceeds from borrowings on term credit facility Proceeds from Issuance of Other Long-Term Debt Finished goods Inventory, Finished Goods, Gross Schedule of Product Warranty Liability Schedule of Product Warranty Liability [Table Text Block] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Net income from continuing operations attributable to noncontrolling interest, net of taxes Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest Increase in the net liability for uncertain tax positions Unrecognized Tax Benefits, Period Increase (Decrease) Document Fiscal Period Focus Document Fiscal Period Focus Capacity for additional indebtedness Line of Credit Facility, Remaining Borrowing Capacity Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Title Trading Arrangement, Individual Title Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Common Stock Common Stock [Member] Defined benefit pension and other post-retirement plan activity, net of tax expense of $203 and $66 Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Individual: Individual [Axis] Loss on discontinued operations (in dollars per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Product and Service [Axis] Product and Service [Axis] Earnings per Share from Continuing Operations Earnings Per Share [Text Block] Income Statement Location [Domain] Income Statement Location [Domain] Repayments of borrowings on term credit facility Repayments of borrowing on term credit facility Repayments of Secured Debt Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Total equity Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Distributions to noncontrolling owners Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Minimum Minimum [Member] Property, plant and equipment, net Property, Plant and Equipment, Net Non-cash interest expense Non-Cash Interest Expense Non-Cash Interest Expense Exercise Price Award Exercise Price Other comprehensive (loss) income Other comprehensive income (loss), net of tax (expense) benefit Other Comprehensive Income (Loss), Net of Tax Less: distributed and undistributed earnings allocated to nonvested shares Participating Securities, Distributed and Undistributed Earnings (Loss), Basic Disposal Group Classification [Axis] Disposal Group Classification [Axis] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] ASSETS Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Indebtedness incurred Proceeds from Issuance of Long-Term Debt Total liabilities at fair value Liabilities, Fair Value Disclosure Schedule of Fair Values of Derivative Instruments in the Financial Statements Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Fiscal Period Fiscal Period, Policy [Policy Text Block] Net income Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Loss from discontinued operations, net of taxes Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Income from continuing operations (in dollars per share) Income per share from continuing operations – assuming dilution (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Other Payments for (Proceeds from) Other Investing Activities Retained Earnings Retained Earnings [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities and equity Liabilities and Equity Other assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Lease assets - right of use Operating Lease, Right-of-Use Asset Unrealized income (loss) on derivatives designated and qualifying as cash flow hedges, net of tax expense (benefit) of $295 and $(1,045) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Net income per share (in dollars per share) Earnings Per Share, Basic Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Arrangement Duration Trading Arrangement Duration Interest expense and other, net Investment Income, Investment Expense Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Interest Expense (Income) and Other, Net Interest Expense (Income) and Other, Net [Member] Interest Expense (Income) and Other, Net Consolidation Consolidation, Policy [Policy Text Block] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Restructuring and other related charges Total Restructuring Charges Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Combinations [Abstract] Business Combinations [Abstract] Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Termination Date Trading Arrangement Termination Date Accounts payable Increase (Decrease) in Accounts Payable Common stock, shares authorized (in shares) Common Stock, Shares Authorized Raw materials Inventory, Raw Materials, Gross Accrued Liabilities [Abstract] Accrued Liabilities [Abstract] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Schedule of Revenue by Major Customers by Reporting Segments Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] Derivative Instrument [Axis] Derivative Instrument [Axis] Loss related to interest rate swap agreements Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax Long-Term Debt, Gross Long-Term Debt, Gross Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] All Trading Arrangements All Trading Arrangements [Member] Bridge Loan Bridge Loan [Member] All Adjustments to Compensation All Adjustments to Compensation [Member] Derivative [Line Items] Derivative [Line Items] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Award Timing Disclosures [Line Items] Proceeds from settlement of interest rate swap Proceeds From Derivative Instrument, Operating Activities Proceeds From Derivative Instrument, Operating Activities Compensation Amount Outstanding Recovery Compensation Amount Russia RUSSIAN FEDERATION Comprehensive income attributable to noncontrolling interest Comprehensive income attributable to noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Loss Contingency, Accrual, Noncurrent Loss Contingency, Accrual, Noncurrent Charged to Expense, net Accounts Receivable, Credit Loss Expense (Reversal) Additional paid-in capital Additional Paid in Capital Derivative assets Derivative Asset Subsequent Event Type [Axis] Subsequent Event Type [Axis] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] The Credit Agreement The Credit Agreement [Member] The Credit Agreement Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block] Short-Term Debt, Type [Axis] Short-Term Debt, Type [Axis] Work in process Inventory, Work in Process, Gross Insider Trading Arrangements [Line Items] Restructuring liability Restructuring Reserve, Current Asbestos liability Accrued Asbestos Liability, Current Carrying value of accrued asbestos liability included in Accrued liabilities. Segment Information (Details) Schedule of Segment Reporting Information, by Segment [Table] Common stock-based award activity (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Movement in Standard Product Warranty Accrual [Roll Forward] Movement in Standard Product Warranty Accrual [Roll Forward] Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Weighted-average interest rate (as a percent) Long-Term Debt, Weighted Average Interest Rate, at Point in Time Adjustment to Compensation, Amount Adjustment to Compensation Amount Proceeds from sale of property, plant and equipment Proceeds from Sale of Property, Plant, and Equipment Termination benefits Employee Severance [Member] Noncontrolling interest Equity, Attributable to Noncontrolling Interest Payments Payments for Restructuring Document Period End Date Document Period End Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Adoption Date Trading Arrangement Adoption Date Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Disposal Group Name [Axis] Disposal Group Name [Axis] Revenue from Contract with Customer Benchmark Revenue from Contract with Customer Benchmark [Member] Schedule of Assets and Liabilities Measured at Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Entity Central Index Key Entity Central Index Key Liabilities: Liabilities, Fair Value Disclosure [Abstract] Realized loss Derivative, Gain (Loss) on Derivative, Net Long-Term Debt Long-Term Debt [Member] Equipment Equipment Products [Member] Equipment Products [Member] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Income tax expense Income Tax Expense (Benefit) Deferred compensation plans Deferred Compensation Liability, Current and Noncurrent Designated as hedging instruments Designated as Hedging Instrument [Member] Write-Offs and Deductions Accounts Receivable, Allowance for Credit Loss, Writeoff Compensation and related benefits Employee-related Liabilities, Current Acquisition - amortization and other related charges Amortization of Acquired Intangible Assets and Acquisition Costs Amortization of Acquired Intangible Assets and Acquisition Costs Name Trading Arrangement, Individual Name Net current period Other comprehensive (loss) income Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Cash used in operating activities, discontinued operations Cash Provided by (Used in) Operating Activities, Discontinued Operations Equity [Abstract] Equity [Abstract] Inventories, Net Inventory Disclosure [Text Block] Net sales Total Revenue from Contract with Customer, Excluding Assessed Tax Entity [Domain] Entity [Domain] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Legal Entity [Axis] Legal Entity [Axis] Change in unrealized gains (losses) Unrealized Gain (Loss) on Derivatives Loss Contingency, Receivable, Current Loss Contingency, Receivable, Current Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Acquisition, net of cash received Payments to Acquire Businesses, Net of Cash Acquired Comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Assets: Assets, Fair Value Disclosure [Abstract] Credit Facility [Domain] Credit Facility [Domain] Foreign Currency Translation Accounts Receivable, Allowance For Credit Loss, Foreign Currency Translation Accounts Receivable, Allowance For Credit Loss, Foreign Currency Translation Basis spread on variable rate (as a percent) Debt Instrument, Basis Spread on Variable Rate Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Computation of earnings per share from continuing operations – basic: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Long-term debt Long-Term Debt, Excluding Current Maturities Number of derivative instruments held Derivative, Number of Instruments Held Weighted-average shares of common stock outstanding - assuming dilution (in shares) Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Assets Assets, Total [Member] Revenue Revenue from Contract with Customer [Text Block] Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Additional Paid in Capital Additional Paid-in Capital [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Depreciation and other amortization Depreciation and Other Amortization Depreciation and Other Amortization Cover [Abstract] Cover [Abstract] Schedule of Asbestos Related Litigation Schedule Of Asbestos Related Litigation [Table Text Block] Tabular disclosure of the presentation of asbestos litigation on the statement of financial position, including the amounts and location of such amounts. Foreign exchange translation effect Standard and Extended Product Warranty Accrual, Foreign Currency Translation Gain (Loss) Deferred AOCI impact from interest rate swap AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax Subsequent Events Subsequent Events [Text Block] Payment of dividends Payment of dividends Payments of Dividends Other liabilities Total accrued and other liabilities, Noncurrent Other Liabilities, Noncurrent Non-NEOs Non-NEOs [Member] Compensation and related benefits Employee-related Liabilities, Noncurrent Employee-related Liabilities, Noncurrent Cash Flow Hedging Cash Flow Hedging [Member] Segment Information Segment Reporting Disclosure [Text Block] Claims resolved Loss Contingency, Claims Settled and Dismissed, Number (Decrease) increase in Cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Term loans Secured Debt [Member] Revenue [Abstract] Revenue [Abstract] Revenue [Abstract] Non-PEO NEO Non-PEO NEO [Member] Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] Net Investment Hedges Accumulated Gain (Loss), Net Investment Hedges, Parent [Member] Accumulated Gain (Loss), Net Investment Hedges, Parent Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Scenario [Axis] Scenario [Axis] Debt Instrument [Line Items] Debt Instrument [Line Items] Weighted-average shares of common stock outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Maximum step-down leverage ratio Debt Instrument, Covenant, Leverage Ratio, Step-Down, Maximum Debt Instrument, Covenant, Leverage Ratio, Step-Down, Maximum Concentration Risk Type [Domain] Concentration Risk Type [Domain] Operating income Operating Income (Loss) Therapy Equipment Limited Therapy Equipment Limited [Member] Therapy Equipment Limited Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Facility closure costs and other Facility Closing [Member] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Segments [Axis] Segments [Axis] Statement [Line Items] Statement [Line Items] Concentration Risk [Table] Concentration Risk [Table] Other comprehensive (loss) income: Other Comprehensive Income (Loss), Net of Tax [Abstract] Scenario [Domain] Scenario [Domain] Schedule of Derivative Instruments Schedule of Derivative Instruments [Table Text Block] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Schedule of Long-Term Debt Schedule of Debt [Table Text Block] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Loss on discontinued operations (in dollars per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share Repayments of borrowings on revolving credit facility and other Proceeds from Long-Term Lines of Credit Type of Restructuring [Domain] Type of Restructuring [Domain] Warranty liability Product Warranty Accrual, Noncurrent Equity: Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Noncontrolling Interest Noncontrolling Interest [Member] EX-101.PRE 10 esab-20240329_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
COVER PAGE - shares
 3 Months Ended
Mar. 29, 2024
Apr. 22, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 29, 2024  
Document Transition Report false  
Entity File Number 001-41297  
Entity Registrant Name ESAB Corporation  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 87-0923837  
Entity Address, Address Line One 909 Rose Avenue  
Entity Address, Address Line Two 8th Floor  
Entity Address, City or Town North Bethesda  
Entity Address, State or Province MD  
Entity Address, Postal Zip Code 20852  
City Area Code (301)  
Local Phone Number 323-9099  
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol ESAB  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   60,424,421
Entity Central Index Key 0001877322  
Current Fiscal Year End Date --12-31  
Amendment Flag false  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2024  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Net sales $ 689,744 $ 684,000
Cost of sales 434,717 436,611
Gross profit 255,027 247,389
Selling, general and administrative expense 142,450 147,282
Restructuring and other related charges 1,924 9,444
Operating income 110,653 90,663
Pension settlement loss 12,155 0
Interest expense and other, net 17,091 19,510
Income from continuing operations before income taxes 81,407 71,153
Income tax expense 18,504 37,024
Net income from continuing operations 62,903 34,129
Loss from discontinued operations, net of taxes (1,309) (913)
Net income 61,594 33,216
Income attributable to noncontrolling interest, net of taxes (1,643) (1,313)
Net income attributable to ESAB Corporation $ 59,951 $ 31,903
Earnings (loss) per share – basic    
Income from continuing operations (in dollars per share) $ 1.01 $ 0.54
Loss on discontinued operations (in dollars per share) (0.02) (0.02)
Net income per share (in dollars per share) 0.99 0.52
Earnings (loss) per share – diluted    
Income from continuing operations (in dollars per share) 1.00 0.54
Loss on discontinued operations (in dollars per share) (0.02) (0.02)
Net income per share - diluted (in dollars per share) $ 0.98 $ 0.52
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Statement of Comprehensive Income [Abstract]    
Net income $ 61,594 $ 33,216
Other comprehensive (loss) income:    
Foreign currency translation, net of tax expense of $1,531 and $45 (25,354) 42,084
Unrealized income (loss) on derivatives designated and qualifying as cash flow hedges, net of tax expense (benefit) of $295 and $(1,045) 1,013 (3,581)
Defined benefit pension and other post-retirement plan activity, net of tax expense of $203 and $66 629 277
Other comprehensive (loss) income (23,712) 38,780
Comprehensive income 37,882 71,996
Comprehensive income attributable to noncontrolling interest 1,320 1,814
Comprehensive income attributable to ESAB Corporation $ 36,562 $ 70,182
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Parenthetical) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Statement of Comprehensive Income [Abstract]    
Unrealized gain on hedging activities, tax expense $ 295 $ (1,045)
Defined benefit pension and other post-retirement plan activity, tax expense (203) 66
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 61,594 33,216
Foreign currency translation adjustment (25,354) 42,084
Unrealized income (loss) on derivatives designated and qualifying as cash flow hedges, net of tax expense (benefit) of $295 and $(1,045) 1,013 (3,581)
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax 629 277
Other comprehensive income (loss), net of tax (expense) benefit (23,712) 38,780
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 37,882 71,996
Comprehensive income attributable to noncontrolling interest (1,320) (1,814)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 36,562 70,182
Foreign currency translation, tax expense (benefit) $ 1,531 $ 45
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED AND COMBINED CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 29, 2024
Dec. 31, 2023
CURRENT ASSETS:    
Cash and cash equivalents $ 76,495 $ 102,003
Trade receivables, less allowance for credit losses of $25,424 and $25,477 430,149 385,198
Inventories, net 405,601 392,858
Prepaid expenses 60,415 61,771
Other current assets 70,088 55,890
Total current assets 1,042,748 997,720
Property, plant and equipment, net 290,431 294,305
Goodwill 1,586,943 1,588,331
Intangible assets, net 484,219 499,535
Lease assets - right of use 94,162 95,607
Other assets 328,986 353,131
Total assets 3,827,489 3,828,629
CURRENT LIABILITIES:    
Accounts payable 338,399 306,593
Accrued liabilities 292,903 313,489
Total current liabilities 631,302 620,082
Long-term debt 992,798 1,018,057
Other liabilities 521,011 542,833
Total liabilities 2,145,111 2,180,972
Equity:    
Common stock - $0.001 par value - 600,000,000 shares authorized, $60,424,421 and 60,295,634 shares outstanding as of March 29, 2024 and December 31, 2023, respectively 60 60
Additional paid-in capital 1,881,534 1,881,054
Retained earnings 406,867 350,557
Accumulated other comprehensive loss (647,661) (624,272)
Total ESAB Corporation equity 1,640,800 1,607,399
Noncontrolling interest 41,578 40,258
Total equity 1,682,378 1,647,657
Total liabilities and equity $ 3,827,489 $ 3,828,629
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED AND COMBINED CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Mar. 29, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Trade receivables, allowance for doubtful accounts $ 25,424 $ 25,477
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 600,000,000 600,000,000
Common stock, shares outstanding (in shares) 60,424,421 60,295,634
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2022   60,094,725        
Beginning balance at Dec. 31, 2022 $ 1,388,458 $ 60 $ 1,865,904 $ 159,231 $ (674,988) $ 38,251
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 33,216     31,903   1,313
Distributions to noncontrolling owners (1,359)         (1,359)
Dividends declared (3,033)     (3,033)    
Other comprehensive income (loss), net of tax (expense) benefit 38,780       38,279 501
Common stock-based award activity (in shares)   127,538        
Common stock-based award activity 2,229   2,229      
Ending balance (in shares) at Mar. 31, 2023   60,222,263        
Ending balance at Mar. 31, 2023 1,458,291 $ 60 1,868,133 188,101 (636,709) 38,706
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive income (loss), tax expense (benefit) $ 934          
Quarterly cash dividend declared (in dollars per share) $ 0.05          
Beginning balance (in shares) at Dec. 31, 2023 60,295,634 60,295,634        
Beginning balance at Dec. 31, 2023 $ 1,647,657 $ 60 1,881,054 350,557 (624,272) 40,258
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 61,594     59,951   1,643
Dividends declared (3,641)     (3,641)    
Other comprehensive income (loss), net of tax (expense) benefit (23,712)       (23,389) (323)
Common stock-based award activity (in shares)   128,787        
Common stock-based award activity $ 480   480      
Ending balance (in shares) at Mar. 29, 2024 60,424,421 60,424,421        
Ending balance at Mar. 29, 2024 $ 1,682,378 $ 60 $ 1,881,534 $ 406,867 $ (647,661) $ 41,578
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive income (loss), tax expense (benefit) $ (2,029)          
Quarterly cash dividend declared (in dollars per share) $ 0.06          
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF EQUITY (Parenthetical) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Statement of Stockholders' Equity [Abstract]    
Dividends on common stock (in dollars per share) $ 0.06 $ 0.05
Other comprehensive income (loss), tax expense (benefit) $ (2,029) $ 934
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income $ 61,594 $ 33,216
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization, and other impairment charges 16,387 21,871
Stock-based compensation expense 4,133 2,994
Deferred income tax (638) 2,290
Non-cash interest expense 1,062 299
Pension settlement loss 12,155 0
Changes in operating assets and liabilities:    
Trade receivables, net (48,946) (21,048)
Inventories, net (16,078) (21,611)
Accounts payable 36,196 28,480
Other operating assets and liabilities (21,398) (8,424)
Net cash provided by operating activities 44,467 38,067
Cash flows from investing activities:    
Purchases of property, plant and equipment (7,414) (7,709)
Proceeds from sale of property, plant and equipment 368 681
Acquisition, net of cash received (18,067) (18,721)
Other (1,501) 0
Net cash used in investing activities (26,614) (25,749)
Cash flows from financing activities:    
Proceeds from borrowings on term credit facility 115,000 187,000
Repayments of borrowings on term credit facility (6,250) 0
Repayments of borrowings on revolving credit facility and other (139,035) (189,765)
Payment of dividends (3,635) (3,033)
Distributions to noncontrolling interest holders 0 (1,249)
Net cash used in financing activities (33,920) (7,047)
Effect of foreign exchange rates on Cash and cash equivalents (9,441) 4,769
(Decrease) increase in Cash and cash equivalents (25,508) 10,040
Cash and cash equivalents, beginning of period 102,003 72,024
Cash and cash equivalents, end of period $ 76,495 $ 82,064
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Organization and Basis of Presentation
 3 Months Ended
Mar. 29, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Basis of Presentation Organization and Basis of Presentation
Founded in 1904, ESAB Corporation (“ESAB” or the “Company”) is a focused premier industrial compounder. ESAB provides its partners with fabrication technology advanced equipment, consumables, gas control equipment, robotics, and digital solutions. The Company’s rich history of innovative products and workflow solutions and its business system ESAB Business Excellence (“EBX”) enables the Company’s purpose of Shaping the world we imagineTM. The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America, and “EMEA & APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific. On April 4, 2022, ESAB Corporation completed its spin-off from Colfax Corporation (“Colfax,” “Enovis” or “Former Parent”) and became an independent, public-traded company (the “Separation”).

The Company’s fiscal year ends December 31. The Company’s first quarter ends on the last business day of the 13th week after the end of the prior quarter. As used herein, the first quarter results for 2024 and 2023 refer to the 13-week periods ended March 29, 2024 and March 31, 2023, respectively.

Russia and Ukraine Conflict

The invasion of Ukraine by Russia and the sanctions imposed in response have increased the level of economic and political uncertainty. While ESAB continues to closely monitor the situation and evaluate options, the Company is meeting current contractual obligations while addressing applicable laws and regulations. For the three months ended March 29, 2024, Russia represented approximately 5% of the Company’s total revenue, and approximately $4 million of its Net income. Russia also has approximately 3% of the Company’s total net assets excluding any goodwill allocation as of March 29, 2024. In case of a disposition of the Russia business, a portion of goodwill would need to be allocated and disposed of at the relative fair value attributable to the Russia business. Russia has a cumulative translation loss of approximately $118 million as of March 29, 2024, which could be realized upon a transition out. The Company is closely monitoring developments in Ukraine and Russia. Changes in laws and regulations or other factors impacting the Company’s ability to fulfill contractual obligations could have an adverse effect on the results of operations.

Basis of Presentation

The Consolidated and Condensed Financial Statements included herein have been prepared by the Company pursuant to the rules and regulations of the Security and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in the financial statements prepared in accordance with the accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted pursuant to SEC rules and regulations; however the Company believes that the disclosures are adequate to make the information presented not misleading.

The Consolidated and Condensed Financial Statements reflect, in the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Intercompany transactions and accounts are eliminated in consolidation.

In the normal course of business, the Company incurs research and development costs related to new product development, which are expensed as incurred and included in Selling, general and administrative expenses on the Company’s Consolidated and Condensed Statements of Operations. Research and development costs were $10.1 million and $9.6 million during the three months ended March 29, 2024 and March 31, 2023, respectively. These amounts do not include development and application engineering costs incurred in conjunction with fulfilling customer orders and executing customer projects, nor do they include costs related to securing third party product rights. The Company expects to continue making significant expenditures for research and development to maintain and improve its competitive positions.

The accompanying interim Consolidated and Condensed Financial Statements and the related notes should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”), filed with the SEC on February 29, 2024.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Discontinued Operations
 3 Months Ended
Mar. 29, 2024
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations Discontinued Operations
The Company holds certain asbestos-related contingencies and insurance coverages from divested businesses for which it does not have an interest in the ongoing operations. The Company has classified asbestos-related activity in its Consolidated and Condensed Statements of Operations as part of Loss from discontinued operations, net of taxes. This activity consists primarily of expected settlements, legal and administrative expenses associated with the above liabilities.

For the three months ended March 29, 2024 and March 31, 2023, respectively, loss from discontinued operations, net of taxes was $1.3 million and $0.9 million. See Note 14, “Commitments and Contingencies” for further information.

Cash used in operating activities related to discontinued operations for the three months ended March 29, 2024 and March 31, 2023 was $3.7 million and $5.4 million, respectively.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Acquisition
 3 Months Ended
Mar. 29, 2024
Business Combinations [Abstract]  
Acquisition Acquisitions
On February 26, 2024, the Company completed the acquisition of Sager S.A., a welding repair and maintenance product and service leader in South America, for $18.1 million, net of cash received.

On January 11, 2023, the Company completed the acquisition of Therapy Equipment Limited, a regional leader in oxygen regulators, for $18.7 million, net of cash received.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue
 3 Months Ended
Mar. 29, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
The Company provides fabrication technology advanced equipment, consumables, gas control equipment, robotics and digital solutions. The Company’s products are utilized to solve challenges in a wide range of industries. Substantially all revenue is recognized at a point in time. The Company disaggregates its revenue into the following product groups:
Three Months Ended
March 29, 2024March 31, 2023
(In thousands)
Equipment$214,860 $200,219 
Consumables474,884 483,781 
Total$689,744 $684,000 

The sales mix in the above table is relatively consistent across both reportable segments. The consumables product grouping generally has less production complexity and shorter production cycles than equipment products.

Given the nature of the business, the total amount of unsatisfied performance obligations with an original contract duration of greater than one year as of March 29, 2024 is immaterial. In some circumstances, customers are billed in advance of revenue recognition, resulting in contract liabilities. As of December 31, 2023 and December 31, 2022, total contract liabilities were $31.2 million and $25.9 million, respectively, and were included in Accrued liabilities on the Consolidated and Condensed Balance Sheets. During the three months ended March 29, 2024 and March 31, 2023, revenue recognized that was included in the contract liabilities balance at the beginning of the year was $16.2 million and $11.1 million, respectively. As of March 29, 2024 and March 31, 2023, total contract liabilities were $29.5 million and $28.3 million, respectively, and were included in Accrued liabilities on the Company’s Consolidated and Condensed Balance Sheets.
Allowance for Credit Losses

A summary of the activity in the Company’s allowance for credit losses included within Trade receivables in the Consolidated and Condensed Balance Sheets is as follows:
Three Months Ended March 29, 2024
Balance at
Beginning
of Period		Charged to Expense, netWrite-Offs and DeductionsForeign
Currency
Translation		Balance at
End of
Period
(In thousands)
Allowance for credit losses$25,477 $651 $(439)$(265)$25,424 
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings per Share from Continuing Operations
 3 Months Ended
Mar. 29, 2024
Earnings Per Share [Abstract]  
Earnings per Share from Continuing Operations Earnings per Share from Continuing Operations
The Company has unvested share-based payment awards with a right to receive non-forfeitable dividends, which are considered participating securities. The Company allocates earnings to participating securities and computed earnings per share using the two-class method as follows:
Three Months Ended
March 29, 2024March 31, 2023
(In thousands, except share and per share data)
Computation of earnings per share from continuing operations – basic:
Income from continuing operations attributable to ESAB Corporation(1)
$61,260 $32,816 
Less: distributed and undistributed earnings allocated to nonvested shares(365)(237)
Income from continuing operations attributable to common stockholders$60,895 $32,579 
Weighted-average shares of Common stock outstanding – basic60,346,121 60,146,348 
Income per share from continuing operations – basic$1.01 $0.54 
Computation of earnings per share from continuing operations – diluted:
Income from continuing operations attributable to common stockholders$60,895 $32,579 
Weighted-average shares of Common stock outstanding – basic60,346,121 60,146,348 
Net effect of potentially dilutive securities(2)
641,836 339,878 
Weighted-average shares of Common stock outstanding – dilution60,987,957 60,486,226 
Net income per share from continuing operations – diluted$1.00 $0.54 
(1) Net income from continuing operations attributable to ESAB Corporation for the respective periods is calculated using Net income from continuing operations, less Income attributable to noncontrolling interest, net of taxes, of $1.6 million for the three months ended March 29, 2024 and $1.3 million for the three months ended March 31, 2023.
(2) Potentially dilutive securities include stock options, performance-based restricted stock units and non-performance-based restricted stock units.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes
 3 Months Ended
Mar. 29, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
During the three months ended March 29, 2024, Income from continuing operations before income taxes was $81.4 million, while Income tax expense was $18.5 million. The effective tax rate was 22.7% for the three months ended March 29, 2024. The effective tax rate differed from the 2024 U.S. federal statutory rate of 21.0% primarily due to withholding taxes.

During the three months ended March 31, 2023, Income from continuing operations before income taxes was $71.2 million, while Income tax expense was $37.0 million. The effective tax rate was 52.0% for the three months ended March 31, 2023. The effective tax rate differed from the 2023 U.S. federal statutory rate of 21.0% primarily due to discrete tax expenses in 2023 for dividend withholding taxes and an increase in the liability for uncertain tax positions as discussed below, that do not recur in 2024.
During the three months ended March 31, 2023, the Company changed its indefinite reinvestment assertion on certain undistributed earnings of the Company’s foreign subsidiaries, resulting in a total tax expense of $10.9 million, as of March 31, 2023 on such earnings that have not been indefinitely reinvested.

The Company records a liability for certain unrecognized income tax benefits for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority (“uncertain tax positions”). During the three months ended March 31, 2023, due to an adverse court ruling in a tax case in a foreign jurisdiction, the Company increased the related liability for uncertain tax positions by $9.4 million partially offset by changes in other positions.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Inventories, Net
 3 Months Ended
Mar. 29, 2024
Inventory Disclosure [Abstract]  
Inventories, Net Inventories, Net
Inventories, net consisted of the following:
March 29, 2024
December 31, 2023
(In thousands)
Raw materials$153,072 $156,583 
Work in process48,627 43,561 
Finished goods253,643 244,580 
455,342 444,724 
LIFO reserve(4,980)(4,279)
Allowance for excess, slow-moving and obsolete inventory(44,761)(47,587)
$405,601 $392,858 

At March 29, 2024 and December 31, 2023, 26.0% and 27.4% of total inventories, respectively, were valued using the LIFO method.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accrued and Other Liabilities
 3 Months Ended
Mar. 29, 2024
Accrued Liabilities [Abstract]  
Accrued and Other Liabilities Accrued and Other Liabilities
Accrued and Other liabilities in the Consolidated and Condensed Balance Sheets consisted of the following:
March 29, 2024December 31, 2023
CurrentNoncurrentCurrentNoncurrent
(In thousands)
Accrued taxes and deferred tax liabilities$44,727 $144,214 $45,681 $144,662 
Compensation and related benefits75,906 50,750 97,052 52,589 
Asbestos liability34,111 223,829 32,908 234,796 
Contract liabilities29,548 — 31,248 — 
Lease liabilities22,936 73,995 22,794 76,609 
Warranty liability12,936 — 12,606 — 
Third-party commissions11,224 — 18,711 — 
Restructuring liability4,045 256 5,345 354 
Other57,470 27,967 47,144 33,823 
$292,903 $521,011 $313,489 $542,833 
Accrued Warranty Liability
A summary of the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated and Condensed Balance Sheets is as follows:
Three Months Ended
March 29, 2024March 31, 2023
(In thousands)
Warranty liability, beginning of period$12,606 $12,946 
Accrued warranty expense2,457 1,393 
Changes in estimates related to pre-existing warranties727 672 
Cost of warranty service work performed(2,647)(2,678)
Foreign exchange translation effect(207)964 
Warranty liability, end of period$12,936 $13,297 

Accrued Restructuring Liability

The Company’s restructuring programs include a series of actions to reduce the structural costs of the Company. A summary of the activity in the Company’s restructuring liability included in Accrued and Other liabilities in the Consolidated and Condensed Balance Sheets is as follows:
Three Months Ended March 29, 2024
Balance at Beginning of PeriodChargesPaymentsForeign Currency TranslationBalance at End of Period
(In thousands)
Restructuring and other related charges:
Termination benefits(1)
$4,595 $1,320 $(1,507)$(352)$4,056 
Facility closure costs and other(2)
1,104604 (1,404)(59)245 
Total$5,699 $1,924 $(2,911)$(411)$4,301 
(1) Includes severance and other termination benefits, including outplacement services.
(2) Includes the cost of relocating associates, relocating equipment, lease termination expense and other costs in connection with the closure and optimization of facilities and product lines.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Benefit Plans
 3 Months Ended
Mar. 29, 2024
Retirement Benefits [Abstract]  
Benefit Plans Benefit Plans
The Company sponsors various defined benefit plans and other post-retirement benefits plans, including health and life insurance, for certain eligible employees or former employees.

During the three months ended March 29, 2024, the Company recognized a non-cash pension settlement loss of $12.2 million related to the transfer of plan assets to a third party as part of externalizing the risk associated with a foreign defined benefit plan. This amount is reflected in Pension settlement loss in the Consolidated and Condensed Statements of Operations.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt
 3 Months Ended
Mar. 29, 2024
Debt Disclosure [Abstract]  
Debt Debt
Long-term debt consisted of the following:
March 29, 2024December 31, 2023
(In thousands)
Term loans$981,250 $987,500 
Revolving credit facilities12,000 32,000 
Total debt993,250 1,019,500 
Unamortized deferred financing fees(452)(1,443)
Long-term debt$992,798 $1,018,057 
Term Loans and Revolving Credit Facility

On April 4, 2022, the Company entered into a credit agreement (as amended and restated from time-to-time, the “Credit Agreement”) in connection with the Separation. The Credit Agreement initially consisted of the following facilities:

•A $750 million revolving credit facility (the “Revolving Facility”) with a maturity date of April 4, 2027;

•A Term A-1 loan with an initial aggregate principal amount of $400 million (the “Term Loan A-1 Facility”), with a maturity date of April 4, 2027; and

•A $600 million 364-day senior term loan facility (the “Term Loan A-2 Facility”) with a maturity date of April 3, 2023.

The Revolving Facility contains a $300 million foreign currency sublimit and a $50 million swing line loan sub-facility.

On April 4, 2022, the Company drew down $1.2 billion available under the credit facilities consisting of (i) $200 million under the Revolving Facility, (ii) $400 million under the Term Loan A-1 Facility and (iii) $600 million under the Term Loan A-2 Facility. The Company used these proceeds to make payments to Enovis of $1.2 billion, which was used as part of the consideration for the contribution of certain assets and liabilities to the Company by Enovis in connection with the Separation.

On June 28, 2022, the Company amended and restated the Credit Agreement by entering into Amendment No. 2 to Credit Agreement (“Credit Agreement Amendment”). The Credit Agreement Amendment provides for a $600 million term loan facility (the “Term Loan A-3 Facility” and, together with the Term Loan A-1 Facility, the “Term Facilities”, and together with the Revolving Facility, the “Facilities”) with a maturity date of April 3, 2025 to refinance the Company’s existing Term Loan A-2 Facility. Also on June 28, 2022, the Company borrowed the entire $600 million under Term Loan A-3 Facility to fund the repayment of the Term Loan A-2 Facility.

As March 29, 2024, the Credit Agreement consisted of the following facilities:

•A $750 million revolving credit facility (the “Revolving Facility”) with a maturity date of April 4, 2027, of which $12 million was drawn;

•A Term A-1 loan with an aggregate principal amount of $393 million (the “Term Loan A-1 Facility”) with a maturity date of April 4, 2027; and

• A Term A-3 loan with an aggregate principal amount of $589 million (the “Term Loan A-3 Facility”) with a maturity date of April 3, 2025. Refer to Note 16, “Subsequent Events” for further information.

The draw-down and repayment related to these term facilities are presented net within the Consolidated and Condensed Statements of Cash Flows.

The Credit Agreement contains customary covenants limiting the ability of the Company and its subsidiaries to, among other things, incur debt or liens, merge or consolidate with others, dispose of assets, make investments or pay dividends. In addition, the Credit Agreement contains financial covenants requiring the Company to maintain (i) a maximum total leverage ratio of not more than 4.00:1.00, with step-downs to, commencing with the fiscal quarter ending June 30, 2023, 3.75:1.00, and commencing with the fiscal quarter ending June 30, 2024, 3.50:1.00, and (ii) a minimum interest coverage ratio of 3.00:1.00. The Credit Agreement contains various events of default (including failure to comply with the covenants under the Credit Agreement and related agreements) and upon an event of default the lenders may, subject to various customary cure rights, require the immediate payment of all amounts outstanding under the Term Facilities and the Revolving Facility. Certain United States subsidiaries of the Company have agreed to guarantee the obligations of the Company under the Credit Agreement.

Loans made under the Term Facilities will bear interest, at the election of the Company, at either the base rate (as defined in the Credit Agreement) or at the term Secured Overnight Financing Rate (“SOFR”) rate plus an adjustment (as defined in the Credit Agreement), in each case, plus the applicable interest rate margin. Loans made under the Revolving Facility will bear interest, at the election of the Company, at either the base rate or, (i) in the case of loans denominated in dollars, the term SOFR rate plus an adjustment or the daily simple SOFR plus an adjustment, (ii) in the case of loans denominated in euros, the adjusted Euro Interbank Offered Rate (“EURIBOR”) rate and, (iii) in the case of loans denominated in sterling, Sterling Overnight Index
Average (“SONIA”) plus an adjustment (as all such rates are defined in the Credit Agreement Amendment), in each case, plus the applicable interest rate margin. The applicable interest rate margin changes based upon the Company’s total leverage ratio (consolidated total debt divided by EBITDA, as defined in the credit agreement and ranging from 1.125% to 1.750% or in the case of the base rate margin, 0.125% to 0.750%). Each swing line loan denominated in dollars will bear interest at the base rate plus the applicable interest rate margin.

To manage exposures to currency exchange rates and interest rates arising in Long-term debt, the Company entered into interest rate and cross currency swap agreements during the year ended December 31, 2022. Refer to Note 11, “Derivatives” for additional information.

As of March 29, 2024, the weighted-average interest rate of borrowings under the Credit Agreement was 5.09%, including the net impact from the interest rate and cross currency swaps and excluding accretion of deferred financing fees, and there was $738 million of borrowing capacity available under the Revolving Facility, subject to meeting financial covenants and other requirements.

Other Indebtedness

In addition to the debt agreements discussed above, the Company also has the ability to incur approximately $77 million of indebtedness pursuant to certain uncommitted credit lines, consisting of an uncommitted credit line that the Company has used from time to time in the past for short-term working capital needs.

The Company is party to letter of credit facilities with an aggregate capacity of $109.0 million. Total letters of credit of $28.3 million were outstanding as of March 29, 2024.

Deferred Financing Fees

The Company had total deferred financing fees of $1.3 million included in its Consolidated Balance Sheet as of March 29, 2024, which will be charged to Interest expense and other, net, using the straight-line method. The costs associated with the Term Facilities will be amortized over the contractual term of the Term Facilities and the costs associated with the Revolving Facility will be amortized over the life of the Credit Agreement. Of the $1.3 million, $0.8 million of deferred financing fees relating to the Revolving Facility are included in Other assets and $0.5 million of deferred financing fees relating to the Term Facilities are recorded as a contra-liability within Long-term debt.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivatives
 3 Months Ended
Mar. 29, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivatives Derivatives
The Company uses derivative instruments to manage exposures to currency exchange rates and interest rates arising in connection with Long-term debt and the normal course of business. The Company has established policies and procedures that govern the risk management of these exposures. Both at inception and on an ongoing basis, the derivative instruments that qualify for hedge accounting are assessed as to their effectiveness, when applicable.

The Company is subject to the credit risk of counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. None of the concentrations of risk with an individual counterparty was considered significant as of March 29, 2024. The Company does not expect any counterparties to fail to meet their obligations. The Company records derivatives in the Consolidated and Condensed Balance Sheets at fair value.

Cash Flow Hedges

On July 14, 2022, the Company entered into two interest rate swap agreements to manage interest rate risk exposure. The aggregate notional amount of these contracts is $600 million and they mature in April 2025. These interest rate swap agreements utilized by the Company effectively modify the Company’s exposure to interest rate risk by converting a portion of the Company’s floating-rate debt to a fixed rate of 3.293%, plus a spread, thus reducing the impact of interest-rate changes on future interest expense. The applicable spread may vary between 1.125% to 1.750%, depending on the total leverage ratio of the Company.

In March 2024, the Company received $5.5 million to settle one of the interest rate swaps associated with the Company’s floating-rate debt. The termination of the interest rate swap related to the anticipated repayment of the Term A-3 Facility when
completed in April with the proceeds of the April 2024 $700 million Senior Note Offering. Refer to Note 16, “Subsequent Events” for further information. As this interest rate swap was designated as a cash flow hedge, $5.5 million was deferred in accumulated other comprehensive income (loss) (“AOCI”) and will be recognized in earnings over the period the originally forecasted hedged transaction impacts earnings. The remaining $300 million swap will continue to be hedged against the remaining floating-rate debt.

For the remaining swap, the spread was 1.250% as of March 29, 2024. This agreement involves the receipt of floating-rate amounts in exchange for fixed-rate interest payments over the life of the agreement without an exchange of the underlying principal amount. This interest rate swap agreement is designated and qualifies as a cash flow hedge and as such, the gain or loss on the derivative instrument due to the change in fair value is reported as a component of AOCI and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is deemed to be ineffective, the change in fair value of the derivative is recognized directly in earnings. The Company did not have any ineffectiveness related to the cash flow hedges during the three months ended March 29, 2024.

The cash inflows and outflows associated with the Company’s interest rate swap agreement designated as cash flow hedges are classified in cash flows from operating activities in the accompanying Consolidated and Condensed Statements of Cash Flows.

The Company expects a gain of $4.0 million, net of tax, related to interest rate swap agreements to be reclassified from AOCI to earnings over the next 12 months as the hedged transactions are realized. The expected gain to be reclassified is based on current forward rates in active markets as of March 29, 2024.

The effects of designated cash flow hedges on the Company’s Consolidated and Condensed Statements of Operations consisted of the following:
Three Months Ended
Derivative type(Gain) recognized in the Consolidated and Condensed Statements of Operations:March 29, 2024March 31, 2023
(In thousands)
Interest rate swap agreementsInterest expense and other, net$(2,722)$(1,977)

Net Investment Hedges

On July 22, 2022, the Company entered into two cross-currency swap agreements to partially hedge its net investment in its Euro-denominated subsidiaries against adverse movements in exchange rates between the U.S. Dollar and the Euro. In addition, the cross-currency swap agreements include provisions to exchange fixed-rate payments in U.S. Dollar for fixed-rate payments in Euro and are designated and qualify as a net investment hedge. These contracts have a Euro aggregate notional amount of approximately €270 million and a U.S. Dollar aggregate notional amount of $275 million at March 29, 2024, and they mature in April 2025.

The changes in the spot rate of these instruments are recorded in AOCI in equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCI. The Company uses the spot method of assessing hedge effectiveness and as such, the initial value of the hedge components excluded from the assessment of effectiveness is recognized in the Interest expense and other, net line item in the Consolidated and Condensed Statement of Operations under a systematic and rational method over the life of the cross-currency swap agreements. Any ineffective portions of net investment hedges are reclassified from AOCI into earnings during the period of change. The Company did not have any ineffectiveness related to net investment hedges during the three months ended March 29, 2024.

The cash inflows and outflows associated with the excluded components of the Company’s cross-currency swap agreements designated as net investment hedges are classified in operating activities in the accompanying Consolidated and Condensed Statements of Cash Flows.
The effects of the excluded components of designated net investment hedges on the Company’s Consolidated and Condensed Statements of Operations consisted of the following:
Three Months Ended
Derivative type(Gain) recognized in the Consolidated and Condensed Statements of Operations:March 29, 2024March 31, 2023
(In thousands)
Cross currency swap agreementsInterest expense and other, net$(1,179)$(1,201)

The table below shows the fair value of the derivatives recognized in the Consolidated Balance Sheet:
March 29, 2024December 31, 2023
Designated as hedging instrumentsOther LiabilitiesOther AssetsOther LiabilitiesOther Assets
(In thousands)
Cross currency swap agreements$15,783 $— $22,232 $— 
Interest rate swap agreements— 5,174 — 9,522 
Total $15,783 $5,174 $22,232 $9,522 

Derivatives Not Designated as Hedging Instruments

The Company has certain foreign currency contracts that are not designated as hedges. As of March 29, 2024 and December 31, 2023, the Company had foreign currency contracts related to purchases and sales with notional values of $267.2 million and $232.5 million, respectively.

The table below shows the fair value of derivative instruments not designated in a hedging relationship recognized in the Consolidated Balance Sheet:
March 29, 2024December 31, 2023
Not designated as hedging instrumentsAccrued LiabilitiesOther Current AssetsAccrued LiabilitiesOther Current Assets
(In thousands)
Foreign currency contracts$431 $874 $596 $1,088 

The amounts in the table above as of March 29, 2024 reflect the fair value of the Company’s foreign currency contracts on a net basis where allowable under master netting agreements. Had these amounts been recognized on a gross basis, the impact would have been a $0.6 million increase in Other current assets with a corresponding increase in Accrued liabilities.

The Company recognized the following in its Consolidated and Condensed Financial Statements related to its derivative instruments not designated in a hedging relationship:
Three Months Ended
Foreign currency contractsMarch 29, 2024March 31, 2023
(In thousands)
Change in unrealized gains (losses)$(49)$143 
Realized gains (losses)(394)1,027 

The above gains or losses on foreign currency contracts are usually offset by foreign exchange exposure on cash and intercompany positions, all of which are recognized in Interest expense and other, net, in the Consolidated and Condensed Statements of Operations.
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value Measurements
 3 Months Ended
Mar. 29, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The carrying values of financial instruments, including Trade receivables and Accounts payable, approximate their fair values due to their short-term maturities. The estimated fair values may not represent actual values of the financial instruments that could be realized as of the balance sheet date or that will be realized in the future.
A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is as follows:
March 29, 2024
Level
One		Level
Two		Level
Three		Total
(In thousands)
Assets:
Cash equivalents$2,968 $— $— $2,968 
Foreign currency contracts - not designated as hedges— 1,457 — 1,457 
Interest rate swap agreements— 5,174 — 5,174 
Deferred compensation plans— 4,281 — 4,281 
$2,968 $10,912 $— $13,880 
Liabilities:
Foreign currency contracts - not designated as hedges$— $1,014 $— $1,014 
Cross currency swap agreements— 15,783 — 15,783 
Deferred compensation plans— 4,281 — 4,281 
$— $21,078 $— $21,078 

December 31, 2023
Level
One		Level
Two		Level
Three		Total
(In thousands)
Assets:
Cash equivalents$6,027 $— $— $6,027 
Foreign currency contracts - not designated as hedges— 2,261 — 2,261 
Interest rate swap agreements— 9,522 — 9,522 
Deferred compensation plans— 3,488 — 3,488 
$6,027 $15,271 $— $21,298 
Liabilities:
Foreign currency contracts - not designated as hedges$— $1,769 $— $1,769 
Cross currency swap agreements — 22,232 — 22,232 
Deferred compensation plans— 3,488 — 3,488 
$— $27,489 $— $27,489 

The Company measures the fair value of foreign currency contracts, cross currency swap agreements and interest rate swap agreements using Level Two inputs based on observable spot and forward rates in active markets. Additionally, the fair value of derivatives designated in hedging relationships includes a credit valuation adjustment to appropriately incorporate nonperformance risk for the Company and the respective counterparty. For the three months ended March 29, 2024, the impact of the credit valuation adjustment on the Company’s derivatives is immaterial. Refer to Note 11, “Derivatives” for additional information.

There were no transfers in or out of Level One, Two or Three during the three months ended March 29, 2024.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity
 3 Months Ended
Mar. 29, 2024
Equity [Abstract]  
Equity Equity
Accumulated Other Comprehensive Loss

The following tables present the changes in the balances of each component of AOCI including reclassifications out of AOCI for the three months ended March 29, 2024 and March 31, 2023. All amounts are net of tax and noncontrolling interest, if any.
Accumulated Other Comprehensive Loss Components
Net Unrecognized Pension and Other Post-Retirement Benefit CostForeign Currency Translation AdjustmentNet Investment HedgesCash Flow HedgesTotal
(In thousands)
Balance at December 31, 2023
$(59,805)$(554,622)$(17,215)$7,370 $(624,272)
Other comprehensive income (loss) before reclassifications:
Foreign currency translation adjustment243 (38,265)4,995 — (33,027)
Gain on long-term intra-entity foreign currency transactions— 7,996 — — 7,996 
Unrealized loss on cash flow hedges— — — 3,920 3,920 
Other comprehensive income (loss) before reclassifications243 (30,269)4,995 3,920 (21,111)
Amounts reclassified from Accumulated other comprehensive loss(1)(2)
629 — — (2,907)(2,278)
Net current period Other comprehensive income (loss)872 (30,269)4,995 1,013 (23,389)
Balance at March 29, 2024
$(58,933)$(584,891)$(12,220)$8,383 $(647,661)
(1) The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost.
(2) During the three months ended March 29, 2024, the amount within Cash Flow Hedges is a component of Interest expense and other, net. See Note 11, “Derivatives” for additional details.
Accumulated Other Comprehensive Loss Components
Net Unrecognized Pension and Other Post-Retirement Benefit CostForeign Currency Translation AdjustmentNet Investment HedgesCash Flow HedgesTotal
(In thousands)
Balance at December 31, 2022
$(63,847)$(613,907)$(8,336)$11,102 $(674,988)
Other comprehensive income (loss) before reclassifications:
Net actuarial loss(2)— — — (2)
Foreign currency translation adjustment(108)31,276 (2,086)— 29,082 
Gain on long-term intra-entity foreign currency transactions— 12,501 — — 12,501 
Unrealized loss on cash flow hedges— — — (2,051)(2,051)
Other comprehensive (loss) income before reclassifications(110)43,777 (2,086)(2,051)39,530 
Amounts reclassified from Accumulated other comprehensive loss(1)(2)
279 — — (1,530)(1,251)
Net current period Other comprehensive (loss) income169 43,777 (2,086)(3,581)38,279 
Balance at March 31, 2023
$(63,678)$(570,130)$(10,422)$7,521 $(636,709)
(1) The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost.
(2) During the three months ended March 31, 2023, the amount within Cash Flow Hedges is a component of Interest expense and other, net. See Note 11, “Derivatives” for additional details.
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies
 3 Months Ended
Mar. 29, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Asbestos Contingencies

Certain entities that became subsidiaries of ESAB Corporation in connection with the Separation are the legal obligor, or owner, for certain asbestos obligations including long-term asbestos insurance assets, long-term asbestos insurance receivables, accrued asbestos liabilities, long-term asbestos liabilities, asbestos indemnity expenses, asbestos-related defense costs and asbestos insurance recoveries related to the asbestos obligations from the Former Parent’s other legacy industrial businesses. As a result, the Company holds certain asbestos-related contingencies and insurance coverages.

These subsidiaries are each one of many defendants in a large number of lawsuits that claim personal injury as a result of exposure to asbestos from products manufactured or used with components that are alleged to have contained asbestos. Such components were acquired from third-party suppliers, and were not manufactured by any of the Company’s, or Former Parent’s, subsidiaries, nor were the subsidiaries, producers or direct suppliers of asbestos. The manufactured products that are alleged to have contained or used asbestos generally were provided to meet the specifications of the subsidiaries’ customers, including the U.S. Navy. The subsidiaries settle asbestos claims for amounts the Company considers reasonable given the facts and circumstances of each claim. The annual average settlement payment per asbestos claimant has fluctuated during the past several years while the number of cases has steadily declined. The Company expects such settlement value fluctuations to continue in the future based upon, among other things, the number and type of claims settled in a particular period and the jurisdictions in which such claims arise. To date, the majority of settled claims have been dismissed for no payment to plaintiffs.

The Company has classified asbestos-related activity in Loss from discontinued operations, net of taxes in the Consolidated and Condensed Statements of Operations. This is consistent with the Former Parent’s classification on the basis that, pursuant to the purchase agreement from the Former Parent’s Fluid Handling business divestiture, the Former Parent retained its asbestos-related contingencies and insurance coverages. However, as the Former Parent did not retain an interest in the ongoing operations of the business subject to the contingencies, asbestos-related activity was classified as part of Loss from discontinued operations, net of taxes in the Condensed Consolidated Statements of Operations of the Former Parent.

The Company has projected each subsidiary’s future asbestos-related liability costs with regard to pending and future unasserted claims based upon the Nicholson methodology. The Nicholson methodology is a standard approach used by experts and has been accepted by numerous courts. Consistent with the Former Parent, it is ESAB’s policy to record a liability for asbestos-related liability costs for the longest period of time that ESAB management can reasonably estimate.

The Company believes that it can reasonably estimate the asbestos-related liability for pending and future claims that will be resolved in the next 15 years and has recorded that liability as its best estimate. While it is reasonably possible that the subsidiaries will incur costs after this period, the Company does not believe the reasonably possible loss or a range of reasonably possible losses is estimable at the current time. Accordingly, no accrual has been recorded for any costs that may be paid after the next 15 years. Defense costs associated with asbestos-related liabilities as well as costs incurred related to efforts to recover insurance from the subsidiaries’ insurers are expensed as incurred.

Each subsidiary has separate insurance coverage acquired prior to Company ownership. The Company estimates the insurance assets for each subsidiary based upon the applicable policy language, expected recoveries and allocation methodologies, and law pertaining to the affected subsidiary’s insurance policies.
Asbestos-related claims activity since December 31 is as follows:
Three Months Ended
March 29, 2024March 31, 2023
(Number of claims)
Claims unresolved, beginning of period13,648 14,106 
Claims filed(1)
1,297 986 
Claims resolved(2)
(714)(749)
Claims unresolved, end of period14,231 14,343 
(1) Claims filed include all asbestos claims for which notification have been received or a file has been opened.
(2) Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants.

The Company’s Consolidated Balance Sheet included the following amounts related to asbestos-related litigation:
March 29, 2024December 31, 2023
(In thousands)
Long-term asbestos insurance asset(1)
$213,323 $221,489 
Long-term asbestos insurance receivable(1)
18,306 17,868 
Accrued asbestos liability(2)
34,111 32,908 
Long-term asbestos liability(3)
223,829 234,796 
(1) Included in Other assets in the Consolidated Balance Sheets.
(2) Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay, and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Consolidated Balance Sheets.
(3) Included in Other liabilities in the Consolidated Balance Sheets.

Management’s analyses are based on currently known facts and assumptions. Projecting future events, such as new claims to be filed each year, the average cost of resolving each claim, coverage issues among layers of insurers, the method in which losses will be allocated to the various insurance policies, interpretation of the effect on coverage of various policy terms and limits and their interrelationships, the continuing solvency of various insurance companies, the amount of remaining insurance available, as well as the numerous uncertainties inherent in asbestos litigation could cause the actual liabilities and insurance recoveries to be higher or lower than those projected or recorded that could materially affect the Company’s financial condition, results of operations or cash flow.

General Litigation

The Company is involved in various pending legal proceedings arising out of the ordinary course of the Company’s business. None of these legal proceedings is expected to have a material adverse effect on the financial condition, results of operations or cash flow of the Company. With respect to these proceedings, and the litigation and claims described in the preceding paragraphs, management of the Company believes that it will either prevail, has adequate insurance coverage or has established appropriate accruals to cover potential liabilities. Legal costs related to proceedings or claims are recorded when incurred. Other costs that management estimates may be paid related to the claims are accrued when the liability is considered probable and the amount can be reasonably estimated. There can be no assurance, however, as to the ultimate outcome of any of these matters, and if all or substantially all of these legal proceedings were to be determined adverse to the Company, there could be a material adverse effect on the financial condition, results of operations or cash flow of the Company.
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Information
 3 Months Ended
Mar. 29, 2024
Segment Reporting [Abstract]  
Segment Information Segment Information
ESAB is a focused premier industrial compounder. ESAB provides its partners with fabrication technology, advanced equipment, consumables, gas control equipment, welding robotics and digital solutions.

The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America, and “EMEA & APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific.
The Company’s management evaluates the operating results of each of its reportable segments based upon Net sales and Adjusted EBITDA, which represents Net income from continuing operations excluding the impact of Income tax expense, Interest expense and other, net, Pension settlement (loss), Restructuring and other related charges, acquisition - amortization and other related charges and depreciation and other amortization.

The Company’s segment results were as follows:
Three Months Ended
March 29, 2024March 31, 2023
(In thousands)
Net sales:
Americas$296,047 $291,569 
EMEA & APAC393,697 392,431 
$689,744 $684,000 
Adjusted EBITDA(1):
Americas$54,098 $49,442 
EMEA & APAC75,039 68,547 
$129,137 $117,989 
(1) The following is a reconciliation of Net income from continuing operations to Adjusted EBITDA.
Three Months Ended
March 29, 2024March 31, 2023
(In thousands)
Net income from continuing operations$62,903 $34,129 
Income tax expense 18,504 37,024 
Interest expense and other, net(1)
17,091 19,510 
Pension settlement loss12,155 — 
Restructuring and other related charges1,924 9,444 
Acquisition - amortization and other related charges(2)
7,777 9,289 
Depreciation and other amortization8,783 8,593 
Adjusted EBITDA$129,137 $117,989 
(1) Relates to removal of interest expense, net included within the Interest expense and other, net line within the Consolidated and Condensed Statements of Operations.
(2) Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Subsequent Events
 3 Months Ended
Mar. 29, 2024
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
On April 9, 2024, the Company completed a $700.0 million Senior Note Offering (“the Offering”). The Offering has a contractual interest rate of 6.25% and expected maturity date of April 15, 2029. The Company used the net proceeds from the Offering to repay $588.8 million of borrowings under its Term Loan A-3 Facility and pay fees associated with the Offering. The Company intends to use the remaining proceeds received to repay borrowings under its Revolving Facility and other general corporate purposes. The Offering did not have any material changes to the required financial covenants for the Company.

The dividend of $3.6 million included in Accrued liabilities in the Consolidated Balance Sheet at March 29, 2024 was paid on April 12, 2024 to stockholders of record as of March 29, 2024.

On April 30, 2024, the Company reached an agreement to acquire SUMIG Soluções para Solda e Corte Ltda, a South American light automation and equipment business for approximately $74 million of cash consideration. This acquisition is expected to be completed during the second half of 2024, subject to the receipt of applicable regulatory approvals and customary closing conditions.
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Pay vs Performance Disclosure    
Net income $ 59,951 $ 31,903
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Insider Trading Arrangements
 3 Months Ended
Mar. 29, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Organization and Basis of Presentation (Policies)
 3 Months Ended
Mar. 29, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Fiscal Period The Company’s fiscal year ends December 31. The Company’s first quarter ends on the last business day of the 13th week after the end of the prior quarter. As used herein, the first quarter results for 2024 and 2023 refer to the 13-week periods ended March 29, 2024 and March 31, 2023, respectively.
Basis of Presentation
The Consolidated and Condensed Financial Statements included herein have been prepared by the Company pursuant to the rules and regulations of the Security and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in the financial statements prepared in accordance with the accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted pursuant to SEC rules and regulations; however the Company believes that the disclosures are adequate to make the information presented not misleading.
The accompanying interim Consolidated and Condensed Financial Statements and the related notes should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”), filed with the SEC on February 29, 2024.
Consolidation
The Consolidated and Condensed Financial Statements reflect, in the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Intercompany transactions and accounts are eliminated in consolidation.
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue (Tables)
 3 Months Ended
Mar. 29, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue by Major Customers by Reporting Segments The Company disaggregates its revenue into the following product groups:
Three Months Ended
March 29, 2024March 31, 2023
(In thousands)
Equipment$214,860 $200,219 
Consumables474,884 483,781 
Total$689,744 $684,000 
Schedule of Allowance for Credit Losses
A summary of the activity in the Company’s allowance for credit losses included within Trade receivables in the Consolidated and Condensed Balance Sheets is as follows:
Three Months Ended March 29, 2024
Balance at
Beginning
of Period		Charged to Expense, netWrite-Offs and DeductionsForeign
Currency
Translation		Balance at
End of
Period
(In thousands)
Allowance for credit losses$25,477 $651 $(439)$(265)$25,424 
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings per Share from Continuing Operations (Tables)
 3 Months Ended
Mar. 29, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share from Continuing Operations The Company allocates earnings to participating securities and computed earnings per share using the two-class method as follows:
Three Months Ended
March 29, 2024March 31, 2023
(In thousands, except share and per share data)
Computation of earnings per share from continuing operations – basic:
Income from continuing operations attributable to ESAB Corporation(1)
$61,260 $32,816 
Less: distributed and undistributed earnings allocated to nonvested shares(365)(237)
Income from continuing operations attributable to common stockholders$60,895 $32,579 
Weighted-average shares of Common stock outstanding – basic60,346,121 60,146,348 
Income per share from continuing operations – basic$1.01 $0.54 
Computation of earnings per share from continuing operations – diluted:
Income from continuing operations attributable to common stockholders$60,895 $32,579 
Weighted-average shares of Common stock outstanding – basic60,346,121 60,146,348 
Net effect of potentially dilutive securities(2)
641,836 339,878 
Weighted-average shares of Common stock outstanding – dilution60,987,957 60,486,226 
Net income per share from continuing operations – diluted$1.00 $0.54 
(1) Net income from continuing operations attributable to ESAB Corporation for the respective periods is calculated using Net income from continuing operations, less Income attributable to noncontrolling interest, net of taxes, of $1.6 million for the three months ended March 29, 2024 and $1.3 million for the three months ended March 31, 2023.
(2) Potentially dilutive securities include stock options, performance-based restricted stock units and non-performance-based restricted stock units.
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Inventories, Net (Tables)
 3 Months Ended
Mar. 29, 2024
Inventory Disclosure [Abstract]  
Schedule of Inventory, Net
Inventories, net consisted of the following:
March 29, 2024
December 31, 2023
(In thousands)
Raw materials$153,072 $156,583 
Work in process48,627 43,561 
Finished goods253,643 244,580 
455,342 444,724 
LIFO reserve(4,980)(4,279)
Allowance for excess, slow-moving and obsolete inventory(44,761)(47,587)
$405,601 $392,858 
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accrued and Other Liabilities (Tables)
 3 Months Ended
Mar. 29, 2024
Accrued Liabilities [Abstract]  
Schedule of Accrued and Other Liabilities
Accrued and Other liabilities in the Consolidated and Condensed Balance Sheets consisted of the following:
March 29, 2024December 31, 2023
CurrentNoncurrentCurrentNoncurrent
(In thousands)
Accrued taxes and deferred tax liabilities$44,727 $144,214 $45,681 $144,662 
Compensation and related benefits75,906 50,750 97,052 52,589 
Asbestos liability34,111 223,829 32,908 234,796 
Contract liabilities29,548 — 31,248 — 
Lease liabilities22,936 73,995 22,794 76,609 
Warranty liability12,936 — 12,606 — 
Third-party commissions11,224 — 18,711 — 
Restructuring liability4,045 256 5,345 354 
Other57,470 27,967 47,144 33,823 
$292,903 $521,011 $313,489 $542,833 
Schedule of Product Warranty Liability
A summary of the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated and Condensed Balance Sheets is as follows:
Three Months Ended
March 29, 2024March 31, 2023
(In thousands)
Warranty liability, beginning of period$12,606 $12,946 
Accrued warranty expense2,457 1,393 
Changes in estimates related to pre-existing warranties727 672 
Cost of warranty service work performed(2,647)(2,678)
Foreign exchange translation effect(207)964 
Warranty liability, end of period$12,936 $13,297 
Schedule of Restructuring Reserve by Type of Cost A summary of the activity in the Company’s restructuring liability included in Accrued and Other liabilities in the Consolidated and Condensed Balance Sheets is as follows:
Three Months Ended March 29, 2024
Balance at Beginning of PeriodChargesPaymentsForeign Currency TranslationBalance at End of Period
(In thousands)
Restructuring and other related charges:
Termination benefits(1)
$4,595 $1,320 $(1,507)$(352)$4,056 
Facility closure costs and other(2)
1,104604 (1,404)(59)245 
Total$5,699 $1,924 $(2,911)$(411)$4,301 
(1) Includes severance and other termination benefits, including outplacement services.
(2) Includes the cost of relocating associates, relocating equipment, lease termination expense and other costs in connection with the closure and optimization of facilities and product lines.
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt (Tables)
 3 Months Ended
Mar. 29, 2024
Debt Disclosure [Abstract]  
Schedule of Long-Term Debt
Long-term debt consisted of the following:
March 29, 2024December 31, 2023
(In thousands)
Term loans$981,250 $987,500 
Revolving credit facilities12,000 32,000 
Total debt993,250 1,019,500 
Unamortized deferred financing fees(452)(1,443)
Long-term debt$992,798 $1,018,057 
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivatives (Tables)
 3 Months Ended
Mar. 29, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)
The effects of designated cash flow hedges on the Company’s Consolidated and Condensed Statements of Operations consisted of the following:
Three Months Ended
Derivative type(Gain) recognized in the Consolidated and Condensed Statements of Operations:March 29, 2024March 31, 2023
(In thousands)
Interest rate swap agreementsInterest expense and other, net$(2,722)$(1,977)
Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location
The effects of the excluded components of designated net investment hedges on the Company’s Consolidated and Condensed Statements of Operations consisted of the following:
Three Months Ended
Derivative type(Gain) recognized in the Consolidated and Condensed Statements of Operations:March 29, 2024March 31, 2023
(In thousands)
Cross currency swap agreementsInterest expense and other, net$(1,179)$(1,201)
Schedule of Fair Values of Derivative Instruments in the Financial Statements
The table below shows the fair value of the derivatives recognized in the Consolidated Balance Sheet:
March 29, 2024December 31, 2023
Designated as hedging instrumentsOther LiabilitiesOther AssetsOther LiabilitiesOther Assets
(In thousands)
Cross currency swap agreements$15,783 $— $22,232 $— 
Interest rate swap agreements— 5,174 — 9,522 
Total $15,783 $5,174 $22,232 $9,522 
Derivatives Not Designated as Hedging Instruments
The table below shows the fair value of derivative instruments not designated in a hedging relationship recognized in the Consolidated Balance Sheet:
March 29, 2024December 31, 2023
Not designated as hedging instrumentsAccrued LiabilitiesOther Current AssetsAccrued LiabilitiesOther Current Assets
(In thousands)
Foreign currency contracts$431 $874 $596 $1,088 
Schedule of Derivative Instruments
The Company recognized the following in its Consolidated and Condensed Financial Statements related to its derivative instruments not designated in a hedging relationship:
Three Months Ended
Foreign currency contractsMarch 29, 2024March 31, 2023
(In thousands)
Change in unrealized gains (losses)$(49)$143 
Realized gains (losses)(394)1,027 

The above gains or losses on foreign currency contracts are usually offset by foreign exchange exposure on cash and intercompany positions, all of which are recognized in Interest expense and other, net, in the Consolidated and Condensed Statements of Operations.
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value Measurements (Tables)
 3 Months Ended
Mar. 29, 2024
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value
A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is as follows:
March 29, 2024
Level
One		Level
Two		Level
Three		Total
(In thousands)
Assets:
Cash equivalents$2,968 $— $— $2,968 
Foreign currency contracts - not designated as hedges— 1,457 — 1,457 
Interest rate swap agreements— 5,174 — 5,174 
Deferred compensation plans— 4,281 — 4,281 
$2,968 $10,912 $— $13,880 
Liabilities:
Foreign currency contracts - not designated as hedges$— $1,014 $— $1,014 
Cross currency swap agreements— 15,783 — 15,783 
Deferred compensation plans— 4,281 — 4,281 
$— $21,078 $— $21,078 

December 31, 2023
Level
One		Level
Two		Level
Three		Total
(In thousands)
Assets:
Cash equivalents$6,027 $— $— $6,027 
Foreign currency contracts - not designated as hedges— 2,261 — 2,261 
Interest rate swap agreements— 9,522 — 9,522 
Deferred compensation plans— 3,488 — 3,488 
$6,027 $15,271 $— $21,298 
Liabilities:
Foreign currency contracts - not designated as hedges$— $1,769 $— $1,769 
Cross currency swap agreements — 22,232 — 22,232 
Deferred compensation plans— 3,488 — 3,488 
$— $27,489 $— $27,489 
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity (Tables)
 3 Months Ended
Mar. 29, 2024
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Loss
The following tables present the changes in the balances of each component of AOCI including reclassifications out of AOCI for the three months ended March 29, 2024 and March 31, 2023. All amounts are net of tax and noncontrolling interest, if any.
Accumulated Other Comprehensive Loss Components
Net Unrecognized Pension and Other Post-Retirement Benefit CostForeign Currency Translation AdjustmentNet Investment HedgesCash Flow HedgesTotal
(In thousands)
Balance at December 31, 2023
$(59,805)$(554,622)$(17,215)$7,370 $(624,272)
Other comprehensive income (loss) before reclassifications:
Foreign currency translation adjustment243 (38,265)4,995 — (33,027)
Gain on long-term intra-entity foreign currency transactions— 7,996 — — 7,996 
Unrealized loss on cash flow hedges— — — 3,920 3,920 
Other comprehensive income (loss) before reclassifications243 (30,269)4,995 3,920 (21,111)
Amounts reclassified from Accumulated other comprehensive loss(1)(2)
629 — — (2,907)(2,278)
Net current period Other comprehensive income (loss)872 (30,269)4,995 1,013 (23,389)
Balance at March 29, 2024
$(58,933)$(584,891)$(12,220)$8,383 $(647,661)
(1) The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost.
(2) During the three months ended March 29, 2024, the amount within Cash Flow Hedges is a component of Interest expense and other, net. See Note 11, “Derivatives” for additional details.
Accumulated Other Comprehensive Loss Components
Net Unrecognized Pension and Other Post-Retirement Benefit CostForeign Currency Translation AdjustmentNet Investment HedgesCash Flow HedgesTotal
(In thousands)
Balance at December 31, 2022
$(63,847)$(613,907)$(8,336)$11,102 $(674,988)
Other comprehensive income (loss) before reclassifications:
Net actuarial loss(2)— — — (2)
Foreign currency translation adjustment(108)31,276 (2,086)— 29,082 
Gain on long-term intra-entity foreign currency transactions— 12,501 — — 12,501 
Unrealized loss on cash flow hedges— — — (2,051)(2,051)
Other comprehensive (loss) income before reclassifications(110)43,777 (2,086)(2,051)39,530 
Amounts reclassified from Accumulated other comprehensive loss(1)(2)
279 — — (1,530)(1,251)
Net current period Other comprehensive (loss) income169 43,777 (2,086)(3,581)38,279 
Balance at March 31, 2023
$(63,678)$(570,130)$(10,422)$7,521 $(636,709)
(1) The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost.
(2) During the three months ended March 31, 2023, the amount within Cash Flow Hedges is a component of Interest expense and other, net. See Note 11, “Derivatives” for additional details.
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies (Tables)
 3 Months Ended
Mar. 29, 2024
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Loss Contingencies by Number of Claims
Asbestos-related claims activity since December 31 is as follows:
Three Months Ended
March 29, 2024March 31, 2023
(Number of claims)
Claims unresolved, beginning of period13,648 14,106 
Claims filed(1)
1,297 986 
Claims resolved(2)
(714)(749)
Claims unresolved, end of period14,231 14,343 
(1) Claims filed include all asbestos claims for which notification have been received or a file has been opened.
(2) Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants.
Schedule of Asbestos Related Litigation
The Company’s Consolidated Balance Sheet included the following amounts related to asbestos-related litigation:
March 29, 2024December 31, 2023
(In thousands)
Long-term asbestos insurance asset(1)
$213,323 $221,489 
Long-term asbestos insurance receivable(1)
18,306 17,868 
Accrued asbestos liability(2)
34,111 32,908 
Long-term asbestos liability(3)
223,829 234,796 
(1) Included in Other assets in the Consolidated Balance Sheets.
(2) Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay, and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Consolidated Balance Sheets.
(3) Included in Other liabilities in the Consolidated Balance Sheets.
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Information (Tables)
 3 Months Ended
Mar. 29, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The Company’s segment results were as follows:
Three Months Ended
March 29, 2024March 31, 2023
(In thousands)
Net sales:
Americas$296,047 $291,569 
EMEA & APAC393,697 392,431 
$689,744 $684,000 
Adjusted EBITDA(1):
Americas$54,098 $49,442 
EMEA & APAC75,039 68,547 
$129,137 $117,989 
(1) The following is a reconciliation of Net income from continuing operations to Adjusted EBITDA.
Three Months Ended
March 29, 2024March 31, 2023
(In thousands)
Net income from continuing operations$62,903 $34,129 
Income tax expense 18,504 37,024 
Interest expense and other, net(1)
17,091 19,510 
Pension settlement loss12,155 — 
Restructuring and other related charges1,924 9,444 
Acquisition - amortization and other related charges(2)
7,777 9,289 
Depreciation and other amortization8,783 8,593 
Adjusted EBITDA$129,137 $117,989 
(1) Relates to removal of interest expense, net included within the Interest expense and other, net line within the Consolidated and Condensed Statements of Operations.
(2) Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Organization and Basis of Presentation (Details)
$ / shares in Units, $ in Thousands
 3 Months Ended
Apr. 04, 2022
USD ($)
Mar. 29, 2024
USD ($)
segment
$ / shares
Mar. 31, 2023
USD ($)
$ / shares
Dec. 31, 2023
USD ($)
Concentration Risk [Line Items]        
Number of reportable segments | segment   2    
Quarterly cash dividend declared (in dollars per share) | $ / shares   $ 0.06 $ 0.05  
Payment of dividends   $ 3,635 $ 3,033  
Net income   59,951 31,903  
Cumulative translation loss   (1,640,800)   $ (1,607,399)
Research and development expense   10,100 $ 9,600  
Foreign Currency Translation Adjustment        
Concentration Risk [Line Items]        
Cumulative translation loss   118,000    
Russia        
Concentration Risk [Line Items]        
Net income   $ 4,000    
Russia | Assets | Geographic Concentration Risk        
Concentration Risk [Line Items]        
Concentration risk (as a percent)   3.00%    
Russia | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk        
Concentration Risk [Line Items]        
Concentration risk (as a percent)   5.00%    
Enovis Corporation        
Concentration Risk [Line Items]        
Cash consideration $ 1,200,000      
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Discontinued Operations (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Loss from discontinued operations, net of taxes $ (1,309) $ (913)
Cash used in operating activities, discontinued operations $ 3,700 5,400
Discontinued Operations Discontinued Operations
The Company holds certain asbestos-related contingencies and insurance coverages from divested businesses for which it does not have an interest in the ongoing operations. The Company has classified asbestos-related activity in its Consolidated and Condensed Statements of Operations as part of Loss from discontinued operations, net of taxes. This activity consists primarily of expected settlements, legal and administrative expenses associated with the above liabilities.

For the three months ended March 29, 2024 and March 31, 2023, respectively, loss from discontinued operations, net of taxes was $1.3 million and $0.9 million. See Note 14, “Commitments and Contingencies” for further information.

Cash used in operating activities related to discontinued operations for the three months ended March 29, 2024 and March 31, 2023 was $3.7 million and $5.4 million, respectively.
  
Asbestos Related Activity    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Loss from discontinued operations, net of taxes $ 1,300 $ 900
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Discontinued Operations (Details)
 3 Months Ended
Mar. 29, 2024
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Discontinued Operations Discontinued Operations
The Company holds certain asbestos-related contingencies and insurance coverages from divested businesses for which it does not have an interest in the ongoing operations. The Company has classified asbestos-related activity in its Consolidated and Condensed Statements of Operations as part of Loss from discontinued operations, net of taxes. This activity consists primarily of expected settlements, legal and administrative expenses associated with the above liabilities.

For the three months ended March 29, 2024 and March 31, 2023, respectively, loss from discontinued operations, net of taxes was $1.3 million and $0.9 million. See Note 14, “Commitments and Contingencies” for further information.

Cash used in operating activities related to discontinued operations for the three months ended March 29, 2024 and March 31, 2023 was $3.7 million and $5.4 million, respectively.
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Acquisition (Details) - USD ($)
$ in Millions
Feb. 26, 2024
Jan. 11, 2023
Therapy Equipment Limited    
Business Acquisition [Line Items]    
Consideration transferred for acquisition   $ 18.7
Sager S.A.    
Business Acquisition [Line Items]    
Consideration transferred for acquisition $ 18.1  
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Disaggregation of Revenue [Line Items]    
Total $ 689,744 $ 684,000
Equipment    
Disaggregation of Revenue [Line Items]    
Total 214,860 200,219
Consumables    
Disaggregation of Revenue [Line Items]    
Total $ 474,884 $ 483,781
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Revenue [Abstract]        
Contract liability $ 29.5 $ 28.3 $ 31.2 $ 25.9
Revenue recognized, contract liability $ 16.2 $ 11.1    
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue - Allowance for Credit Loss Rollforward (Details)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
USD ($)
Financing Receivable, Allowance for Credit Loss [Roll Forward]  
Balance at Beginning of Period $ 25,477
Charged to Expense, net 651
Write-Offs and Deductions (439)
Foreign Currency Translation (265)
Balance at End of Period $ 25,424
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings per Share from Continuing Operations (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Computation of earnings per share from continuing operations – basic:    
Income from continuing operations attributable to ESAB Corporation $ 61,260 $ 32,816
Less: distributed and undistributed earnings allocated to nonvested shares (365) (237)
Net Income (Loss) Available to Common Stockholders $ 60,895 $ 32,579
Weighted-average shares of common stock outstanding - basic (in shares) 60,346,121 60,146,348
Income per share from continuing operations – basic (in dollars per share) $ 1.01 $ 0.54
Computation of earnings per share from continuing operations – diluted:    
Net effect of potentially dilutive securities (in shares) 641,836 339,878
Weighted-average shares of common stock outstanding - assuming dilution (in shares) 60,987,957 60,486,226
Income per share from continuing operations – assuming dilution (in dollars per share) $ 1.00 $ 0.54
Net income from continuing operations attributable to noncontrolling interest, net of taxes $ 1,600 $ 1,300
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Income Tax Disclosure [Abstract]    
Income from continuing operations before income taxes $ 81,407 $ 71,153
Income tax expense $ 18,504 $ 37,024
Effective tax rate (as a percent) 22.70% 52.00%
Undistributed foreign earnings, tax expense $ 10,900  
Increase in the net liability for uncertain tax positions $ 9,400  
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Inventories, Net (Details) - USD ($)
$ in Thousands
Mar. 29, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Raw materials $ 153,072 $ 156,583
Work in process 48,627 43,561
Finished goods 253,643 244,580
Inventories, gross 455,342 444,724
LIFO reserve (4,980) (4,279)
Allowance for excess, slow-moving and obsolete inventory (44,761) (47,587)
Inventories, net $ 405,601 $ 392,858
Percentage of inventory valued at LIFO 26.00% 27.40%
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accrued and Other Liabilities - Current and Noncurrent (Details) - USD ($)
$ in Thousands
Mar. 29, 2024
Dec. 31, 2023
Current    
Accrued taxes and deferred tax liabilities $ 44,727 $ 45,681
Compensation and related benefits 75,906 97,052
Asbestos liability 34,111 32,908
Contract liabilities $ 29,548 31,248
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Total accrued and other liabilities, Current  
Lease liabilities $ 22,936 22,794
Warranty liability 12,936 12,606
Third-party commissions 11,224 18,711
Restructuring liability 4,045 5,345
Other 57,470 47,144
Total accrued and other liabilities, Current 292,903 313,489
Noncurrent    
Accrued taxes and deferred tax liabilities 144,214 144,662
Compensation and related benefits 50,750 52,589
Asbestos liability 223,829 234,796
Contract liabilities $ 0 0
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Total accrued and other liabilities, Noncurrent  
Lease liabilities $ 73,995 76,609
Warranty liability 0 0
Third-party commissions 0 0
Restructuring liability 256 354
Other 27,967 33,823
Total accrued and other liabilities, Noncurrent $ 521,011 $ 542,833
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accrued and Other Liabilities - Warranty Liability Rollforward (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Movement in Standard Product Warranty Accrual [Roll Forward]    
Warranty liability, beginning of period $ 12,606 $ 12,946
Accrued warranty expense 2,457 1,393
Changes in estimates related to pre-existing warranties 727 672
Cost of warranty service work performed (2,647) (2,678)
Foreign exchange translation effect 207 (964)
Warranty liability, end of period $ 12,936 $ 13,297
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accrued and Other Liabilities - Restructuring Rollforward (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Restructuring Reserve [Roll Forward]    
Balance at Beginning of Period $ 5,699  
Payments (2,911)  
Foreign Currency Translation (411)  
Balance at End of Period 4,301  
Total 1,924 $ 9,444
Termination benefits    
Restructuring Reserve [Roll Forward]    
Balance at Beginning of Period 4,595  
Payments (1,507)  
Foreign Currency Translation (352)  
Balance at End of Period 4,056  
Total 1,320  
Facility closure costs and other    
Restructuring Reserve [Roll Forward]    
Balance at Beginning of Period 1,104  
Payments (1,404)  
Foreign Currency Translation (59)  
Balance at End of Period 245  
Total $ 604  
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Benefit Plans (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Retirement Benefits [Abstract]    
Pension settlement loss $ 12,155 $ 0
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt - Schedule of Long-Term Debt (Details) - USD ($)
Mar. 29, 2024
Dec. 31, 2023
Apr. 04, 2022
Debt Instrument [Line Items]      
Long-term debt $ 992,798,000 $ 1,018,057,000  
Long-Term Debt, Gross 993,250,000 1,019,500,000  
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net (452,000) (1,443,000)  
Long-term Debt 992,798,000 1,018,057,000  
Term loans | The Credit Agreement | Line of Credit      
Debt Instrument [Line Items]      
Long-Term Debt, Gross 981,250,000 987,500,000  
Revolving credit facilities | The Credit Agreement | Line of Credit      
Debt Instrument [Line Items]      
Long-Term Debt, Gross 12,000,000 $ 32,000,000  
Long-term Debt 12,000,000    
Aggregate principal amount $ 750,000,000   $ 750,000,000
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt - Narrative (Details)
Apr. 04, 2022
USD ($)
Jun. 30, 2024
Mar. 29, 2024
USD ($)
Dec. 31, 2023
USD ($)
Jun. 30, 2023
Jun. 28, 2022
USD ($)
Debt Instrument [Line Items]            
Deferred financing fees     $ 1,300,000      
Letters of credit outstanding     28,300,000      
Long-term Debt     992,798,000 $ 1,018,057,000    
Long-Term Debt            
Debt Instrument [Line Items]            
Deferred financing fees     500,000      
Other Liabilities            
Debt Instrument [Line Items]            
Deferred financing fees     $ 800,000      
Enovis Corporation            
Debt Instrument [Line Items]            
Cash consideration $ 1,200,000,000          
The Credit Agreement            
Debt Instrument [Line Items]            
Indebtedness incurred $ 1,200,000,000          
Weighted-average interest rate (as a percent)     5.09%      
The Credit Agreement | SOFR | Minimum            
Debt Instrument [Line Items]            
Basis spread on variable rate (as a percent) 1.125%          
The Credit Agreement | SOFR | Maximum            
Debt Instrument [Line Items]            
Basis spread on variable rate (as a percent) 1.75%          
The Credit Agreement | Base Rate | Minimum            
Debt Instrument [Line Items]            
Basis spread on variable rate (as a percent) 0.125%          
The Credit Agreement | Base Rate | Maximum            
Debt Instrument [Line Items]            
Basis spread on variable rate (as a percent) 0.75%          
The Credit Agreement | Line of Credit            
Debt Instrument [Line Items]            
Maximum total leverage ratio     4      
Maximum step-down leverage ratio         3.75  
Minimum interest coverage ratio     3      
The Credit Agreement | Line of Credit | Scenario, Forecast            
Debt Instrument [Line Items]            
Maximum step-down leverage ratio   3.5        
Revolving credit facilities | The Credit Agreement | Line of Credit            
Debt Instrument [Line Items]            
Aggregate principal amount $ 750,000,000   $ 750,000,000      
Repayments of borrowings on revolving credit facility and other 200,000,000          
Capacity for additional indebtedness     738,000,000      
Long-term Debt     12,000,000      
Term loans | The Credit Agreement | Senior Notes            
Debt Instrument [Line Items]            
Principal amount $ 600,000,000   589,000,000     $ 600,000,000
Debt term 364 days          
Indebtedness incurred $ 600,000,000          
Term loans | The Credit Agreement | Line of Credit            
Debt Instrument [Line Items]            
Principal amount 400,000,000   393,000,000      
Indebtedness incurred 400,000,000          
Letter of Credit            
Debt Instrument [Line Items]            
Aggregate principal amount     109,000,000      
Letter of Credit | The Credit Agreement | Line of Credit            
Debt Instrument [Line Items]            
Aggregate principal amount 300,000,000          
Letter of Credit | Uncommitted Credit Line            
Debt Instrument [Line Items]            
Aggregate principal amount     $ 77,000,000      
Bridge Loan | The Credit Agreement | Line of Credit            
Debt Instrument [Line Items]            
Aggregate principal amount $ 50,000,000          
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivatives - Narratives (Details)
€ in Millions, $ in Millions
 3 Months Ended
Mar. 29, 2024
USD ($)
Apr. 09, 2024
USD ($)
Apr. 01, 2024
USD ($)
Dec. 31, 2023
USD ($)
Jul. 22, 2022
USD ($)
agreement
Jul. 22, 2022
EUR (€)
agreement
Jul. 14, 2022
USD ($)
agreement
Derivatives, Fair Value [Line Items]              
Increase in derivative assets and liabilities $ 0.6            
Senior Note Offering | Senior Notes | Subsequent Event              
Derivatives, Fair Value [Line Items]              
Principal amount   $ 700.0          
Cash Flow Hedging | Designated as hedging instruments              
Derivatives, Fair Value [Line Items]              
Notional amount         $ 275.0 € 270  
Basis spread on variable rate (as a percent)             3.293%
Cash Flow Hedging | Designated as hedging instruments | Minimum              
Derivatives, Fair Value [Line Items]              
Basis spread on variable rate (as a percent)             1.125%
Cash Flow Hedging | Designated as hedging instruments | Maximum              
Derivatives, Fair Value [Line Items]              
Basis spread on variable rate (as a percent)             1.75%
Interest rate swap agreements              
Derivatives, Fair Value [Line Items]              
Number of derivative instruments held | agreement             2
Notional amount             $ 600.0
Basis spread on variable rate (as a percent) 1.25%            
Loss related to interest rate swap agreements $ 4.0            
Interest rate swap agreements | Scenario, Forecast              
Derivatives, Fair Value [Line Items]              
Notional amount     $ 300.0        
Interest rate swap agreements | Cash Flow Hedging              
Derivatives, Fair Value [Line Items]              
Proceeds from settlement of interest rate swap 5.5            
Deferred AOCI impact from interest rate swap 5.5            
Cross currency swap agreements              
Derivatives, Fair Value [Line Items]              
Number of derivative instruments held | agreement         2 2  
Cross currency swap agreements | Not Designated as Hedging Instrument              
Derivatives, Fair Value [Line Items]              
Notional amount $ 267.2     $ 232.5      
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivatives - Schedule of Derivative Instruments (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Interest rate swap agreements    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Realized loss $ (1,179) $ (1,201)
Interest rate swap agreements | Interest Expense (Income) and Other, Net    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax (2,722) (1,977)
Cross currency swap agreements | Not Designated as Hedging Instrument    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Realized loss (394) 1,027
Change in unrealized gains (losses) $ (49) $ 143
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivatives - Derivatives Not Designated as Hedging Instruments (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
Dec. 31, 2023
Derivative [Line Items]    
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] Accrued liabilities Accrued liabilities
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] Other current assets Other current assets
Increase in derivative assets and liabilities $ 600  
Foreign currency contracts | Not Designated as Hedging Instrument    
Derivative [Line Items]    
Derivative liability, current 431 $ 596
Derivative asset, current $ 874 $ 1,088
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivatives - Schedule of Fair Values of Derivative Instruments in the Financial Statements (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Dec. 31, 2023
Derivatives, Fair Value [Line Items]      
Derivative assets $ 5,174   $ 9,522
Derivative liabilities 15,783   22,232
Cross currency swap agreements      
Derivatives, Fair Value [Line Items]      
Derivative assets 0   0
Derivative liabilities 15,783   22,232
Interest rate swap agreements      
Derivatives, Fair Value [Line Items]      
Derivative assets 5,174   9,522
Derivative liabilities 0   $ 0
Realized loss (1,179) $ (1,201)  
Not Designated as Hedging Instrument | Cross currency swap agreements      
Derivatives, Fair Value [Line Items]      
Change in unrealized gains (losses) (49) 143  
Realized loss $ (394) $ 1,027  
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value Measurements - Fair Value Hierarchy (Details) - USD ($)
$ in Thousands
Mar. 29, 2024
Dec. 31, 2023
Assets:    
Cash equivalents $ 2,968 $ 6,027
Deferred compensation plans 4,281 3,488
Total assets at fair value 13,880 21,298
Liabilities:    
Deferred compensation plans 4,281 3,488
Total liabilities at fair value 21,078 27,489
Cross currency swap agreements | Not Designated as Hedging Instrument    
Assets:    
Derivative assets 1,457 2,261
Liabilities:    
Derivative liabilities 1,014 1,769
Cross currency swap agreements | Designated as hedging instruments    
Liabilities:    
Derivative liabilities 15,783 22,232
Interest rate swap agreements    
Assets:    
Derivative assets 5,174 9,522
Level One    
Assets:    
Cash equivalents 2,968 6,027
Deferred compensation plans 0 0
Total assets at fair value 2,968 6,027
Liabilities:    
Deferred compensation plans 0 0
Total liabilities at fair value 0 0
Level One | Cross currency swap agreements | Not Designated as Hedging Instrument    
Assets:    
Derivative assets 0 0
Liabilities:    
Derivative liabilities 0 0
Level One | Cross currency swap agreements | Designated as hedging instruments    
Liabilities:    
Derivative liabilities 0 0
Level One | Interest rate swap agreements    
Assets:    
Derivative assets 0 0
Level Two    
Assets:    
Cash equivalents 0 0
Deferred compensation plans 4,281 3,488
Total assets at fair value 10,912 15,271
Liabilities:    
Deferred compensation plans 4,281 3,488
Total liabilities at fair value 21,078 27,489
Level Two | Cross currency swap agreements | Not Designated as Hedging Instrument    
Assets:    
Derivative assets 1,457 2,261
Liabilities:    
Derivative liabilities 1,014 1,769
Level Two | Cross currency swap agreements | Designated as hedging instruments    
Liabilities:    
Derivative liabilities 15,783 22,232
Level Two | Interest rate swap agreements    
Assets:    
Derivative assets 5,174 9,522
Level Three    
Assets:    
Cash equivalents 0 0
Deferred compensation plans 0 0
Total assets at fair value 0 0
Liabilities:    
Deferred compensation plans 0 0
Total liabilities at fair value 0 0
Level Three | Cross currency swap agreements | Not Designated as Hedging Instrument    
Assets:    
Derivative assets 0 0
Liabilities:    
Derivative liabilities 0 0
Level Three | Cross currency swap agreements | Designated as hedging instruments    
Liabilities:    
Derivative liabilities 0 0
Level Three | Interest rate swap agreements    
Assets:    
Derivative assets $ 0 $ 0
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Beginning balance $ 1,647,657 $ 1,388,458
Net actuarial loss   (2)
Foreign currency translation adjustment (33,027) 29,082
Gain on long-term intra-entity foreign currency transactions 7,996 12,501
Unrealized gain on cash flow hedges 3,920 (2,051)
Other comprehensive income (loss) before reclassifications (21,111) 39,530
Amounts reclassified from Accumulated other comprehensive loss (2,278) (1,251)
Net current period Other comprehensive (loss) income (23,389) 38,279
Ending balance 1,682,378 1,458,291
Total    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Beginning balance (624,272) (674,988)
Ending balance (647,661) (636,709)
Net Unrecognized Pension and Other Post-Retirement Benefit Cost    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Beginning balance (59,805) (63,847)
Net actuarial loss   (2)
Foreign currency translation adjustment 243 (108)
Gain on long-term intra-entity foreign currency transactions 0 0
Unrealized gain on cash flow hedges 0 0
Other comprehensive income (loss) before reclassifications (243) 110
Amounts reclassified from Accumulated other comprehensive loss 629 279
Net current period Other comprehensive (loss) income 872 169
Ending balance (58,933) (63,678)
Foreign Currency Translation Adjustment    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Beginning balance (554,622) (613,907)
Net actuarial loss   0
Foreign currency translation adjustment (38,265) 31,276
Gain on long-term intra-entity foreign currency transactions 7,996 12,501
Unrealized gain on cash flow hedges 0 0
Other comprehensive income (loss) before reclassifications 30,269 (43,777)
Amounts reclassified from Accumulated other comprehensive loss 0 0
Net current period Other comprehensive (loss) income (30,269) 43,777
Ending balance (584,891) (570,130)
Net Investment Hedges    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Beginning balance (17,215) (8,336)
Net actuarial loss   0
Foreign currency translation adjustment 4,995 (2,086)
Gain on long-term intra-entity foreign currency transactions 0 0
Unrealized gain on cash flow hedges 0 0
Other comprehensive income (loss) before reclassifications (4,995) 2,086
Amounts reclassified from Accumulated other comprehensive loss 0 0
Net current period Other comprehensive (loss) income 4,995 (2,086)
Ending balance (12,220) (10,422)
Cash Flow Hedges    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Beginning balance 7,370 11,102
Net actuarial loss   0
Foreign currency translation adjustment 0 0
Gain on long-term intra-entity foreign currency transactions 0 0
Unrealized gain on cash flow hedges 3,920 (2,051)
Other comprehensive income (loss) before reclassifications (3,920) 2,051
Amounts reclassified from Accumulated other comprehensive loss (2,907) (1,530)
Net current period Other comprehensive (loss) income 1,013 (3,581)
Ending balance $ 8,383 $ 7,521
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies - Narrative (Details)
 3 Months Ended
Mar. 29, 2024
Commitments and Contingencies Disclosure [Abstract]  
Future claims period 15 years
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies - Asbestos-Related Claims Activity (Details) - claim
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Loss Contingency Accrual [Roll Forward]    
Claims unresolved, beginning of period 13,648 14,106
Claims filed 1,297 986
Claims resolved (714) (749)
Claims unresolved, end of period 14,231 14,343
XML 74 R63.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies - Asbestos Litigation (Details) - USD ($)
$ in Thousands
Mar. 29, 2024
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]    
Long-term asbestos liability $ 223,829 $ 234,796
Loss Contingency, Receivable, Current 213,323 221,489
Loss Contingency, Receivable, Noncurrent 18,306 17,868
Loss Contingency, Accrual, Current 34,111 32,908
Loss Contingency, Accrual, Noncurrent $ 223,829 $ 234,796
XML 75 R64.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Information - Narrative (Details)
 3 Months Ended
Mar. 29, 2024
segment
Segment Reporting [Abstract]  
Number of reportable segments 2
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Information - Segment Results (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Net sales $ 689,744 $ 684,000
Adjusted EBITA 129,137 117,989
Net income from continuing operations 62,903 34,129
Income tax expense 18,504 37,024
Interest expense and other, net 17,091 19,510
Restructuring and other related charges 1,924 9,444
Acquisition - amortization and other related charges 7,777 9,289
Depreciation and other amortization 8,783 8,593
Pension settlement loss 12,155 0
Americas Segment    
Net sales 296,047 291,569
Adjusted EBITA 54,098 49,442
EMEA and APAC Segment    
Net sales 393,697 392,431
Adjusted EBITA $ 75,039 $ 68,547
XML 77 R66.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Subsequent Events (Details) - USD ($)
 3 Months Ended
Apr. 30, 2024
Apr. 09, 2024
Mar. 29, 2024
Mar. 31, 2023
Jun. 28, 2022
Apr. 04, 2022
Subsequent Event [Line Items]            
Repayments of borrowing on term credit facility     $ 6,250,000 $ 0    
Dividends payable included in accrued liabilities     3,600,000      
Subsequent Event | SUMIG Soluções para Solda Ltda            
Subsequent Event [Line Items]            
Purchase price for business combination agreement $ 74,000,000          
Senior Note Offering | Subsequent Event | Senior Notes            
Subsequent Event [Line Items]            
Outstanding borrowings   $ 700,000,000        
Contractual interest rate   6.25%        
Term loans | The Credit Agreement | Senior Notes            
Subsequent Event [Line Items]            
Outstanding borrowings     $ 589,000,000   $ 600,000,000 $ 600,000,000
Term loans | The Credit Agreement | Senior Notes | Subsequent Event            
Subsequent Event [Line Items]            
Repayments of borrowing on term credit facility   $ 588,800,000        
EXCEL 78 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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Ꮉ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�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end XML 79 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 80 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 82 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 160 278 1 false 51 0 false 8 false false R1.htm 0000001 - Document - COVER PAGE Sheet http://www.esab.com/role/COVERPAGE COVER PAGE Cover 1 false false R2.htm 0000002 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF OPERATIONS Sheet http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF OPERATIONS Statements 2 false false R3.htm 0000003 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME Sheet http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME Statements 3 false false R4.htm 0000004 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Parenthetical) Sheet http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Parenthetical) Statements 4 false false R5.htm 0000005 - Statement - CONSOLIDATED AND COMBINED CONDENSED BALANCE SHEETS Sheet http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS CONSOLIDATED AND COMBINED CONDENSED BALANCE SHEETS Statements 5 false false R6.htm 0000006 - Statement - CONSOLIDATED AND COMBINED CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETSParenthetical CONSOLIDATED AND COMBINED CONDENSED BALANCE SHEETS (Parenthetical) Statements 6 false false R7.htm 0000007 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF EQUITY Sheet http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF EQUITY Statements 7 false false R8.htm 0000008 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF EQUITY (Parenthetical) Sheet http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITYParenthetical CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF EQUITY (Parenthetical) Statements 8 false false R9.htm 0000009 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF CASH FLOWS Sheet http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF CASH FLOWS Statements 9 false false R10.htm 0000010 - Disclosure - Organization and Basis of Presentation Sheet http://www.esab.com/role/OrganizationandBasisofPresentation Organization and Basis of Presentation Notes 10 false false R11.htm 0000011 - Disclosure - Discontinued Operations Sheet http://www.esab.com/role/DiscontinuedOperations Discontinued Operations Notes 11 false false R12.htm 0000012 - Disclosure - Acquisition Sheet http://www.esab.com/role/Acquisition Acquisition Notes 12 false false R13.htm 0000013 - Disclosure - Revenue Sheet http://www.esab.com/role/Revenue Revenue Notes 13 false false R14.htm 0000014 - Disclosure - Earnings per Share from Continuing Operations Sheet http://www.esab.com/role/EarningsperSharefromContinuingOperations Earnings per Share from Continuing Operations Notes 14 false false R15.htm 0000015 - Disclosure - Income Taxes Sheet http://www.esab.com/role/IncomeTaxes Income Taxes Notes 15 false false R16.htm 0000016 - Disclosure - Inventories, Net Sheet http://www.esab.com/role/InventoriesNet Inventories, Net Notes 16 false false R17.htm 0000017 - Disclosure - Accrued and Other Liabilities Sheet http://www.esab.com/role/AccruedandOtherLiabilities Accrued and Other Liabilities Notes 17 false false R18.htm 0000018 - Disclosure - Benefit Plans Sheet http://www.esab.com/role/BenefitPlans Benefit Plans Notes 18 false false R19.htm 0000019 - Disclosure - Debt Sheet http://www.esab.com/role/Debt Debt Notes 19 false false R20.htm 0000020 - Disclosure - Derivatives Sheet http://www.esab.com/role/Derivatives Derivatives Notes 20 false false R21.htm 0000021 - Disclosure - Fair Value Measurements Sheet http://www.esab.com/role/FairValueMeasurements Fair Value Measurements Notes 21 false false R22.htm 0000022 - Disclosure - Equity Sheet http://www.esab.com/role/Equity Equity Notes 22 false false R23.htm 0000023 - Disclosure - Commitments and Contingencies Sheet http://www.esab.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 23 false false R24.htm 0000024 - Disclosure - Segment Information Sheet http://www.esab.com/role/SegmentInformation Segment Information Notes 24 false false R25.htm 0000025 - Disclosure - Subsequent Events Sheet http://www.esab.com/role/SubsequentEvents Subsequent Events Notes 25 false false R26.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 26 false false R27.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 27 false false R28.htm 9954471 - Disclosure - Organization and Basis of Presentation (Policies) Sheet http://www.esab.com/role/OrganizationandBasisofPresentationPolicies Organization and Basis of Presentation (Policies) Policies 28 false false R29.htm 9954472 - Disclosure - Revenue (Tables) Sheet http://www.esab.com/role/RevenueTables Revenue (Tables) Tables http://www.esab.com/role/Revenue 29 false false R30.htm 9954473 - Disclosure - Earnings per Share from Continuing Operations (Tables) Sheet http://www.esab.com/role/EarningsperSharefromContinuingOperationsTables Earnings per Share from Continuing Operations (Tables) Tables http://www.esab.com/role/EarningsperSharefromContinuingOperations 30 false false R31.htm 9954474 - Disclosure - Inventories, Net (Tables) Sheet http://www.esab.com/role/InventoriesNetTables Inventories, Net (Tables) Tables http://www.esab.com/role/InventoriesNet 31 false false R32.htm 9954475 - Disclosure - Accrued and Other Liabilities (Tables) Sheet http://www.esab.com/role/AccruedandOtherLiabilitiesTables Accrued and Other Liabilities (Tables) Tables http://www.esab.com/role/AccruedandOtherLiabilities 32 false false R33.htm 9954476 - Disclosure - Debt (Tables) Sheet http://www.esab.com/role/DebtTables Debt (Tables) Tables http://www.esab.com/role/Debt 33 false false R34.htm 9954477 - Disclosure - Derivatives (Tables) Sheet http://www.esab.com/role/DerivativesTables Derivatives (Tables) Tables http://www.esab.com/role/Derivatives 34 false false R35.htm 9954478 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.esab.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.esab.com/role/FairValueMeasurements 35 false false R36.htm 9954479 - Disclosure - Equity (Tables) Sheet http://www.esab.com/role/EquityTables Equity (Tables) Tables http://www.esab.com/role/Equity 36 false false R37.htm 9954480 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.esab.com/role/CommitmentsandContingenciesTables Commitments and Contingencies (Tables) Tables http://www.esab.com/role/CommitmentsandContingencies 37 false false R38.htm 9954481 - Disclosure - Segment Information (Tables) Sheet http://www.esab.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.esab.com/role/SegmentInformation 38 false false R39.htm 9954482 - Disclosure - Organization and Basis of Presentation (Details) Sheet http://www.esab.com/role/OrganizationandBasisofPresentationDetails Organization and Basis of Presentation (Details) Details http://www.esab.com/role/OrganizationandBasisofPresentationPolicies 39 false false R40.htm 9954483 - Disclosure - Discontinued Operations (Details) Sheet http://www.esab.com/role/DiscontinuedOperationsDetails Discontinued Operations (Details) Details http://www.esab.com/role/DiscontinuedOperations 40 false false R41.htm 9954484 - Disclosure - Discontinued Operations (Details) Sheet http://www.esab.com/role/DiscontinuedOperationsDetails_1 Discontinued Operations (Details) Details http://www.esab.com/role/DiscontinuedOperations 41 false false R42.htm 9954485 - Disclosure - Acquisition (Details) Sheet http://www.esab.com/role/AcquisitionDetails Acquisition (Details) Details http://www.esab.com/role/Acquisition 42 false false R43.htm 9954486 - Disclosure - Revenue - Disaggregation of Revenue (Details) Sheet http://www.esab.com/role/RevenueDisaggregationofRevenueDetails Revenue - Disaggregation of Revenue (Details) Details 43 false false R44.htm 9954487 - Disclosure - Revenue - Narrative (Details) Sheet http://www.esab.com/role/RevenueNarrativeDetails Revenue - Narrative (Details) Details 44 false false R45.htm 9954488 - Disclosure - Revenue - Allowance for Credit Loss Rollforward (Details) Sheet http://www.esab.com/role/RevenueAllowanceforCreditLossRollforwardDetails Revenue - Allowance for Credit Loss Rollforward (Details) Details 45 false false R46.htm 9954489 - Disclosure - Earnings per Share from Continuing Operations (Details) Sheet http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails Earnings per Share from Continuing Operations (Details) Details http://www.esab.com/role/EarningsperSharefromContinuingOperationsTables 46 false false R47.htm 9954490 - Disclosure - Income Taxes (Details) Sheet http://www.esab.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.esab.com/role/IncomeTaxes 47 false false R48.htm 9954491 - Disclosure - Inventories, Net (Details) Sheet http://www.esab.com/role/InventoriesNetDetails Inventories, Net (Details) Details http://www.esab.com/role/InventoriesNetTables 48 false false R49.htm 9954492 - Disclosure - Accrued and Other Liabilities - Current and Noncurrent (Details) Sheet http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails Accrued and Other Liabilities - Current and Noncurrent (Details) Details 49 false false R50.htm 9954493 - Disclosure - Accrued and Other Liabilities - Warranty Liability Rollforward (Details) Sheet http://www.esab.com/role/AccruedandOtherLiabilitiesWarrantyLiabilityRollforwardDetails Accrued and Other Liabilities - Warranty Liability Rollforward (Details) Details 50 false false R51.htm 9954494 - Disclosure - Accrued and Other Liabilities - Restructuring Rollforward (Details) Sheet http://www.esab.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails Accrued and Other Liabilities - Restructuring Rollforward (Details) Details 51 false false R52.htm 9954495 - Disclosure - Benefit Plans (Details) Sheet http://www.esab.com/role/BenefitPlansDetails Benefit Plans (Details) Details http://www.esab.com/role/BenefitPlans 52 false false R53.htm 9954496 - Disclosure - Debt - Schedule of Long-Term Debt (Details) Sheet http://www.esab.com/role/DebtScheduleofLongTermDebtDetails Debt - Schedule of Long-Term Debt (Details) Details 53 false false R54.htm 9954497 - Disclosure - Debt - Narrative (Details) Sheet http://www.esab.com/role/DebtNarrativeDetails Debt - Narrative (Details) Details 54 false false R55.htm 9954498 - Disclosure - Derivatives - Narratives (Details) Sheet http://www.esab.com/role/DerivativesNarrativesDetails Derivatives - Narratives (Details) Details 55 false false R56.htm 9954499 - Disclosure - Derivatives - Schedule of Derivative Instruments (Details) Sheet http://www.esab.com/role/DerivativesScheduleofDerivativeInstrumentsDetails Derivatives - Schedule of Derivative Instruments (Details) Details 56 false false R57.htm 9954500 - Disclosure - Derivatives - Derivatives Not Designated as Hedging Instruments (Details) Sheet http://www.esab.com/role/DerivativesDerivativesNotDesignatedasHedgingInstrumentsDetails Derivatives - Derivatives Not Designated as Hedging Instruments (Details) Details 57 false false R58.htm 9954501 - Disclosure - Derivatives - Schedule of Fair Values of Derivative Instruments in the Financial Statements (Details) Sheet http://www.esab.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails Derivatives - Schedule of Fair Values of Derivative Instruments in the Financial Statements (Details) Details 58 false false R59.htm 9954502 - Disclosure - Fair Value Measurements - Fair Value Hierarchy (Details) Sheet http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails Fair Value Measurements - Fair Value Hierarchy (Details) Details 59 false false R60.htm 9954503 - Disclosure - Equity (Details) Sheet http://www.esab.com/role/EquityDetails Equity (Details) Details http://www.esab.com/role/EquityTables 60 false false R61.htm 9954504 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.esab.com/role/CommitmentsandContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 61 false false R62.htm 9954505 - Disclosure - Commitments and Contingencies - Asbestos-Related Claims Activity (Details) Sheet http://www.esab.com/role/CommitmentsandContingenciesAsbestosRelatedClaimsActivityDetails Commitments and Contingencies - Asbestos-Related Claims Activity (Details) Details 62 false false R63.htm 9954506 - Disclosure - Commitments and Contingencies - Asbestos Litigation (Details) Sheet http://www.esab.com/role/CommitmentsandContingenciesAsbestosLitigationDetails Commitments and Contingencies - Asbestos Litigation (Details) Details 63 false false R64.htm 9954507 - Disclosure - Segment Information - Narrative (Details) Sheet http://www.esab.com/role/SegmentInformationNarrativeDetails Segment Information - Narrative (Details) Details 64 false false R65.htm 9954508 - Disclosure - Segment Information - Segment Results (Details) Sheet http://www.esab.com/role/SegmentInformationSegmentResultsDetails Segment Information - Segment Results (Details) Details 65 false false R66.htm 9954509 - Disclosure - Subsequent Events (Details) Sheet http://www.esab.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.esab.com/role/SubsequentEvents 66 false false All Reports Book All Reports esab-20240329.htm esab-20240329.xsd esab-20240329_cal.xml esab-20240329_def.xml esab-20240329_lab.xml esab-20240329_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 84 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "esab-20240329.htm": { "nsprefix": "esab", "nsuri": "http://www.esab.com/20240329", "dts": { "inline": { "local": [ "esab-20240329.htm" ] }, "schema": { "local": [ "esab-20240329.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "esab-20240329_cal.xml" ] }, "definitionLink": { "local": [ "esab-20240329_def.xml" ] }, "labelLink": { "local": [ "esab-20240329_lab.xml" ] }, "presentationLink": { "local": [ "esab-20240329_pre.xml" ] } }, "keyStandard": 257, "keyCustom": 21, "axisStandard": 23, "axisCustom": 0, "memberStandard": 36, "memberCustom": 14, "hidden": { "total": 11, "http://xbrl.sec.gov/dei/2023": 5, "http://fasb.org/us-gaap/2023": 6 }, "contextCount": 160, "entityCount": 1, "segmentCount": 51, "elementCount": 543, "unitCount": 8, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 673, "http://xbrl.sec.gov/dei/2023": 30, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://www.esab.com/role/COVERPAGE", "longName": "0000001 - Document - COVER PAGE", "shortName": "COVER PAGE", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS", "longName": "0000002 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF OPERATIONS", "shortName": "CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "unique": true } }, "R3": { "role": "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME", "longName": "0000003 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME", "shortName": "CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": null }, "R4": { "role": "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical", "longName": "0000004 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Parenthetical)", "shortName": "CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS", "longName": "0000005 - Statement - CONSOLIDATED AND COMBINED CONDENSED BALANCE SHEETS", "shortName": "CONSOLIDATED AND COMBINED CONDENSED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETSParenthetical", "longName": "0000006 - Statement - CONSOLIDATED AND COMBINED CONDENSED BALANCE SHEETS (Parenthetical)", "shortName": "CONSOLIDATED AND COMBINED CONDENSED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "unique": true } }, "R7": { "role": "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY", "longName": "0000007 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF EQUITY", "shortName": "CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-21", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-21", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITYParenthetical", "longName": "0000008 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF EQUITY (Parenthetical)", "shortName": "CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF EQUITY (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": null }, "R9": { "role": "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS", "longName": "0000009 - Statement - CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "unique": true } }, "R10": { "role": "http://www.esab.com/role/OrganizationandBasisofPresentation", "longName": "0000010 - Disclosure - Organization and Basis of Presentation", "shortName": "Organization and Basis of Presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.esab.com/role/DiscontinuedOperations", "longName": "0000011 - Disclosure - Discontinued Operations", "shortName": "Discontinued Operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": null }, "R12": { "role": "http://www.esab.com/role/Acquisition", "longName": "0000012 - Disclosure - Acquisition", "shortName": "Acquisition", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.esab.com/role/Revenue", "longName": "0000013 - Disclosure - Revenue", "shortName": "Revenue", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.esab.com/role/EarningsperSharefromContinuingOperations", "longName": "0000014 - Disclosure - Earnings per Share from Continuing Operations", "shortName": "Earnings per Share from Continuing Operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.esab.com/role/IncomeTaxes", "longName": "0000015 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.esab.com/role/InventoriesNet", "longName": "0000016 - Disclosure - Inventories, Net", "shortName": "Inventories, Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.esab.com/role/AccruedandOtherLiabilities", "longName": "0000017 - Disclosure - Accrued and Other Liabilities", "shortName": "Accrued and Other Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "esab:AccruedAndOtherLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "esab:AccruedAndOtherLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.esab.com/role/BenefitPlans", "longName": "0000018 - Disclosure - Benefit Plans", "shortName": "Benefit Plans", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.esab.com/role/Debt", "longName": "0000019 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.esab.com/role/Derivatives", "longName": "0000020 - Disclosure - Derivatives", "shortName": "Derivatives", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.esab.com/role/FairValueMeasurements", "longName": "0000021 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.esab.com/role/Equity", "longName": "0000022 - Disclosure - Equity", "shortName": "Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.esab.com/role/CommitmentsandContingencies", "longName": "0000023 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.esab.com/role/SegmentInformation", "longName": "0000024 - Disclosure - Segment Information", "shortName": "Segment Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.esab.com/role/SubsequentEvents", "longName": "0000025 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R26": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": null }, "R27": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.esab.com/role/OrganizationandBasisofPresentationPolicies", "longName": "9954471 - Disclosure - Organization and Basis of Presentation (Policies)", "shortName": "Organization and Basis of Presentation (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FiscalPeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FiscalPeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.esab.com/role/RevenueTables", "longName": "9954472 - Disclosure - Revenue (Tables)", "shortName": "Revenue (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.esab.com/role/EarningsperSharefromContinuingOperationsTables", "longName": "9954473 - Disclosure - Earnings per Share from Continuing Operations (Tables)", "shortName": "Earnings per Share from Continuing Operations (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.esab.com/role/InventoriesNetTables", "longName": "9954474 - Disclosure - Inventories, Net (Tables)", "shortName": "Inventories, Net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.esab.com/role/AccruedandOtherLiabilitiesTables", "longName": "9954475 - Disclosure - Accrued and Other Liabilities (Tables)", "shortName": "Accrued and Other Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.esab.com/role/DebtTables", "longName": "9954476 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.esab.com/role/DerivativesTables", "longName": "9954477 - Disclosure - Derivatives (Tables)", "shortName": "Derivatives (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.esab.com/role/FairValueMeasurementsTables", "longName": "9954478 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.esab.com/role/EquityTables", "longName": "9954479 - Disclosure - Equity (Tables)", "shortName": "Equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.esab.com/role/CommitmentsandContingenciesTables", "longName": "9954480 - Disclosure - Commitments and Contingencies (Tables)", "shortName": "Commitments and Contingencies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "esab:ScheduleOfLossContingenciesByClaimsQuantitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "esab:ScheduleOfLossContingenciesByClaimsQuantitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.esab.com/role/SegmentInformationTables", "longName": "9954481 - Disclosure - Segment Information (Tables)", "shortName": "Segment Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.esab.com/role/OrganizationandBasisofPresentationDetails", "longName": "9954482 - Disclosure - Organization and Basis of Presentation (Details)", "shortName": "Organization and Basis of Presentation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ResearchAndDevelopmentExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "unique": true } }, "R40": { "role": "http://www.esab.com/role/DiscontinuedOperationsDetails", "longName": "9954483 - Disclosure - Discontinued Operations (Details)", "shortName": "Discontinued Operations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "unique": true } }, "R41": { "role": "http://www.esab.com/role/DiscontinuedOperationsDetails_1", "longName": "9954484 - Disclosure - Discontinued Operations (Details)", "shortName": "Discontinued Operations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": null }, "R42": { "role": "http://www.esab.com/role/AcquisitionDetails", "longName": "9954485 - Disclosure - Acquisition (Details)", "shortName": "Acquisition (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-45", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-45", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.esab.com/role/RevenueDisaggregationofRevenueDetails", "longName": "9954486 - Disclosure - Revenue - Disaggregation of Revenue (Details)", "shortName": "Revenue - Disaggregation of Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-46", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "unique": true } }, "R44": { "role": "http://www.esab.com/role/RevenueNarrativeDetails", "longName": "9954487 - Disclosure - Revenue - Narrative (Details)", "shortName": "Revenue - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:ContractWithCustomerLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:ContractWithCustomerLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.esab.com/role/RevenueAllowanceforCreditLossRollforwardDetails", "longName": "9954488 - Disclosure - Revenue - Allowance for Credit Loss Rollforward (Details)", "shortName": "Revenue - Allowance for Credit Loss Rollforward (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ProvisionForDoubtfulAccounts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "unique": true } }, "R46": { "role": "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails", "longName": "9954489 - Disclosure - Earnings per Share from Continuing Operations (Details)", "shortName": "Earnings per Share from Continuing Operations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-1", "name": "esab:NetIncomeLossFromContinuingOperationsAttributableToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "esab:NetIncomeLossFromContinuingOperationsAttributableToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.esab.com/role/IncomeTaxesDetails", "longName": "9954490 - Disclosure - Income Taxes (Details)", "shortName": "Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "unique": true } }, "R48": { "role": "http://www.esab.com/role/InventoriesNetDetails", "longName": "9954491 - Disclosure - Inventories, Net (Details)", "shortName": "Inventories, Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:InventoryRawMaterials", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:InventoryRawMaterials", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails", "longName": "9954492 - Disclosure - Accrued and Other Liabilities - Current and Noncurrent (Details)", "shortName": "Accrued and Other Liabilities - Current and Noncurrent (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-4", "name": "esab:AccruedTaxesAndDeferredIncomeTaxLiabilitiesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "esab:AccruedTaxesAndDeferredIncomeTaxLiabilitiesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.esab.com/role/AccruedandOtherLiabilitiesWarrantyLiabilityRollforwardDetails", "longName": "9954493 - Disclosure - Accrued and Other Liabilities - Warranty Liability Rollforward (Details)", "shortName": "Accrued and Other Liabilities - Warranty Liability Rollforward (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:ProductWarrantyAccrual", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:ProductWarrantyAccrual", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.esab.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails", "longName": "9954494 - Disclosure - Accrued and Other Liabilities - Restructuring Rollforward (Details)", "shortName": "Accrued and Other Liabilities - Restructuring Rollforward (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.esab.com/role/BenefitPlansDetails", "longName": "9954495 - Disclosure - Benefit Plans (Details)", "shortName": "Benefit Plans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": null }, "R53": { "role": "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails", "longName": "9954496 - Disclosure - Debt - Schedule of Long-Term Debt (Details)", "shortName": "Debt - Schedule of Long-Term Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:LongTermDebtNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfDebtTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "unique": true } }, "R54": { "role": "http://www.esab.com/role/DebtNarrativeDetails", "longName": "9954497 - Disclosure - Debt - Narrative (Details)", "shortName": "Debt - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:DeferredFinanceCostsNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:DeferredFinanceCostsNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.esab.com/role/DerivativesNarrativesDetails", "longName": "9954498 - Disclosure - Derivatives - Narratives (Details)", "shortName": "Derivatives - Narratives (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-97", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "unique": true } }, "R56": { "role": "http://www.esab.com/role/DerivativesScheduleofDerivativeInstrumentsDetails", "longName": "9954499 - Disclosure - Derivatives - Schedule of Derivative Instruments (Details)", "shortName": "Derivatives - Schedule of Derivative Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-93", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-94", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "unique": true } }, "R57": { "role": "http://www.esab.com/role/DerivativesDerivativesNotDesignatedasHedgingInstrumentsDetails", "longName": "9954500 - Disclosure - Derivatives - Derivatives Not Designated as Hedging Instruments (Details)", "shortName": "Derivatives - Derivatives Not Designated as Hedging Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-102", "name": "us-gaap:DerivativeLiabilitiesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "unique": true } }, "R58": { "role": "http://www.esab.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails", "longName": "9954501 - Disclosure - Derivatives - Schedule of Fair Values of Derivative Instruments in the Financial Statements (Details)", "shortName": "Derivatives - Schedule of Fair Values of Derivative Instruments in the Financial Statements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails", "longName": "9954502 - Disclosure - Fair Value Measurements - Fair Value Hierarchy (Details)", "shortName": "Fair Value Measurements - Fair Value Hierarchy (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.esab.com/role/EquityDetails", "longName": "9954503 - Disclosure - Equity (Details)", "shortName": "Equity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "unique": true } }, "R61": { "role": "http://www.esab.com/role/CommitmentsandContingenciesNarrativeDetails", "longName": "9954504 - Disclosure - Commitments and Contingencies - Narrative (Details)", "shortName": "Commitments and Contingencies - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-1", "name": "esab:FutureClaimsPeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "esab:FutureClaimsPeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R62": { "role": "http://www.esab.com/role/CommitmentsandContingenciesAsbestosRelatedClaimsActivityDetails", "longName": "9954505 - Disclosure - Commitments and Contingencies - Asbestos-Related Claims Activity (Details)", "shortName": "Commitments and Contingencies - Asbestos-Related Claims Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:LossContingencyPendingClaimsNumber", "unitRef": "claim", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "esab:ScheduleOfLossContingenciesByClaimsQuantitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:LossContingencyPendingClaimsNumber", "unitRef": "claim", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "esab:ScheduleOfLossContingenciesByClaimsQuantitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.esab.com/role/CommitmentsandContingenciesAsbestosLitigationDetails", "longName": "9954506 - Disclosure - Commitments and Contingencies - Asbestos Litigation (Details)", "shortName": "Commitments and Contingencies - Asbestos Litigation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-4", "name": "esab:AsbestosLiabilityNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:LossContingencyReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "esab:ScheduleOfAsbestosRelatedLitigationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "unique": true } }, "R64": { "role": "http://www.esab.com/role/SegmentInformationNarrativeDetails", "longName": "9954507 - Disclosure - Segment Information - Narrative (Details)", "shortName": "Segment Information - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": null }, "R65": { "role": "http://www.esab.com/role/SegmentInformationSegmentResultsDetails", "longName": "9954508 - Disclosure - Segment Information - Segment Results (Details)", "shortName": "Segment Information - Segment Results (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true, "unique": true } }, "R66": { "role": "http://www.esab.com/role/SubsequentEventsDetails", "longName": "9954509 - Disclosure - Subsequent Events (Details)", "shortName": "Subsequent Events (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RepaymentsOfSecuredDebt", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:DividendsPayableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "esab-20240329.htm", "unique": true } } }, "tag": { "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r28", "r751" ] }, "esab_AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.esab.com/20240329", "localname": "AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslation", "crdr": "credit", "presentation": [ "http://www.esab.com/role/RevenueAllowanceforCreditLossRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Translation", "label": "Accounts Receivable, Allowance For Credit Loss, Foreign Currency Translation", "documentation": "Accounts Receivable, Allowance For Credit Loss, Foreign Currency Translation" } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Trade receivables, less allowance for credit losses of $25,424 and $25,477", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r301", "r302" ] }, "esab_AccruedAndOtherLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.esab.com/20240329", "localname": "AccruedAndOtherLiabilitiesDisclosureTextBlock", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilities" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued and Other Liabilities", "label": "Accrued and Other Liabilities Disclosure [Text Block]", "documentation": "The entire disclosure for the accrued and other liabilities during the reporting period." } } }, "auth_ref": [] }, "esab_AccruedAsbestosLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.esab.com/20240329", "localname": "AccruedAsbestosLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asbestos liability", "label": "Accrued Asbestos Liability, Current", "documentation": "Carrying value of accrued asbestos liability included in Accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 }, "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued liabilities", "totalLabel": "Total accrued and other liabilities, Current", "label": "Accrued Liabilities, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r32" ] }, "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accrued Liabilities [Abstract]", "label": "Accrued Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccruedSalesCommissionCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedSalesCommissionCurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Third-party commissions", "label": "Accrued Sales Commission, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r32", "r720" ] }, "esab_AccruedTaxesAndDeferredIncomeTaxLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.esab.com/20240329", "localname": "AccruedTaxesAndDeferredIncomeTaxLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued taxes and deferred tax liabilities", "label": "Accrued Taxes and Deferred Income Tax Liabilities, Current", "documentation": "Accrued Taxes and Deferred Income Tax Liabilities, Current" } } }, "auth_ref": [] }, "esab_AccruedThirdPartyCommisionsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.esab.com/20240329", "localname": "AccruedThirdPartyCommisionsNoncurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Third-party commissions", "label": "Accrued Third-Party Commisions, Noncurrent", "documentation": "Accrued Third-Party Commisions, Noncurrent" } } }, "auth_ref": [] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "presentation": [ "http://www.esab.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Unrecognized Pension and Other Post-Retirement Benefit Cost", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r8", "r19", "r40", "r860", "r861", "r862" ] }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "presentation": [ "http://www.esab.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Flow Hedges", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r210", "r218", "r219", "r490", "r722", "r860" ] }, "esab_AccumulatedGainLossNetInvestmentHedgesParentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.esab.com/20240329", "localname": "AccumulatedGainLossNetInvestmentHedgesParentMember", "presentation": [ "http://www.esab.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Investment Hedges", "label": "Accumulated Gain (Loss), Net Investment Hedges, Parent [Member]", "documentation": "Accumulated Gain (Loss), Net Investment Hedges, Parent" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.esab.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r217", "r218", "r516", "r518", "r519", "r520", "r521", "r523" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r39", "r40", "r140", "r198", "r550", "r588", "r589" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.esab.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r217", "r218", "r516", "r518", "r519", "r520", "r521", "r523" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY", "http://www.esab.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Loss", "verboseLabel": "Total", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r19", "r40", "r497", "r500", "r529", "r584", "r585", "r860", "r861", "r862", "r869", "r870", "r871" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.esab.com/role/EquityDetails", "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Translation Adjustment", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r6", "r19", "r40", "r218", "r219", "r518", "r519", "r520", "r521", "r523", "r860" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r804" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r131", "r751", "r922" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid in Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r460", "r461", "r462", "r602", "r869", "r870", "r871", "r903", "r923" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r810" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r810" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r810" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r810" ] }, "esab_AdjustedEarningsBeforeInterestTaxesAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://www.esab.com/20240329", "localname": "AdjustedEarningsBeforeInterestTaxesAndAmortization", "crdr": "credit", "presentation": [ "http://www.esab.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Adjusted EBITA", "label": "Adjusted Earnings Before Interest, Taxes And Amortization", "documentation": "Adjusted Earnings Before Interest, Taxes And Amortization" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r775", "r786", "r796", "r821" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r778", "r789", "r799", "r824" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r810" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r817" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r782", "r790", "r800", "r817", "r825", "r829", "r837" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r835" ] }, "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "presentation": [ "http://www.esab.com/role/RevenueTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Allowance for Credit Losses", "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]", "documentation": "Tabular disclosure of allowance for credit loss on financing receivable." } } }, "auth_ref": [ "r56", "r877" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETSParenthetical", "http://www.esab.com/role/RevenueAllowanceforCreditLossRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade receivables, allowance for doubtful accounts", "periodStartLabel": "Balance at Beginning of Period", "periodEndLabel": "Balance at End of Period", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r199", "r303", "r310" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "crdr": "debit", "presentation": [ "http://www.esab.com/role/RevenueAllowanceforCreditLossRollforwardDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Write-Offs and Deductions", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance." } } }, "auth_ref": [ "r312" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "esab_AmericasSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.esab.com/20240329", "localname": "AmericasSegmentMember", "presentation": [ "http://www.esab.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Americas Segment", "label": "Americas Segment [Member]", "documentation": "Americas Segment" } } }, "auth_ref": [] }, "esab_AmortizationOfAcquiredIntangibleAssetsAndAcquisitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.esab.com/20240329", "localname": "AmortizationOfAcquiredIntangibleAssetsAndAcquisitionCosts", "crdr": "debit", "presentation": [ "http://www.esab.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition - amortization and other related charges", "label": "Amortization of Acquired Intangible Assets and Acquisition Costs", "documentation": "Amortization of Acquired Intangible Assets and Acquisition Costs" } } }, "auth_ref": [] }, "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax", "crdr": "credit", "presentation": [ "http://www.esab.com/role/DerivativesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred AOCI impact from interest rate swap", "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax", "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r208" ] }, "esab_AsbestosLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.esab.com/20240329", "localname": "AsbestosLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails", "http://www.esab.com/role/CommitmentsandContingenciesAsbestosLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asbestos liability", "verboseLabel": "Long-term asbestos liability", "label": "Asbestos Liability Noncurrent", "documentation": "Asbestos liability noncurrent." } } }, "auth_ref": [] }, "esab_AsbestosRelatedActivityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.esab.com/20240329", "localname": "AsbestosRelatedActivityMember", "presentation": [ "http://www.esab.com/role/DiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asbestos Related Activity", "label": "Asbestos Related Activity [Member]", "documentation": "Asbestos Related Activity" } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r169", "r193", "r232", "r271", "r286", "r292", "r307", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r486", "r491", "r510", "r547", "r644", "r751", "r766", "r893", "r894", "r907" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r188", "r203", "r232", "r307", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r486", "r491", "r510", "r751", "r893", "r894", "r907" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "CURRENT ASSETS:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets at fair value", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r99" ] }, "us-gaap_AssetsFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosureAbstract", "presentation": [ "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets:", "label": "Assets, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsTotalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsTotalMember", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets, Total [Member]", "documentation": "Total assets, when it serves as a benchmark in a concentration of risk calculation, representing the sum of all reported assets as of the balance sheet date." } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r832" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r833" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r828" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r828" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r828" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r828" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r828" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r828" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r831" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r830" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r829" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r829" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Axis]", "label": "Balance Sheet Location [Axis]", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Domain]", "label": "Balance Sheet Location [Domain]", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r85", "r90" ] }, "us-gaap_BaseRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BaseRateMember", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Base Rate", "label": "Base Rate [Member]", "documentation": "Minimum rate investor will accept." } } }, "auth_ref": [] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_BridgeLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BridgeLoanMember", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bridge Loan", "label": "Bridge Loan [Member]", "documentation": "Financing which is expected to be replaced by a medium to long-term loan. The loan \"bridges\" the gap in time when otherwise no financing would be in place." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.esab.com/role/AcquisitionDetails", "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/OrganizationandBasisofPresentationDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r482", "r745", "r746" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.esab.com/role/AcquisitionDetails", "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/OrganizationandBasisofPresentationDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r68", "r69", "r482", "r745", "r746" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://www.esab.com/role/AcquisitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Line Items]", "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r482" ] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://www.esab.com/role/AcquisitionDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Consideration transferred for acquisition", "terseLabel": "Purchase price for business combination agreement", "label": "Business Combination, Consideration Transferred", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r1", "r2", "r17" ] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://www.esab.com/role/Acquisition" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition", "label": "Business Combination Disclosure [Text Block]", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r163", "r483" ] }, "us-gaap_BusinessCombinationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Business Combinations [Abstract]", "label": "Business Combinations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r47", "r190", "r717" ] }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash equivalents", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents, beginning of period", "periodEndLabel": "Cash and cash equivalents, end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r47", "r150", "r230" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "(Decrease) increase in Cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r3", "r150" ] }, "us-gaap_CashFlowHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowHedgingMember", "presentation": [ "http://www.esab.com/role/DerivativesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Flow Hedging", "label": "Cash Flow Hedging [Member]", "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk." } } }, "auth_ref": [ "r82" ] }, "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://www.esab.com/role/DiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cash used in operating activities, discontinued operations", "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations", "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r122", "r150" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r808" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r182", "r195", "r196", "r197", "r232", "r253", "r254", "r257", "r259", "r265", "r266", "r307", "r351", "r353", "r354", "r355", "r358", "r359", "r390", "r391", "r392", "r393", "r394", "r510", "r594", "r595", "r596", "r597", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r632", "r653", "r671", "r694", "r695", "r696", "r697", "r698", "r844", "r866", "r873" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r809" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r809" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.esab.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "verboseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r156", "r337", "r338", "r702", "r884" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITYParenthetical", "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quarterly cash dividend declared (in dollars per share)", "verboseLabel": "Dividends on common stock (in dollars per share)", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r161" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY", "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r754", "r755", "r756", "r758", "r759", "r760", "r763", "r869", "r870", "r903", "r920", "r923" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r130" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r130", "r632" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETSParenthetical", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r20", "r130", "r632", "r650", "r923", "r924" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock - $0.001 par value - 600,000,000 shares authorized, $60,424,421 and 60,295,634 shares outstanding as of March 29, 2024 and December\u00a031, 2023, respectively", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r130", "r549", "r751" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r814" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r813" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r815" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r812" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Retirement Benefits [Abstract]", "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income attributable to ESAB Corporation", "terseLabel": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r41", "r214", "r216", "r224", "r543", "r563" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Comprehensive income attributable to noncontrolling interest", "negatedTerseLabel": "Comprehensive income attributable to noncontrolling interest", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r12", "r73", "r77", "r214", "r216", "r223", "r542", "r562" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income", "terseLabel": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r77", "r165", "r214", "r216", "r222", "r541", "r561" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r49", "r51", "r100", "r101", "r300", "r701" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r49", "r51", "r100", "r101", "r300", "r590", "r701" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r49", "r51", "r100", "r101", "r300", "r701", "r849" ] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Line Items]", "label": "Concentration Risk [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r701" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration risk (as a percent)", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r49", "r51", "r100", "r101", "r300" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Table]", "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r48", "r49", "r51", "r52", "r100", "r168", "r701" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r49", "r51", "r100", "r101", "r300", "r701" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation", "label": "Consolidation, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r74", "r723" ] }, "esab_ConsumableProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.esab.com/20240329", "localname": "ConsumableProductsMember", "presentation": [ "http://www.esab.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consumables", "label": "Consumable Products [Member]", "documentation": "Consumable Products [Member]" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiability", "crdr": "credit", "presentation": [ "http://www.esab.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract liability", "label": "Contract with Customer, Liability", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r396", "r397", "r408" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract liabilities", "label": "Contract with Customer, Liability, Current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r396", "r397", "r408" ] }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract liabilities", "label": "Contract with Customer, Liability, Noncurrent", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r396", "r397", "r408" ] }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityRevenueRecognized", "crdr": "credit", "presentation": [ "http://www.esab.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue recognized, contract liability", "label": "Contract with Customer, Liability, Revenue Recognized", "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due." } } }, "auth_ref": [ "r409" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "verboseLabel": "Cost of sales", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r145", "r538" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.esab.com/role/Debt" ], "lang": { "en-us": { "role": { "terseLabel": "Debt", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r157", "r231", "r360", "r366", "r367", "r368", "r369", "r370", "r371", "r376", "r383", "r384", "r386" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails", "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r25", "r127", "r128", "r170", "r171", "r234", "r361", "r362", "r363", "r364", "r365", "r367", "r372", "r373", "r374", "r375", "r377", "r378", "r379", "r380", "r381", "r382", "r525", "r729", "r730", "r731", "r732", "r733", "r867" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basis spread on variable rate (as a percent)", "label": "Debt Instrument, Basis Spread on Variable Rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "presentation": [ "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Term Debt, Gross", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r25", "r171", "r387" ] }, "esab_DebtInstrumentCovenantInterestCoverageRatioMinimum": { "xbrltype": "pureItemType", "nsuri": "http://www.esab.com/20240329", "localname": "DebtInstrumentCovenantInterestCoverageRatioMinimum", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum interest coverage ratio", "label": "Debt Instrument, Covenant, Interest Coverage Ratio, Minimum", "documentation": "Debt Instrument, Covenant, Interest Coverage Ratio, Minimum" } } }, "auth_ref": [] }, "esab_DebtInstrumentCovenantLeverageRatioMaximum": { "xbrltype": "pureItemType", "nsuri": "http://www.esab.com/20240329", "localname": "DebtInstrumentCovenantLeverageRatioMaximum", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum total leverage ratio", "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum", "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum" } } }, "auth_ref": [] }, "esab_DebtInstrumentCovenantLeverageRatioStepDownMaximum": { "xbrltype": "pureItemType", "nsuri": "http://www.esab.com/20240329", "localname": "DebtInstrumentCovenantLeverageRatioStepDownMaximum", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum step-down leverage ratio", "label": "Debt Instrument, Covenant, Leverage Ratio, Step-Down, Maximum", "documentation": "Debt Instrument, Covenant, Leverage Ratio, Step-Down, Maximum" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Principal amount", "verboseLabel": "Outstanding borrowings", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r103", "r105", "r361", "r525", "r730", "r731" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contractual interest rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r34", "r362" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r234", "r361", "r362", "r363", "r364", "r365", "r367", "r372", "r373", "r374", "r375", "r377", "r378", "r379", "r380", "r381", "r382", "r385", "r525", "r729", "r730", "r731", "r732", "r733", "r867" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails", "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r35", "r234", "r361", "r362", "r363", "r364", "r365", "r367", "r372", "r373", "r374", "r375", "r377", "r378", "r379", "r380", "r381", "r382", "r525", "r729", "r730", "r731", "r732", "r733", "r867" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r35", "r65", "r66", "r102", "r103", "r105", "r107", "r159", "r160", "r234", "r361", "r362", "r363", "r364", "r365", "r367", "r372", "r373", "r374", "r375", "r377", "r378", "r379", "r380", "r381", "r382", "r385", "r525", "r729", "r730", "r731", "r732", "r733", "r867" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTerm", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt term", "label": "Debt Instrument, Term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "crdr": "debit", "presentation": [ "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r104", "r372", "r388", "r730", "r731" ] }, "us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationLiabilityCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred compensation plans", "label": "Deferred Compensation Liability, Current and Noncurrent", "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date." } } }, "auth_ref": [] }, "us-gaap_DeferredCompensationPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationPlanAssets", "crdr": "debit", "calculation": { "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred compensation plans", "label": "Deferred Compensation Plan Assets", "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements." } } }, "auth_ref": [ "r852" ] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred financing fees", "label": "Debt Issuance Costs, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r104", "r896" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued taxes and deferred tax liabilities", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r465", "r466", "r548" ] }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxesAndTaxCredits", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income tax", "label": "Deferred Income Taxes and Tax Credits", "documentation": "Amount of deferred income tax expense (benefit) and income tax credits." } } }, "auth_ref": [ "r152" ] }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 }, "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.esab.com/role/BenefitPlansDetails", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.esab.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Pension settlement loss", "negatedLabel": "Pension settlement loss", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement", "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement." } } }, "auth_ref": [ "r412", "r421", "r428" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation, amortization, and other impairment charges", "label": "Depreciation, Depletion and Amortization, Nonproduction", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r14", "r61" ] }, "esab_DepreciationAndOtherAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://www.esab.com/20240329", "localname": "DepreciationAndOtherAmortization", "crdr": "debit", "presentation": [ "http://www.esab.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and other amortization", "label": "Depreciation and Other Amortization", "documentation": "Depreciation and Other Amortization" } } }, "auth_ref": [] }, "us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.esab.com/role/DerivativesDerivativesNotDesignatedasHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative asset classified as current." } } }, "auth_ref": [ "r493" ] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssets", "crdr": "debit", "calculation": { "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative assets", "label": "Derivative Asset", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r205", "r206", "r509", "r614", "r615", "r616", "r617", "r618", "r620", "r621", "r622", "r623", "r624", "r638", "r639", "r681", "r686", "r688", "r689", "r690", "r691", "r721", "r756", "r921" ] }, "us-gaap_DerivativeAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetsCurrent", "crdr": "debit", "presentation": [ "http://www.esab.com/role/DerivativesDerivativesNotDesignatedasHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative asset, current", "label": "Derivative Asset, Current", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r205" ] }, "us-gaap_DerivativeBasisSpreadOnVariableRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeBasisSpreadOnVariableRate", "presentation": [ "http://www.esab.com/role/DerivativesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basis spread on variable rate (as a percent)", "label": "Derivative, Basis Spread on Variable Rate", "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative." } } }, "auth_ref": [] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.esab.com/role/DerivativesDerivativesNotDesignatedasHedgingInstrumentsDetails", "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/DerivativesScheduleofDerivativeInstrumentsDetails", "http://www.esab.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails", "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r622", "r624", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r645", "r646", "r647", "r648", "r659", "r660", "r661", "r662", "r665", "r666", "r667", "r668", "r681", "r683", "r688", "r690", "r754", "r756" ] }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeAsset", "crdr": "debit", "presentation": [ "http://www.esab.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative assets", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset", "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement." } } }, "auth_ref": [ "r23", "r88", "r139", "r204", "r721" ] }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeLiability", "crdr": "credit", "presentation": [ "http://www.esab.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liabilities", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement." } } }, "auth_ref": [ "r23", "r88", "r139", "r204", "r721" ] }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeGainLossOnDerivativeNet", "crdr": "credit", "presentation": [ "http://www.esab.com/role/DerivativesScheduleofDerivativeInstrumentsDetails", "http://www.esab.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Realized loss", "label": "Derivative, Gain (Loss) on Derivative, Net", "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement." } } }, "auth_ref": [ "r901" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.esab.com/role/DerivativesDerivativesNotDesignatedasHedgingInstrumentsDetails", "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/DerivativesScheduleofDerivativeInstrumentsDetails", "http://www.esab.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails", "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r86", "r89", "r91", "r94", "r622", "r624", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r645", "r646", "r647", "r648", "r659", "r660", "r661", "r662", "r665", "r666", "r667", "r668", "r681", "r683", "r688", "r690", "r721", "r754", "r756" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.esab.com/role/Derivatives" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r167", "r495", "r502" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems", "presentation": [ "http://www.esab.com/role/DerivativesScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable", "presentation": [ "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/DerivativesScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]", "label": "Derivative Instruments and Hedging Activities Disclosures [Table]", "documentation": "Disclosure of information about derivatives and hedging activities." } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "presentation": [ "http://www.esab.com/role/DerivativesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Axis]", "label": "Hedging Relationship [Axis]", "documentation": "Information by type of hedging relationship." } } }, "auth_ref": [ "r21", "r86", "r91" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilities", "crdr": "credit", "calculation": { "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liabilities", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r205", "r206", "r509", "r614", "r615", "r616", "r617", "r620", "r621", "r622", "r623", "r624", "r645", "r647", "r648", "r683", "r684", "r686", "r688", "r689", "r690", "r691", "r721", "r921" ] }, "us-gaap_DerivativeLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://www.esab.com/role/DerivativesDerivativesNotDesignatedasHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liability, current", "label": "Derivative Liability, Current", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r205" ] }, "us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.esab.com/role/DerivativesDerivativesNotDesignatedasHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative liability classified as current." } } }, "auth_ref": [ "r493" ] }, "us-gaap_DerivativeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLineItems", "presentation": [ "http://www.esab.com/role/DerivativesDerivativesNotDesignatedasHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Line Items]", "label": "Derivative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r502" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.esab.com/role/DerivativesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r899", "r900" ] }, "us-gaap_DerivativeNumberOfInstrumentsHeld": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNumberOfInstrumentsHeld", "presentation": [ "http://www.esab.com/role/DerivativesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of derivative instruments held", "label": "Derivative, Number of Instruments Held", "documentation": "The number of derivative instruments of a particular group held by the entity." } } }, "auth_ref": [ "r80", "r81", "r623", "r681", "r682", "r685", "r756" ] }, "us-gaap_DerivativeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeTable", "presentation": [ "http://www.esab.com/role/DerivativesDerivativesNotDesignatedasHedgingInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Table]", "label": "Derivative [Table]", "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [ "r21", "r78", "r79", "r81", "r83", "r87", "r91", "r95", "r96", "r98", "r502" ] }, "us-gaap_DerivativesFairValueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesFairValueLineItems", "presentation": [ "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives, Fair Value [Line Items]", "label": "Derivatives, Fair Value [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails", "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Designated as hedging instruments", "label": "Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r21" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.esab.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Line Items]", "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r407", "r735", "r736", "r737", "r738", "r739", "r740", "r741" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.esab.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Table]", "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r407", "r735", "r736", "r737", "r738", "r739", "r740", "r741" ] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on discontinued operations (in dollars per share)", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share", "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation." } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on discontinued operations (in dollars per share)", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share", "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation." } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]", "label": "Discontinued Operations and Disposal Groups [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://www.esab.com/role/DiscontinuedOperationsDetails_1" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Classification [Axis]", "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r186" ] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://www.esab.com/role/DiscontinuedOperationsDetails_1" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Classification [Domain]", "label": "Disposal Group Classification [Domain]", "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "presentation": [ "http://www.esab.com/role/DiscontinuedOperations", "http://www.esab.com/role/DiscontinuedOperationsDetails", "http://www.esab.com/role/DiscontinuedOperationsDetails_1" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued Operations", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r110", "r154" ] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "presentation": [ "http://www.esab.com/role/DiscontinuedOperationsDetails", "http://www.esab.com/role/DiscontinuedOperationsDetails_1" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Name [Domain]", "label": "Disposal Group Name [Domain]", "documentation": "Name of disposal group." } } }, "auth_ref": [ "r745", "r746" ] }, "us-gaap_DividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStock", "crdr": "debit", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Dividends declared", "label": "Dividends, Common Stock", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r11", "r161" ] }, "us-gaap_DividendsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableCurrent", "crdr": "credit", "presentation": [ "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends payable included in accrued liabilities", "label": "Dividends Payable, Current", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r32" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r770" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r803" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "esab_EMEAAndAPACSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.esab.com/20240329", "localname": "EMEAAndAPACSegmentMember", "presentation": [ "http://www.esab.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EMEA and APAC Segment", "label": "EMEA and APAC Segment [Member]", "documentation": "EMEA and APAC Segment" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share [Abstract]", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Net income per share (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r225", "r240", "r241", "r242", "r243", "r244", "r250", "r253", "r257", "r258", "r259", "r263", "r504", "r505", "r544", "r564", "r724" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings (loss) per share \u2013 basic", "label": "Earnings Per Share, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Net income per share - diluted (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r225", "r240", "r241", "r242", "r243", "r244", "r253", "r257", "r258", "r259", "r263", "r504", "r505", "r544", "r564", "r724" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings (loss) per share \u2013 diluted", "verboseLabel": "Computation of earnings per share from continuing operations \u2013 diluted:", "label": "Earnings Per Share, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.esab.com/role/EarningsperSharefromContinuingOperations" ], "lang": { "en-us": { "role": { "verboseLabel": "Earnings per Share from Continuing Operations", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r249", "r260", "r261", "r262" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of foreign exchange rates on Cash and cash equivalents", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r514" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.esab.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective tax rate (as a percent)", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r468" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Compensation and related benefits", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r32" ] }, "esab_EmployeeRelatedLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.esab.com/20240329", "localname": "EmployeeRelatedLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation and related benefits", "label": "Employee-related Liabilities, Noncurrent", "documentation": "Employee-related Liabilities, Noncurrent" } } }, "auth_ref": [] }, "us-gaap_EmployeeSeveranceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeSeveranceMember", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Termination benefits", "label": "Employee Severance [Member]", "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "esab_EnovisCorporationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.esab.com/20240329", "localname": "EnovisCorporationMember", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Enovis Corporation", "label": "Enovis Corporation [Member]", "documentation": "Enovis Corporation" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r768" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Entity [Domain]", "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r768" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r768" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r842" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r768" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r768" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r768" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r768" ] }, "esab_EquipmentProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.esab.com/20240329", "localname": "EquipmentProductsMember", "presentation": [ "http://www.esab.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equipment", "label": "Equipment Products [Member]", "documentation": "Equipment Products [Member]" } } }, "auth_ref": [] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Equity [Abstract]", "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY", "http://www.esab.com/role/EquityDetails", "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r20", "r183", "r217", "r218", "r219", "r235", "r236", "r237", "r239", "r245", "r247", "r264", "r308", "r309", "r395", "r460", "r461", "r462", "r472", "r473", "r496", "r497", "r498", "r499", "r500", "r501", "r503", "r516", "r518", "r519", "r520", "r521", "r523", "r529", "r584", "r585", "r586", "r602", "r671" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment, Name [Domain]", "label": "Investment, Name [Domain]" } } }, "auth_ref": [ "r304", "r305", "r306" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r811" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r775", "r786", "r796", "r821" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r772", "r783", "r793", "r818" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r817" ] }, "us-gaap_FacilityClosingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FacilityClosingMember", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Facility closure costs and other", "label": "Facility Closing [Member]", "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r506", "r507", "r508" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r506", "r507", "r508" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r374", "r415", "r416", "r417", "r418", "r419", "r420", "r507", "r533", "r534", "r535", "r730", "r731", "r742", "r743", "r744" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level One", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r374", "r415", "r420", "r507", "r533", "r742", "r743", "r744" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level Two", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r374", "r415", "r420", "r507", "r534", "r730", "r731", "r742", "r743", "r744" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level Three", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r374", "r415", "r416", "r417", "r418", "r419", "r420", "r507", "r535", "r730", "r731", "r742", "r743", "r744" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r374", "r415", "r416", "r417", "r418", "r419", "r420", "r533", "r534", "r535", "r730", "r731", "r742", "r743", "r744" ] }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "presentation": [ "http://www.esab.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r85", "r87", "r97" ] }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentsDisclosureTextBlock", "presentation": [ "http://www.esab.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "verboseLabel": "Fair Value Measurements", "label": "Financial Instruments Disclosure [Text Block]", "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures." } } }, "auth_ref": [] }, "us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivableAllowanceForCreditLossesRollForward", "presentation": [ "http://www.esab.com/role/RevenueAllowanceforCreditLossRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financing Receivable, Allowance for Credit Loss [Roll Forward]", "label": "Financing Receivable, Allowance for Credit Loss [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_FiscalPeriod": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiscalPeriod", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Fiscal Period", "label": "Fiscal Period, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed." } } }, "auth_ref": [ "r70" ] }, "us-gaap_ForeignExchangeContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeContractMember", "presentation": [ "http://www.esab.com/role/DerivativesDerivativesNotDesignatedasHedgingInstrumentsDetails", "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/DerivativesScheduleofDerivativeInstrumentsDetails", "http://www.esab.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails", "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cross currency swap agreements", "verboseLabel": "Foreign currency contracts", "label": "Foreign Exchange Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates." } } }, "auth_ref": [ "r721", "r742", "r750" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r779", "r790", "r800", "r825" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r779", "r790", "r800", "r825" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r779", "r790", "r800", "r825" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r779", "r790", "r800", "r825" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r779", "r790", "r800", "r825" ] }, "esab_FutureClaimsPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.esab.com/20240329", "localname": "FutureClaimsPeriod", "presentation": [ "http://www.esab.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future claims period", "label": "Future Claims Period", "documentation": "Period for which the Company believes it can reasonably estimate the asbestos-related liability for pending and future claims that will be resolved." } } }, "auth_ref": [] }, "us-gaap_GeographicConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeographicConcentrationRiskMember", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographic Concentration Risk", "label": "Geographic Concentration Risk [Member]", "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa)." } } }, "auth_ref": [ "r50", "r701" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r191", "r316", "r539", "r728", "r751", "r878", "r879" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r144", "r232", "r271", "r285", "r291", "r294", "r307", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r510", "r726", "r893" ] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.esab.com/role/DerivativesDerivativesNotDesignatedasHedgingInstrumentsDetails", "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/DerivativesScheduleofDerivativeInstrumentsDetails", "http://www.esab.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails", "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r21", "r494" ] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.esab.com/role/DerivativesDerivativesNotDesignatedasHedgingInstrumentsDetails", "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/DerivativesScheduleofDerivativeInstrumentsDetails", "http://www.esab.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails", "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r21" ] }, "us-gaap_HedgingRelationshipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingRelationshipDomain", "presentation": [ "http://www.esab.com/role/DerivativesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Domain]", "label": "Hedging Relationship [Domain]", "documentation": "Nature or intent of a hedge." } } }, "auth_ref": [ "r21" ] }, "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity", "crdr": "debit", "presentation": [ "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net income from continuing operations attributable to noncontrolling interest, net of taxes", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest." } } }, "auth_ref": [ "r71", "r165" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.esab.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Income from continuing operations before income taxes", "verboseLabel": "Income from continuing operations before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r142", "r175", "r271", "r285", "r291", "r294", "r545", "r555", "r726" ] }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.esab.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net income from continuing operations", "terseLabel": "Net income from continuing operations", "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r165", "r232", "r238", "r271", "r285", "r291", "r294", "r307", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r505", "r510", "r555", "r726", "r893" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income from continuing operations (in dollars per share)", "verboseLabel": "Income per share from continuing operations \u2013 basic (in dollars per share)", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r141", "r174", "r176", "r225", "r238", "r240", "r241", "r242", "r243", "r253", "r257", "r258", "r505", "r544", "r918" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income from continuing operations (in dollars per share)", "verboseLabel": "Income per share from continuing operations \u2013 assuming dilution (in dollars per share)", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r141", "r225", "r238", "r240", "r241", "r242", "r243", "r253", "r257", "r258", "r259", "r505", "r544", "r918" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.esab.com/role/DiscontinuedOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss from discontinued operations, net of taxes", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r112", "r113", "r114", "r115", "r116", "r124", "r187", "r479", "r556" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "presentation": [ "http://www.esab.com/role/DiscontinuedOperationsDetails", "http://www.esab.com/role/DiscontinuedOperationsDetails_1" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Name [Axis]", "label": "Disposal Group Name [Axis]", "documentation": "Information by name of disposal group." } } }, "auth_ref": [ "r745", "r746" ] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "presentation": [ "http://www.esab.com/role/DiscontinuedOperationsDetails", "http://www.esab.com/role/DiscontinuedOperationsDetails_1" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "presentation": [ "http://www.esab.com/role/DiscontinuedOperationsDetails", "http://www.esab.com/role/DiscontinuedOperationsDetails_1" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]", "label": "Disposal Groups, Including Discontinued Operations [Table]", "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r16", "r22", "r26", "r111", "r117", "r118", "r119", "r120", "r121", "r123", "r125", "r126", "r155" ] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.esab.com/role/DerivativesScheduleofDerivativeInstrumentsDetails", "http://www.esab.com/role/DiscontinuedOperationsDetails_1" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r326", "r330", "r656" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.esab.com/role/DerivativesScheduleofDerivativeInstrumentsDetails", "http://www.esab.com/role/DiscontinuedOperationsDetails_1" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r330", "r656" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.esab.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "verboseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r233", "r464", "r469", "r470", "r471", "r474", "r476", "r480", "r481", "r599" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.esab.com/role/IncomeTaxesDetails", "http://www.esab.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax expense", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r178", "r180", "r246", "r247", "r279", "r467", "r475", "r565" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r13" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Trade receivables, net", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r13" ] }, "us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDerivativeAssetsAndLiabilities", "crdr": "credit", "presentation": [ "http://www.esab.com/role/DerivativesDerivativesNotDesignatedasHedgingInstrumentsDetails", "http://www.esab.com/role/DerivativesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in derivative assets and liabilities", "label": "Increase (Decrease) in Derivative Assets and Liabilities", "documentation": "The increase (decrease) during the period in the net carrying value of derivative instruments reported as assets and liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer)." } } }, "auth_ref": [ "r865" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories, net", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r13" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other operating assets and liabilities", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other." } } }, "auth_ref": [ "r13" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r782", "r790", "r800", "r817", "r825", "r829", "r837" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r835" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r771", "r841" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r771", "r841" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r771", "r841" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r59", "r60" ] }, "esab_InterestExpenseIncomeAndOtherNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.esab.com/20240329", "localname": "InterestExpenseIncomeAndOtherNet", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense and other, net", "label": "Interest Expense (Income) and Other, Net", "documentation": "Interest Expense (Income) and Other, Net" } } }, "auth_ref": [] }, "esab_InterestExpenseIncomeAndOtherNetMember": { "xbrltype": "domainItemType", "nsuri": "http://www.esab.com/20240329", "localname": "InterestExpenseIncomeAndOtherNetMember", "presentation": [ "http://www.esab.com/role/DerivativesScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Expense (Income) and Other, Net", "label": "Interest Expense (Income) and Other, Net [Member]", "documentation": "Interest Expense (Income) and Other, Net" } } }, "auth_ref": [] }, "us-gaap_InterestRateSwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateSwapMember", "presentation": [ "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/DerivativesScheduleofDerivativeInstrumentsDetails", "http://www.esab.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails", "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate swap agreements", "label": "Interest Rate Swap [Member]", "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period." } } }, "auth_ref": [ "r714", "r761", "r762" ] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Inventory Disclosure [Abstract]", "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://www.esab.com/role/InventoriesNet" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventories, Net", "label": "Inventory Disclosure [Text Block]", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r313" ] }, "us-gaap_InventoryFinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoods", "crdr": "debit", "calculation": { "http://www.esab.com/role/InventoriesNetDetails": { "parentTag": "us-gaap_InventoryGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.esab.com/role/InventoriesNetDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Finished goods", "label": "Inventory, Finished Goods, Gross", "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer." } } }, "auth_ref": [ "r854" ] }, "us-gaap_InventoryGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryGross", "crdr": "debit", "calculation": { "http://www.esab.com/role/InventoriesNetDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/InventoriesNetDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Inventories, gross", "label": "Inventory, Gross", "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r858" ] }, "us-gaap_InventoryLIFOReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryLIFOReserve", "crdr": "credit", "calculation": { "http://www.esab.com/role/InventoriesNetDetails": { "parentTag": "us-gaap_InventoryNet", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.esab.com/role/InventoriesNetDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "LIFO reserve", "label": "Inventory, LIFO Reserve", "documentation": "Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods." } } }, "auth_ref": [ "r857" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 }, "http://www.esab.com/role/InventoriesNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS", "http://www.esab.com/role/InventoriesNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories, net", "totalLabel": "Inventories, net", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r200", "r718", "r751" ] }, "us-gaap_InventoryRawMaterials": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterials", "crdr": "debit", "calculation": { "http://www.esab.com/role/InventoriesNetDetails": { "parentTag": "us-gaap_InventoryGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/InventoriesNetDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Raw materials", "label": "Inventory, Raw Materials, Gross", "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r856" ] }, "us-gaap_InventoryValuationReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryValuationReserves", "crdr": "credit", "calculation": { "http://www.esab.com/role/InventoriesNetDetails": { "parentTag": "us-gaap_InventoryNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/InventoriesNetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Allowance for excess, slow-moving and obsolete inventory", "label": "Inventory Valuation Reserves", "documentation": "Amount of valuation reserve for inventory." } } }, "auth_ref": [ "r57", "r858" ] }, "us-gaap_InventoryWorkInProcess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWorkInProcess", "crdr": "debit", "calculation": { "http://www.esab.com/role/InventoriesNetDetails": { "parentTag": "us-gaap_InventoryGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/InventoriesNetDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Work in process", "label": "Inventory, Work in Process, Gross", "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r855" ] }, "us-gaap_InvestmentIncomeInvestmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInvestmentExpense", "crdr": "debit", "presentation": [ "http://www.esab.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense and other, net", "label": "Investment Income, Investment Expense", "documentation": "Amount of expenses related to the generation of investment income." } } }, "auth_ref": [ "r147", "r764", "r917" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legal Entity [Axis]", "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LetterOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LetterOfCreditMember", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letter of Credit", "label": "Letter of Credit [Member]", "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)." } } }, "auth_ref": [] }, "us-gaap_LettersOfCreditOutstandingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LettersOfCreditOutstandingAmount", "crdr": "credit", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letters of credit outstanding", "label": "Letters of Credit Outstanding, Amount", "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r31", "r232", "r307", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r487", "r491", "r492", "r510", "r631", "r725", "r766", "r893", "r907", "r908" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r135", "r173", "r553", "r751", "r868", "r876", "r904" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "LIABILITIES AND EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r33", "r189", "r232", "r307", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r487", "r491", "r492", "r510", "r751", "r893", "r907", "r908" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "CURRENT LIABILITIES:", "verboseLabel": "Current", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "calculation": { "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities at fair value", "label": "Liabilities, Fair Value Disclosure", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r99" ] }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosureAbstract", "presentation": [ "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities:", "label": "Liabilities, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Noncurrent", "label": "Liabilities, Noncurrent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate principal amount", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r29" ] }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capacity for additional indebtedness", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)." } } }, "auth_ref": [ "r29" ] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditMember", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt", "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r25", "r171", "r373", "r389", "r730", "r731", "r916" ] }, "us-gaap_LongTermDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMember", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Term Debt", "label": "Long-Term Debt [Member]", "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS", "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r194" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails", "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r35" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails", "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r35", "r64" ] }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtWeightedAverageInterestRate", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average interest rate (as a percent)", "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time", "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time." } } }, "auth_ref": [] }, "us-gaap_LossContingencyAccrualCarryingValueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyAccrualCarryingValueCurrent", "crdr": "credit", "presentation": [ "http://www.esab.com/role/CommitmentsandContingenciesAsbestosLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency, Accrual, Current", "label": "Loss Contingency, Accrual, Current", "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r339" ] }, "us-gaap_LossContingencyAccrualCarryingValueNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyAccrualCarryingValueNoncurrent", "crdr": "credit", "presentation": [ "http://www.esab.com/role/CommitmentsandContingenciesAsbestosLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency, Accrual, Noncurrent", "label": "Loss Contingency, Accrual, Noncurrent", "documentation": "Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r339" ] }, "us-gaap_LossContingencyAccrualRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyAccrualRollForward", "presentation": [ "http://www.esab.com/role/CommitmentsandContingenciesAsbestosRelatedClaimsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency Accrual [Roll Forward]", "label": "Loss Contingency Accrual [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_LossContingencyClaimsSettledAndDismissedNumber": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyClaimsSettledAndDismissedNumber", "presentation": [ "http://www.esab.com/role/CommitmentsandContingenciesAsbestosRelatedClaimsActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Claims resolved", "label": "Loss Contingency, Claims Settled and Dismissed, Number", "documentation": "The number of claims settled and dismissed during the period." } } }, "auth_ref": [ "r885", "r886" ] }, "us-gaap_LossContingencyNewClaimsFiledNumber": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyNewClaimsFiledNumber", "presentation": [ "http://www.esab.com/role/CommitmentsandContingenciesAsbestosRelatedClaimsActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Claims filed", "label": "Loss Contingency, New Claims Filed, Number", "documentation": "The total number of new claims filed pertaining to a loss contingency during the period." } } }, "auth_ref": [ "r885", "r886" ] }, "us-gaap_LossContingencyPendingClaimsNumber": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyPendingClaimsNumber", "presentation": [ "http://www.esab.com/role/CommitmentsandContingenciesAsbestosRelatedClaimsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Claims unresolved, beginning of period", "periodEndLabel": "Claims unresolved, end of period", "label": "Loss Contingency, Pending Claims, Number", "documentation": "Number of pending claims pertaining to a loss contingency." } } }, "auth_ref": [ "r885", "r886" ] }, "us-gaap_LossContingencyReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyReceivableCurrent", "crdr": "debit", "presentation": [ "http://www.esab.com/role/CommitmentsandContingenciesAsbestosLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency, Receivable, Current", "label": "Loss Contingency, Receivable, Current", "documentation": "Amount of receivable related to a loss contingency accrual that is expected to be collected within one year or the normal operating cycle, if longer. For example, an insurance recovery receivable." } } }, "auth_ref": [ "r889" ] }, "us-gaap_LossContingencyReceivableNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyReceivableNoncurrent", "crdr": "debit", "presentation": [ "http://www.esab.com/role/CommitmentsandContingenciesAsbestosLitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency, Receivable, Noncurrent", "label": "Loss Contingency, Receivable, Noncurrent", "documentation": "Amount of receivable related to a loss contingency accrual that is expected to be collected after one year or beyond the normal operating cycle, if longer. For example, an insurance recovery receivable." } } }, "auth_ref": [ "r889" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DerivativesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r340", "r341", "r342", "r343", "r432", "r537", "r583", "r623", "r624", "r674", "r676", "r678", "r679", "r692", "r712", "r713", "r727", "r734", "r747", "r753", "r895", "r909", "r910", "r911", "r912", "r913", "r914" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r809" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r809" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DerivativesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r340", "r341", "r342", "r343", "r432", "r537", "r583", "r623", "r624", "r674", "r676", "r678", "r679", "r692", "r712", "r713", "r727", "r734", "r747", "r753", "r895", "r909", "r910", "r911", "r912", "r913", "r914" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interest", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r38", "r172", "r232", "r307", "r351", "r353", "r354", "r355", "r358", "r359", "r510", "r552", "r634" ] }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "crdr": "debit", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Distributions to noncontrolling owners", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders." } } }, "auth_ref": [ "r161" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r828" ] }, "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MovementInStandardProductWarrantyAccrualRollForward", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesWarrantyLiabilityRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]", "label": "Movement in Standard Product Warranty Accrual [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r836" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r810" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r229" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities:", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r229" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash flows from investing activities:", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r150", "r151", "r152" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities:", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.esab.com/role/OrganizationandBasisofPresentationDetails", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net income attributable to ESAB Corporation", "terseLabel": "Net income", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r143", "r152", "r177", "r187", "r212", "r215", "r219", "r232", "r238", "r240", "r241", "r242", "r243", "r246", "r247", "r255", "r271", "r285", "r291", "r294", "r307", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r505", "r510", "r559", "r652", "r669", "r670", "r726", "r764", "r893" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Income attributable to noncontrolling interest, net of taxes", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r76", "r166", "r212", "r215", "r246", "r247", "r558", "r862" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Income (Loss) Available to Common Stockholders", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r227", "r240", "r241", "r242", "r243", "r250", "r251", "r256", "r259", "r271", "r285", "r291", "r294", "r726" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "presentation": [ "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Computation of earnings per share from continuing operations \u2013 basic:", "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]" } } }, "auth_ref": [] }, "esab_NetIncomeLossFromContinuingOperationsAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.esab.com/20240329", "localname": "NetIncomeLossFromContinuingOperationsAttributableToParent", "crdr": "credit", "calculation": { "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income from continuing operations attributable to ESAB Corporation", "label": "Net Income (Loss) from Continuing Operations Attributable to Parent", "documentation": "Net Income from continuing operations attributable to Parent: Net income from continuing operations attributable to parent for the respective periods is calculated using Net income from continuing operations less the income attributable to noncontrolling interest, net of taxes." } } }, "auth_ref": [] }, "esab_NonCashInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.esab.com/20240329", "localname": "NonCashInterestExpense", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash interest expense", "label": "Non-Cash Interest Expense", "documentation": "Non-Cash Interest Expense" } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r809" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r779", "r790", "r800", "r817", "r825" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r807" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r806" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r817" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r836" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r836" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling Interest", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r71", "r395", "r869", "r870", "r871", "r923" ] }, "us-gaap_NondesignatedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NondesignatedMember", "presentation": [ "http://www.esab.com/role/DerivativesDerivativesNotDesignatedasHedgingInstrumentsDetails", "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/DerivativesScheduleofDerivativeInstrumentsDetails", "http://www.esab.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails", "http://www.esab.com/role/FairValueMeasurementsFairValueHierarchyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Not Designated as Hedging Instrument", "label": "Not Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r21" ] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails", "http://www.esab.com/role/SegmentInformationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r875" ] }, "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent", "crdr": "credit", "presentation": [ "http://www.esab.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income (loss) before reclassifications", "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent", "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent." } } }, "auth_ref": [ "r24", "r40" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Operating income", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r271", "r285", "r291", "r294", "r726" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r527" ] }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes current operating lease liability." } } }, "auth_ref": [ "r528" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r527" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability." } } }, "auth_ref": [ "r528" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Lease assets - right of use", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r526" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentation" ], "lang": { "en-us": { "role": { "verboseLabel": "Organization and Basis of Presentation", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r109", "r164", "r591", "r592" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r32" ] }, "us-gaap_OtherAccruedLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Accrued Liabilities, Noncurrent", "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r36" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other current assets", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r202", "r751" ] }, "us-gaap_OtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsMember", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Liabilities", "label": "Other Assets [Member]", "documentation": "Primary financial statement caption encompassing other assets." } } }, "auth_ref": [ "r85", "r97" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r192" ] }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent", "crdr": "debit", "presentation": [ "http://www.esab.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Net actuarial loss", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent", "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent." } } }, "auth_ref": [ "r9", "r18", "r140", "r165" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "crdr": "credit", "presentation": [ "http://www.esab.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on long-term intra-entity foreign currency transactions", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity." } } }, "auth_ref": [ "r12", "r18", "r165" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "crdr": "credit", "presentation": [ "http://www.esab.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r7", "r140", "r511", "r512", "r515" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized income (loss) on derivatives designated and qualifying as cash flow hedges, net of tax expense (benefit) of $295 and $(1,045)", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r207", "r208" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent", "crdr": "credit", "presentation": [ "http://www.esab.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gain on cash flow hedges", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent", "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r208" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax", "crdr": "credit", "presentation": [ "http://www.esab.com/role/DerivativesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss related to interest rate swap agreements", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax", "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r207", "r208" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax", "crdr": "debit", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gain on hedging activities, tax expense", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax", "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r209" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "crdr": "debit", "presentation": [ "http://www.esab.com/role/DerivativesScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r179", "r208", "r211" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical" ], "lang": { "en-us": { "role": { "verboseLabel": "Foreign currency translation, net of tax expense of $1,531 and $45", "terseLabel": "Foreign currency translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r5" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "crdr": "debit", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation, tax expense (benefit)", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r5", "r10", "r513", "r522" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive (loss) income", "terseLabel": "Other comprehensive income (loss), net of tax (expense) benefit", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r20", "r24", "r213", "r216", "r221", "r516", "r517", "r523", "r540", "r560", "r860", "r861" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss) income:", "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "presentation": [ "http://www.esab.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net current period Other comprehensive (loss) income", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r12", "r18", "r165", "r213", "r216" ] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical" ], "lang": { "en-us": { "role": { "negatedLabel": "Defined benefit pension and other post-retirement plan activity, net of tax expense of $203 and $66", "negatedTerseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan." } } }, "auth_ref": [ "r9", "r140" ] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax", "crdr": "credit", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Defined benefit pension and other post-retirement plan activity, tax expense", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax", "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan." } } }, "auth_ref": [ "r9", "r10", "r165" ] }, "us-gaap_OtherComprehensiveIncomeLossTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTax", "crdr": "debit", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITYParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income (loss), tax expense (benefit)", "label": "Other Comprehensive Income (Loss), Tax", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss)." } } }, "auth_ref": [ "r10", "r217", "r221", "r467", "r477", "r478", "r516", "r520", "r523", "r540", "r560" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 }, "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "totalLabel": "Total accrued and other liabilities, Noncurrent", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r36" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r809" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r777", "r788", "r798", "r823" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r780", "r791", "r801", "r826" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r780", "r791", "r801", "r826" ] }, "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic", "crdr": "debit", "calculation": { "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: distributed and undistributed earnings allocated to nonvested shares", "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic", "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method." } } }, "auth_ref": [ "r256", "r843" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r805" ] }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForProceedsFromOtherInvestingActivities", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other", "label": "Payments for (Proceeds from) Other Investing Activities", "documentation": "Amount of cash (inflow) outflow from investing activities classified as other." } } }, "auth_ref": [ "r847", "r863" ] }, "us-gaap_PaymentsForRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRestructuring", "crdr": "credit", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payments", "label": "Payments for Restructuring", "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r329", "r864" ] }, "us-gaap_PaymentsOfDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividends", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS", "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payment of dividends", "terseLabel": "Payment of dividends", "label": "Payments of Dividends", "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests." } } }, "auth_ref": [ "r45" ] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash consideration", "label": "Payments to Acquire Businesses, Gross", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r42", "r484" ] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Acquisition, net of cash received", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r42" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchases of property, plant and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r149" ] }, "us-gaap_PaymentsToMinorityShareholders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToMinorityShareholders", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Distributions to noncontrolling interest holders", "label": "Payments to Noncontrolling Interests", "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest." } } }, "auth_ref": [ "r44" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r808" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r808" ] }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "presentation": [ "http://www.esab.com/role/BenefitPlans" ], "lang": { "en-us": { "role": { "verboseLabel": "Benefit Plans", "label": "Retirement Benefits [Text Block]", "documentation": "The entire disclosure for retirement benefits." } } }, "auth_ref": [ "r411", "r413", "r414", "r420", "r422", "r423", "r424", "r425", "r426", "r427", "r429", "r430", "r431", "r744" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r807" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r817" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r810" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r806" ] }, "us-gaap_PercentageOfLIFOInventory": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PercentageOfLIFOInventory", "presentation": [ "http://www.esab.com/role/InventoriesNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of inventory valued at LIFO", "label": "Percentage of LIFO Inventory", "documentation": "The percentage of LIFO (last in first out) inventory to total inventory as of the balance sheet date if other than 100 percent." } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses", "label": "Prepaid Expense, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r201", "r314", "r315", "r719" ] }, "esab_ProceedsFromDerivativeInstrumentOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.esab.com/20240329", "localname": "ProceedsFromDerivativeInstrumentOperatingActivities", "crdr": "debit", "presentation": [ "http://www.esab.com/role/DerivativesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from settlement of interest rate swap", "label": "Proceeds From Derivative Instrument, Operating Activities", "documentation": "Proceeds From Derivative Instrument, Operating Activities" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfLongTermDebt", "crdr": "debit", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indebtedness incurred", "label": "Proceeds from Issuance of Long-Term Debt", "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r43", "r594" ] }, "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfOtherLongTermDebt", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from borrowings on term credit facility", "label": "Proceeds from Issuance of Other Long-Term Debt", "documentation": "Amount of cash inflow from issuance of long-term debt classified as other." } } }, "auth_ref": [ "r43" ] }, "us-gaap_ProceedsFromLongTermLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLongTermLinesOfCredit", "crdr": "debit", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repayments of borrowings on revolving credit facility and other", "label": "Proceeds from Long-Term Lines of Credit", "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer." } } }, "auth_ref": [ "r43" ] }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of property, plant and equipment", "label": "Proceeds from Sale of Property, Plant, and Equipment", "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r148" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.esab.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r296", "r538", "r577", "r578", "r579", "r580", "r581", "r582", "r715", "r735", "r752", "r851", "r887", "r888", "r897", "r919" ] }, "us-gaap_ProductWarrantyAccrual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrual", "crdr": "credit", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesWarrantyLiabilityRollforwardDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warranty liability, beginning of period", "periodEndLabel": "Warranty liability, end of period", "label": "Standard and Extended Product Warranty Accrual", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers." } } }, "auth_ref": [ "r106", "r344", "r346", "r350" ] }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualClassifiedCurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Warranty liability", "label": "Product Warranty Accrual, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r32", "r891", "r892" ] }, "us-gaap_ProductWarrantyAccrualNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualNoncurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warranty liability", "label": "Product Warranty Accrual, Noncurrent", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer) for estimated claims under standard and extended warranty protection rights granted to customers." } } }, "auth_ref": [ "r36", "r891", "r892" ] }, "us-gaap_ProductWarrantyAccrualPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualPayments", "crdr": "debit", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesWarrantyLiabilityRollforwardDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Cost of warranty service work performed", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty." } } }, "auth_ref": [ "r347" ] }, "us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualPreexistingIncreaseDecrease", "crdr": "credit", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesWarrantyLiabilityRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in estimates related to pre-existing warranties", "label": "Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties", "documentation": "Amount of increase (decrease) in the standard and extended product warranty accrual from changes in estimates attributable to preexisting product warranties." } } }, "auth_ref": [ "r349" ] }, "us-gaap_ProductWarrantyAccrualWarrantiesIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualWarrantiesIssued", "crdr": "credit", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesWarrantyLiabilityRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued warranty expense", "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued", "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued." } } }, "auth_ref": [ "r348" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.esab.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r296", "r538", "r577", "r578", "r579", "r580", "r581", "r582", "r715", "r735", "r752", "r851", "r887", "r888", "r897", "r919" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 }, "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCOMPREHENSIVELOSSINCOMEParenthetical", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Net income", "verboseLabel": "Net income", "terseLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r187", "r212", "r215", "r228", "r232", "r238", "r246", "r247", "r271", "r285", "r291", "r294", "r307", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r485", "r488", "r489", "r505", "r510", "r545", "r557", "r601", "r652", "r669", "r670", "r726", "r748", "r749", "r765", "r862", "r893" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r15", "r546", "r554", "r751" ] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "presentation": [ "http://www.esab.com/role/RevenueAllowanceforCreditLossRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Charged to Expense, net", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r226", "r311" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r805" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r805" ] }, "country_RU": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "RU", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Russia", "label": "RUSSIAN FEDERATION" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DerivativesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r340", "r341", "r342", "r343", "r413", "r432", "r456", "r457", "r458", "r536", "r537", "r583", "r623", "r624", "r674", "r676", "r678", "r679", "r692", "r712", "r713", "r727", "r734", "r747", "r753", "r756", "r880", "r895", "r910", "r911", "r912", "r913", "r914" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DerivativesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r340", "r341", "r342", "r343", "r413", "r432", "r456", "r457", "r458", "r536", "r537", "r583", "r623", "r624", "r674", "r676", "r678", "r679", "r692", "r712", "r713", "r727", "r734", "r747", "r753", "r756", "r880", "r895", "r910", "r911", "r912", "r913", "r914" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract", "presentation": [ "http://www.esab.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "crdr": "debit", "presentation": [ "http://www.esab.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amounts reclassified from Accumulated other comprehensive loss", "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent", "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent." } } }, "auth_ref": [ "r24", "r40" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r772", "r783", "r793", "r818" ] }, "us-gaap_RepaymentsOfLongTermLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermLinesOfCredit", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayments of borrowings on revolving credit facility and other", "label": "Repayments of Long-Term Lines of Credit", "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer." } } }, "auth_ref": [ "r46" ] }, "us-gaap_RepaymentsOfSecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfSecuredDebt", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repayments of borrowings on term credit facility", "terseLabel": "Repayments of borrowing on term credit facility", "label": "Repayments of Secured Debt", "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt." } } }, "auth_ref": [ "r46" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development expense", "label": "Research and Development Expense", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r108", "r463", "r915" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r773", "r784", "r794", "r819" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r774", "r785", "r795", "r820" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r781", "r792", "r802", "r827" ] }, "us-gaap_RestructuringCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCharges", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.esab.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Restructuring and other related charges", "terseLabel": "Total", "label": "Restructuring Charges", "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r14", "r332", "r334", "r881" ] }, "us-gaap_RestructuringCostAndReserveAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveAxis", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Restructuring Cost and Reserve [Axis]", "label": "Restructuring Type [Axis]", "documentation": "Information by type of restructuring cost." } } }, "auth_ref": [ "r328", "r329", "r334", "r335" ] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Cost and Reserve [Line Items]", "label": "Restructuring Cost and Reserve [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r328", "r329", "r330", "r331", "r334", "r335", "r336" ] }, "us-gaap_RestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserve", "crdr": "credit", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at Beginning of Period", "periodEndLabel": "Balance at End of Period", "label": "Restructuring Reserve", "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan." } } }, "auth_ref": [ "r329", "r333" ] }, "us-gaap_RestructuringReserveCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveCurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Restructuring liability", "label": "Restructuring Reserve, Current", "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset." } } }, "auth_ref": [ "r853", "r882", "r883" ] }, "us-gaap_RestructuringReserveNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveNoncurrent", "crdr": "credit", "calculation": { "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails": { "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesCurrentandNoncurrentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring liability", "label": "Restructuring Reserve, Noncurrent", "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset." } } }, "auth_ref": [ "r859", "r882", "r883" ] }, "us-gaap_RestructuringReserveRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveRollForward", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Reserve [Roll Forward]", "label": "Restructuring Reserve [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_RestructuringReserveTranslationAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveTranslationAdjustment", "crdr": "credit", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Translation", "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve." } } }, "auth_ref": [ "r882", "r883" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r132", "r161", "r551", "r587", "r589", "r598", "r633", "r751" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r183", "r235", "r236", "r237", "r239", "r245", "r247", "r308", "r309", "r460", "r461", "r462", "r472", "r473", "r496", "r498", "r499", "r501", "r503", "r584", "r586", "r602", "r923" ] }, "esab_RevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.esab.com/20240329", "localname": "RevenueAbstract", "lang": { "en-us": { "role": { "terseLabel": "Revenue [Abstract]", "label": "Revenue [Abstract]", "documentation": "Revenue [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerAbstract", "lang": { "en-us": { "role": { "terseLabel": "Revenue from Contract with Customer [Abstract]", "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.esab.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net sales", "verboseLabel": "Total", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r272", "r273", "r284", "r289", "r290", "r296", "r298", "r300", "r406", "r407", "r538" ] }, "us-gaap_RevenueFromContractWithCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerMember", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue from Contract with Customer Benchmark", "label": "Revenue from Contract with Customer Benchmark [Member]", "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r300", "r848" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.esab.com/role/Revenue" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue", "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r181", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r410" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "presentation": [ "http://www.esab.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net sales", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r220", "r232", "r272", "r273", "r284", "r289", "r290", "r296", "r298", "r300", "r307", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r510", "r545", "r893" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving credit facilities", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r836" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r836" ] }, "esab_SUMIGSolucoesParaSoldaLtdaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.esab.com/20240329", "localname": "SUMIGSolucoesParaSoldaLtdaMember", "presentation": [ "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SUMIG Solu\u00e7\u00f5es para Solda Ltda", "label": "SUMIG Solu\u00e7\u00f5es para Solda Ltda [Member]", "documentation": "SUMIG Solu\u00e7\u00f5es para Solda Ltda" } } }, "auth_ref": [] }, "esab_SagerS.A.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.esab.com/20240329", "localname": "SagerS.A.Member", "presentation": [ "http://www.esab.com/role/AcquisitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sager S.A.", "label": "Sager S.A. [Member]", "documentation": "Sager S.A." } } }, "auth_ref": [] }, "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioForecastMember", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DerivativesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario, Forecast", "label": "Forecast [Member]" } } }, "auth_ref": [ "r433", "r872" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DerivativesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Domain]", "label": "Scenario [Domain]" } } }, "auth_ref": [ "r248", "r433", "r845", "r872" ] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of Accrued and Other Liabilities", "label": "Schedule of Accrued Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.esab.com/role/EquityTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of Accumulated Other Comprehensive Loss", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r40", "r905", "r906" ] }, "esab_ScheduleOfAsbestosRelatedLitigationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.esab.com/20240329", "localname": "ScheduleOfAsbestosRelatedLitigationTableTextBlock", "presentation": [ "http://www.esab.com/role/CommitmentsandContingenciesTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of Asbestos Related Litigation", "label": "Schedule Of Asbestos Related Litigation [Table Text Block]", "documentation": "Tabular disclosure of the presentation of asbestos litigation on the statement of financial position, including the amounts and location of such amounts." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://www.esab.com/role/AcquisitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r68", "r69", "r482" ] }, "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.esab.com/role/DerivativesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)", "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings." } } }, "auth_ref": [ "r92" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.esab.com/role/DebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-Term Debt", "label": "Schedule of Debt [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "presentation": [ "http://www.esab.com/role/DerivativesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fair Values of Derivative Instruments in the Financial Statements", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r87" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "presentation": [ "http://www.esab.com/role/DerivativesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Derivative Instruments", "label": "Schedule of Derivative Instruments [Table Text Block]", "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [ "r21", "r78", "r79", "r81", "r83", "r87", "r91", "r95", "r96" ] }, "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "presentation": [ "http://www.esab.com/role/DerivativesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location", "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]", "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position." } } }, "auth_ref": [ "r84" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.esab.com/role/EarningsperSharefromContinuingOperationsTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of Earnings Per Share from Continuing Operations", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r874" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment, Name [Axis]", "label": "Investment, Name [Axis]" } } }, "auth_ref": [ "r304", "r305", "r306" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.esab.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of Assets and Liabilities Measured at Fair Value", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r506", "r507" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.esab.com/role/InventoriesNetTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of Inventory, Net", "label": "Schedule of Inventory, Current [Table Text Block]", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r27", "r136", "r137", "r138" ] }, "esab_ScheduleOfLossContingenciesByClaimsQuantitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.esab.com/20240329", "localname": "ScheduleOfLossContingenciesByClaimsQuantitiesTableTextBlock", "presentation": [ "http://www.esab.com/role/CommitmentsandContingenciesTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of Loss Contingencies by Number of Claims", "label": "Schedule Of Loss Contingencies By Claims Quantities [Table Text Block]", "documentation": "Tabular disclosure of the rollforward of asbestos claims activity during the year, including claims filed and resolved." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "presentation": [ "http://www.esab.com/role/DerivativesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives Not Designated as Hedging Instruments", "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]", "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument." } } }, "auth_ref": [ "r93", "r850" ] }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of Product Warranty Liability", "label": "Schedule of Product Warranty Liability [Table Text Block]", "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability." } } }, "auth_ref": [ "r345" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring and Related Costs [Table]", "label": "Schedule of Restructuring and Related Costs [Table]", "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring." } } }, "auth_ref": [ "r328", "r329", "r330", "r331", "r334", "r335", "r336" ] }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of Restructuring Reserve by Type of Cost", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period." } } }, "auth_ref": [ "r62", "r63" ] }, "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock", "presentation": [ "http://www.esab.com/role/RevenueTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Revenue by Major Customers by Reporting Segments", "label": "Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]", "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.esab.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Information (Details)", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r53", "r54", "r55", "r58" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.esab.com/role/SegmentInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r53", "r54", "r55", "r58" ] }, "us-gaap_SecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredDebtMember", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term loans", "label": "Secured Debt [Member]", "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets." } } }, "auth_ref": [] }, "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SOFR", "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg." } } }, "auth_ref": [ "r902" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r767" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r769" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://www.esab.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r268", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r294", "r300", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r331", "r336", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r728", "r851", "r919" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [ "r298", "r299", "r616", "r619", "r621", "r675", "r677", "r680", "r693", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r716", "r736", "r756", "r897", "r919" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.esab.com/role/SegmentInformation" ], "lang": { "en-us": { "role": { "verboseLabel": "Segment Information", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r267", "r268", "r269", "r270", "r271", "r283", "r288", "r292", "r293", "r294", "r295", "r296", "r297", "r300" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative expense", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r146" ] }, "esab_SeniorNoteOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.esab.com/20240329", "localname": "SeniorNoteOfferingMember", "presentation": [ "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Note Offering", "label": "Senior Note Offering [Member]", "documentation": "Senior Note Offering" } } }, "auth_ref": [] }, "us-gaap_SeniorNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeniorNotesMember", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Notes", "label": "Senior Notes [Member]", "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r13" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Award Types", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459" ] }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "presentation": [ "http://www.esab.com/role/Equity" ], "lang": { "en-us": { "role": { "verboseLabel": "Equity", "label": "Shareholders' Equity and Share-Based Payments [Text Block]", "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)." } } }, "auth_ref": [ "r158", "r162" ] }, "us-gaap_ShortTermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeAxis", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-Term Debt, Type [Axis]", "label": "Short-Term Debt, Type [Axis]", "documentation": "Information by type of short-term debt arrangement." } } }, "auth_ref": [ "r30" ] }, "us-gaap_ShortTermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeDomain", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-Term Debt, Type [Domain]", "label": "Short-Term Debt, Type [Domain]", "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "auth_ref": [ "r28" ] }, "us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesWarrantyLiabilityRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange translation effect", "label": "Standard and Extended Product Warranty Accrual, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the standard and extended product warranty accrual." } } }, "auth_ref": [ "r890" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.esab.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r185", "r268", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r294", "r300", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r327", "r331", "r336", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r728", "r851", "r919" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r182", "r195", "r196", "r197", "r232", "r253", "r254", "r257", "r259", "r265", "r266", "r307", "r351", "r353", "r354", "r355", "r358", "r359", "r390", "r391", "r392", "r393", "r394", "r510", "r594", "r595", "r596", "r597", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r632", "r653", "r671", "r694", "r695", "r696", "r697", "r698", "r844", "r866", "r873" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY", "http://www.esab.com/role/EquityDetails", "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r20", "r37", "r183", "r217", "r218", "r219", "r235", "r236", "r237", "r239", "r245", "r247", "r264", "r308", "r309", "r395", "r460", "r461", "r462", "r472", "r473", "r496", "r497", "r498", "r499", "r500", "r501", "r503", "r516", "r518", "r519", "r520", "r521", "r523", "r529", "r584", "r585", "r586", "r602", "r671" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [ "r298", "r299", "r616", "r619", "r621", "r675", "r677", "r680", "r693", "r700", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r716", "r736", "r756", "r897", "r919" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY", "http://www.esab.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r235", "r236", "r237", "r264", "r538", "r593", "r613", "r625", "r626", "r627", "r628", "r629", "r630", "r632", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r645", "r646", "r647", "r648", "r649", "r651", "r654", "r655", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r671", "r757" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DerivativesNarrativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Axis]", "label": "Scenario [Axis]" } } }, "auth_ref": [ "r248", "r433", "r845", "r846", "r872" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r235", "r236", "r237", "r264", "r538", "r593", "r613", "r625", "r626", "r627", "r628", "r629", "r630", "r632", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r645", "r646", "r647", "r648", "r649", "r651", "r654", "r655", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r671", "r757" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r776", "r787", "r797", "r822" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock-based award activity (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r20", "r129", "r130", "r161" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock-based award activity", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r67", "r129", "r130", "r161" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS", "http://www.esab.com/role/OrganizationandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total ESAB Corporation equity", "negatedTerseLabel": "Cumulative translation loss", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r130", "r133", "r134", "r153", "r634", "r650", "r672", "r673", "r751", "r766", "r868", "r876", "r904", "r923" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS", "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDSTATEMENTSOFEQUITY", "http://www.esab.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r71", "r72", "r75", "r183", "r184", "r218", "r235", "r236", "r237", "r239", "r245", "r308", "r309", "r395", "r460", "r461", "r462", "r472", "r473", "r496", "r497", "r498", "r499", "r500", "r501", "r503", "r516", "r518", "r523", "r529", "r585", "r586", "r600", "r634", "r650", "r672", "r673", "r699", "r765", "r868", "r876", "r904", "r923" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://www.esab.com/role/CONSOLIDATEDANDCOMBINEDCONDENSEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Equity:", "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Line Items]", "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r524", "r531" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r524", "r531" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Table]", "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r524", "r531" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Axis]", "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r524", "r531" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.esab.com/role/DerivativesNarrativesDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Domain]", "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r524", "r531" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events [Abstract]", "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.esab.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r530", "r532" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r816" ] }, "esab_TheCreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.esab.com/20240329", "localname": "TheCreditAgreementMember", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails", "http://www.esab.com/role/DebtScheduleofLongTermDebtDetails", "http://www.esab.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "The Credit Agreement", "label": "The Credit Agreement [Member]", "documentation": "The Credit Agreement" } } }, "auth_ref": [] }, "esab_TherapyEquipmentLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.esab.com/20240329", "localname": "TherapyEquipmentLimitedMember", "presentation": [ "http://www.esab.com/role/AcquisitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Therapy Equipment Limited", "label": "Therapy Equipment Limited [Member]", "documentation": "Therapy Equipment Limited" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r808" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r815" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r835" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r837" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.esab.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r838" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r839" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r837" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r837" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r840" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r838" ] }, "us-gaap_TypeOfRestructuringDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfRestructuringDomain", "presentation": [ "http://www.esab.com/role/AccruedandOtherLiabilitiesRestructuringRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Type of Restructuring [Domain]", "label": "Type of Restructuring [Domain]", "documentation": "Identification of the types of restructuring costs." } } }, "auth_ref": [ "r328", "r329", "r334", "r335" ] }, "esab_UncommittedCreditLineMember": { "xbrltype": "domainItemType", "nsuri": "http://www.esab.com/20240329", "localname": "UncommittedCreditLineMember", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Uncommitted Credit Line", "label": "Uncommitted Credit Line [Member]", "documentation": "Uncommitted Credit Line" } } }, "auth_ref": [] }, "esab_UndistributedForeignEarningsTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.esab.com/20240329", "localname": "UndistributedForeignEarningsTaxExpense", "crdr": "debit", "presentation": [ "http://www.esab.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Undistributed foreign earnings, tax expense", "label": "Undistributed Foreign Earnings, Tax Expense", "documentation": "Undistributed Foreign Earnings, Tax Expense" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r834" ] }, "us-gaap_UnrealizedGainLossOnDerivatives": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrealizedGainLossOnDerivatives", "crdr": "credit", "presentation": [ "http://www.esab.com/role/DerivativesScheduleofDerivativeInstrumentsDetails", "http://www.esab.com/role/DerivativesScheduleofFairValuesofDerivativeInstrumentsintheFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in unrealized gains (losses)", "label": "Unrealized Gain (Loss) on Derivatives", "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period." } } }, "auth_ref": [ "r14", "r665", "r666", "r667", "r668", "r687" ] }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "presentation": [ "http://www.esab.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in the net liability for uncertain tax positions", "label": "Unrecognized Tax Benefits, Period Increase (Decrease)", "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns." } } }, "auth_ref": [ "r898" ] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Axis]", "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://www.esab.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Domain]", "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "calculation": { "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net effect of potentially dilutive securities (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment", "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation." } } }, "auth_ref": [ "r874" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Weighted-average shares of common stock outstanding - assuming dilution (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r252", "r259" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.esab.com/role/EarningsperSharefromContinuingOperationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted-average shares of common stock outstanding - basic (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r250", "r259" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a),(b),(c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a-c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i),(j),(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i-k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(c)(2)", "SubTopic": "20", "Topic": "860", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Section": "50", "Paragraph": "11B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "330", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-12" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a),(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-20/tableOfContent" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3A" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3B" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-4" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-1" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815/tableOfContent" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715/tableOfContent" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-11" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482551/740-270-45-3" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r715": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r716": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r717": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r718": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8" }, "r721": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r722": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r723": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r724": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r725": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r726": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r727": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r728": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r729": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r730": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r731": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r732": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r733": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r734": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r735": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r736": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r737": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r738": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r739": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r740": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r741": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r742": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r743": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r744": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r745": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r746": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r747": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r748": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r749": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r750": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r751": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r752": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r753": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r754": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r756": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r757": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r758": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r759": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r760": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r761": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r762": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r763": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r764": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r765": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r766": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r767": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r768": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r769": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r770": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r771": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r772": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r773": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r774": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r775": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r776": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r777": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r778": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r779": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r780": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r781": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r782": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r783": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r784": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r785": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r786": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r787": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r788": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r789": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r790": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r791": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r792": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r793": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r794": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r795": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r796": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r797": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r798": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r799": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r800": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r801": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r802": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r803": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r804": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r805": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r806": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r807": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r808": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r809": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r810": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r811": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r812": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r813": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r814": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r815": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r816": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r817": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r818": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r819": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r820": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r821": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r822": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r823": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r824": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r825": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r826": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r827": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r828": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r829": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r830": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r831": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r832": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r833": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r834": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r835": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r836": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r837": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r838": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r839": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r840": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r841": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r842": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r843": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60" }, "r844": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r845": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r846": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r847": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r848": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r849": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r850": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CC", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CC" }, "r851": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r852": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r853": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "210-10-S99-1(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r901": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r902": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A" }, "r903": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r904": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r905": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r906": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r907": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r908": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r909": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r910": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r911": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r912": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r913": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r914": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r915": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r916": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r917": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r918": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r919": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r920": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r921": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r922": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r923": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r924": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 85 0001877322-24-000088-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001877322-24-000088-xbrl.zip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

  •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®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�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esab-20240329_htm.xml IDEA: XBRL DOCUMENT 0001877322 2024-01-01 2024-03-29 0001877322 2024-04-22 0001877322 2023-01-01 2023-03-31 0001877322 2024-03-29 0001877322 2023-12-31 0001877322 us-gaap:CommonStockMember 2023-12-31 0001877322 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001877322 us-gaap:RetainedEarningsMember 2023-12-31 0001877322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001877322 us-gaap:NoncontrollingInterestMember 2023-12-31 0001877322 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-29 0001877322 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-29 0001877322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-29 0001877322 us-gaap:CommonStockMember 2024-01-01 2024-03-29 0001877322 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-29 0001877322 us-gaap:CommonStockMember 2024-03-29 0001877322 us-gaap:AdditionalPaidInCapitalMember 2024-03-29 0001877322 us-gaap:RetainedEarningsMember 2024-03-29 0001877322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-29 0001877322 us-gaap:NoncontrollingInterestMember 2024-03-29 0001877322 us-gaap:CommonStockMember 2022-12-31 0001877322 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001877322 us-gaap:RetainedEarningsMember 2022-12-31 0001877322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001877322 us-gaap:NoncontrollingInterestMember 2022-12-31 0001877322 2022-12-31 0001877322 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001877322 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001877322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001877322 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001877322 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001877322 us-gaap:CommonStockMember 2023-03-31 0001877322 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001877322 us-gaap:RetainedEarningsMember 2023-03-31 0001877322 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001877322 us-gaap:NoncontrollingInterestMember 2023-03-31 0001877322 2023-03-31 0001877322 country:RU us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2024-01-01 2024-03-29 0001877322 country:RU 2024-01-01 2024-03-29 0001877322 country:RU us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2024-01-01 2024-03-29 0001877322 us-gaap:AccumulatedTranslationAdjustmentMember 2024-03-29 0001877322 esab:AsbestosRelatedActivityMember 2024-01-01 2024-03-29 0001877322 esab:AsbestosRelatedActivityMember 2023-01-01 2023-03-31 0001877322 esab:SagerS.A.Member 2024-02-26 2024-02-26 0001877322 esab:TherapyEquipmentLimitedMember 2023-01-11 2023-01-11 0001877322 esab:EquipmentProductsMember 2024-01-01 2024-03-29 0001877322 esab:EquipmentProductsMember 2023-01-01 2023-03-31 0001877322 esab:ConsumableProductsMember 2024-01-01 2024-03-29 0001877322 esab:ConsumableProductsMember 2023-01-01 2023-03-31 0001877322 us-gaap:EmployeeSeveranceMember 2023-12-31 0001877322 us-gaap:EmployeeSeveranceMember 2024-01-01 2024-03-29 0001877322 us-gaap:EmployeeSeveranceMember 2024-03-29 0001877322 us-gaap:FacilityClosingMember 2023-12-31 0001877322 us-gaap:FacilityClosingMember 2024-01-01 2024-03-29 0001877322 us-gaap:FacilityClosingMember 2024-03-29 0001877322 us-gaap:SecuredDebtMember esab:TheCreditAgreementMember us-gaap:LineOfCreditMember 2024-03-29 0001877322 us-gaap:SecuredDebtMember esab:TheCreditAgreementMember us-gaap:LineOfCreditMember 2023-12-31 0001877322 us-gaap:RevolvingCreditFacilityMember esab:TheCreditAgreementMember us-gaap:LineOfCreditMember 2024-03-29 0001877322 us-gaap:RevolvingCreditFacilityMember esab:TheCreditAgreementMember us-gaap:LineOfCreditMember 2023-12-31 0001877322 us-gaap:RevolvingCreditFacilityMember esab:TheCreditAgreementMember us-gaap:LineOfCreditMember 2022-04-04 0001877322 us-gaap:SecuredDebtMember esab:TheCreditAgreementMember us-gaap:LineOfCreditMember 2022-04-04 0001877322 us-gaap:SecuredDebtMember esab:TheCreditAgreementMember us-gaap:SeniorNotesMember 2022-04-04 0001877322 us-gaap:SecuredDebtMember esab:TheCreditAgreementMember us-gaap:SeniorNotesMember 2022-04-04 2022-04-04 0001877322 us-gaap:LetterOfCreditMember esab:TheCreditAgreementMember us-gaap:LineOfCreditMember 2022-04-04 0001877322 us-gaap:BridgeLoanMember esab:TheCreditAgreementMember us-gaap:LineOfCreditMember 2022-04-04 0001877322 esab:TheCreditAgreementMember 2022-04-04 2022-04-04 0001877322 us-gaap:RevolvingCreditFacilityMember esab:TheCreditAgreementMember us-gaap:LineOfCreditMember 2022-04-04 2022-04-04 0001877322 us-gaap:SecuredDebtMember esab:TheCreditAgreementMember us-gaap:LineOfCreditMember 2022-04-04 2022-04-04 0001877322 esab:EnovisCorporationMember 2022-04-04 2022-04-04 0001877322 us-gaap:SecuredDebtMember esab:TheCreditAgreementMember us-gaap:SeniorNotesMember 2022-06-28 0001877322 us-gaap:SecuredDebtMember esab:TheCreditAgreementMember us-gaap:SeniorNotesMember 2024-03-29 0001877322 esab:TheCreditAgreementMember us-gaap:LineOfCreditMember 2024-03-29 0001877322 esab:TheCreditAgreementMember us-gaap:LineOfCreditMember 2023-06-30 0001877322 srt:ScenarioForecastMember esab:TheCreditAgreementMember us-gaap:LineOfCreditMember 2024-06-30 0001877322 srt:MinimumMember esab:TheCreditAgreementMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-04-04 2022-04-04 0001877322 srt:MaximumMember esab:TheCreditAgreementMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-04-04 2022-04-04 0001877322 srt:MinimumMember esab:TheCreditAgreementMember us-gaap:BaseRateMember 2022-04-04 2022-04-04 0001877322 srt:MaximumMember esab:TheCreditAgreementMember us-gaap:BaseRateMember 2022-04-04 2022-04-04 0001877322 esab:TheCreditAgreementMember 2024-03-29 0001877322 us-gaap:LetterOfCreditMember esab:UncommittedCreditLineMember 2024-03-29 0001877322 us-gaap:LetterOfCreditMember 2024-03-29 0001877322 us-gaap:OtherAssetsMember 2024-03-29 0001877322 us-gaap:LongTermDebtMember 2024-03-29 0001877322 us-gaap:InterestRateSwapMember 2022-07-14 0001877322 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-07-14 0001877322 srt:MinimumMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-07-14 0001877322 srt:MaximumMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-07-14 0001877322 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2024-01-01 2024-03-29 0001877322 esab:SeniorNoteOfferingMember us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2024-04-09 0001877322 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2024-03-29 0001877322 srt:ScenarioForecastMember us-gaap:InterestRateSwapMember 2024-04-01 0001877322 us-gaap:InterestRateSwapMember 2024-03-29 0001877322 us-gaap:InterestRateSwapMember 2024-01-01 2024-03-29 0001877322 us-gaap:InterestRateSwapMember esab:InterestExpenseIncomeAndOtherNetMember 2024-01-01 2024-03-29 0001877322 us-gaap:InterestRateSwapMember esab:InterestExpenseIncomeAndOtherNetMember 2023-01-01 2023-03-31 0001877322 us-gaap:ForeignExchangeContractMember 2022-07-22 0001877322 us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-07-22 0001877322 us-gaap:InterestRateSwapMember 2023-01-01 2023-03-31 0001877322 us-gaap:ForeignExchangeContractMember 2024-03-29 0001877322 us-gaap:ForeignExchangeContractMember 2023-12-31 0001877322 us-gaap:InterestRateSwapMember 2023-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-03-29 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-01-01 2024-03-29 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-01-01 2023-03-31 0001877322 us-gaap:FairValueInputsLevel1Member 2024-03-29 0001877322 us-gaap:FairValueInputsLevel2Member 2024-03-29 0001877322 us-gaap:FairValueInputsLevel3Member 2024-03-29 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:NondesignatedMember 2024-03-29 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:NondesignatedMember 2024-03-29 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:NondesignatedMember 2024-03-29 0001877322 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member 2024-03-29 0001877322 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2024-03-29 0001877322 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel3Member 2024-03-29 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-29 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-29 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-29 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-29 0001877322 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001877322 us-gaap:FairValueInputsLevel2Member 2023-12-31 0001877322 us-gaap:FairValueInputsLevel3Member 2023-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:NondesignatedMember 2023-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:NondesignatedMember 2023-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:NondesignatedMember 2023-12-31 0001877322 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001877322 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0001877322 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001877322 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001877322 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-12-31 0001877322 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0001877322 esab:AccumulatedGainLossNetInvestmentHedgesParentMember 2023-12-31 0001877322 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-12-31 0001877322 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-01-01 2024-03-29 0001877322 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-03-29 0001877322 esab:AccumulatedGainLossNetInvestmentHedgesParentMember 2024-01-01 2024-03-29 0001877322 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-01 2024-03-29 0001877322 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-03-29 0001877322 esab:AccumulatedGainLossNetInvestmentHedgesParentMember 2024-03-29 0001877322 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-03-29 0001877322 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001877322 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001877322 esab:AccumulatedGainLossNetInvestmentHedgesParentMember 2022-12-31 0001877322 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001877322 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-03-31 0001877322 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0001877322 esab:AccumulatedGainLossNetInvestmentHedgesParentMember 2023-01-01 2023-03-31 0001877322 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-03-31 0001877322 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-03-31 0001877322 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0001877322 esab:AccumulatedGainLossNetInvestmentHedgesParentMember 2023-03-31 0001877322 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-03-31 0001877322 esab:AmericasSegmentMember 2024-01-01 2024-03-29 0001877322 esab:AmericasSegmentMember 2023-01-01 2023-03-31 0001877322 esab:EMEAAndAPACSegmentMember 2024-01-01 2024-03-29 0001877322 esab:EMEAAndAPACSegmentMember 2023-01-01 2023-03-31 0001877322 us-gaap:SecuredDebtMember esab:TheCreditAgreementMember us-gaap:SeniorNotesMember us-gaap:SubsequentEventMember 2024-04-09 2024-04-09 0001877322 esab:SUMIGSolucoesParaSoldaLtdaMember us-gaap:SubsequentEventMember 2024-04-30 2024-04-30 shares iso4217:USD iso4217:USD shares esab:segment pure esab:agreement iso4217:EUR esab:claim 0001877322 --12-31 false Q1 2024 http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherAssetsCurrent 10-Q true 2024-03-29 false 001-41297 ESAB Corporation DE 87-0923837 909 Rose Avenue 8th Floor North Bethesda MD 20852 (301) 323-9099 Common Stock, par value $0.001 per share ESAB NYSE Yes Yes Large Accelerated Filer false false false 60424421 689744000 684000000 434717000 436611000 255027000 247389000 142450000 147282000 1924000 9444000 110653000 90663000 -12155000 0 17091000 19510000 81407000 71153000 18504000 37024000 62903000 34129000 -1309000 -913000 61594000 33216000 1643000 1313000 59951000 31903000 1.01 0.54 -0.02 -0.02 0.99 0.52 1.00 0.54 -0.02 -0.02 0.98 0.52 61594000 33216000 1531000 45000 -25354000 42084000 295000 -1045000 1013000 -3581000 203000 -66000 -629000 -277000 -23712000 38780000 37882000 71996000 1320000 1814000 36562000 70182000 76495000 102003000 25424000 25477000 430149000 385198000 405601000 392858000 60415000 61771000 70088000 55890000 1042748000 997720000 290431000 294305000 1586943000 1588331000 484219000 499535000 94162000 95607000 328986000 353131000 3827489000 3828629000 338399000 306593000 292903000 313489000 631302000 620082000 992798000 1018057000 521011000 542833000 2145111000 2180972000 0.001 0.001 600000000 600000000 60424421 60295634 60000 60000 1881534000 1881054000 406867000 350557000 -647661000 -624272000 1640800000 1607399000 41578000 40258000 1682378000 1647657000 3827489000 3828629000 60295634 60000 1881054000 350557000 -624272000 40258000 1647657000 59951000 1643000 61594000 0.06 3641000 3641000 -2029000 -23389000 -323000 -23712000 128787 480000 480000 60424421 60000 1881534000 406867000 -647661000 41578000 1682378000 60094725 60000 1865904000 159231000 -674988000 38251000 1388458000 31903000 1313000 33216000 0.05 3033000 3033000 1359000 1359000 934000 38279000 501000 38780000 127538 2229000 2229000 60222263 60000 1868133000 188101000 -636709000 38706000 1458291000 61594000 33216000 16387000 21871000 4133000 2994000 -638000 2290000 1062000 299000 -12155000 0 48946000 21048000 16078000 21611000 36196000 28480000 21398000 8424000 44467000 38067000 7414000 7709000 368000 681000 18067000 18721000 1501000 0 -26614000 -25749000 115000000 187000000 6250000 0 139035000 189765000 3635000 3033000 0 1249000 -33920000 -7047000 -9441000 4769000 -25508000 10040000 102003000 72024000 76495000 82064000 Organization and Basis of Presentation<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Founded in 1904, ESAB Corporation (“ESAB” or the “Company”) is a focused premier industrial compounder. ESAB provides its partners with fabrication technology advanced equipment, consumables, gas control equipment, robotics, and digital solutions. The Company’s rich history of innovative products and workflow solutions and its business system ESAB Business Excellence (“EBX”) enables the Company’s purpose of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shaping the world we imagine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America, and “EMEA &amp; APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific. On April 4, 2022, ESAB Corporation completed its spin-off from Colfax Corporation (“Colfax,” “Enovis” or “Former Parent”) and became an independent, public-traded company (the “Separation”). </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year ends December 31. The Company’s first quarter ends on the last business day of the 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> week after the end of the prior quarter. As used herein, the first quarter results for 2024 and 2023 refer to the 13-week periods ended March 29, 2024 and March 31, 2023, respectively. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Russia and Ukraine Conflict</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The invasion of Ukraine by Russia and the sanctions imposed in response have increased the level of economic and political uncertainty. While ESAB continues to closely monitor the situation and evaluate options, the Company is meeting current contractual obligations while addressing applicable laws and regulations. For the three months ended March 29, 2024, Russia represented approximately 5% of the Company’s total revenue, and approximately $4 million of its Net income. Russia also has approximately 3% of the Company’s total net assets excluding any goodwill allocation as of March 29, 2024. In case of a disposition of the Russia business, a portion of goodwill would need to be allocated and disposed of at the relative fair value attributable to the Russia business. Russia has a cumulative translation loss of approximately $118 million as of March 29, 2024, which could be realized upon a transition out. The Company is closely monitoring developments in Ukraine and Russia. Changes in laws and regulations or other factors impacting the Company’s ability to fulfill contractual obligations could have an adverse effect on the results of operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated and Condensed Financial Statements included herein have been prepared by the Company pursuant to the rules and regulations of the Security and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in the financial statements prepared in accordance with the accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted pursuant to SEC rules and regulations; however the Company believes that the disclosures are adequate to make the information presented not misleading.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated and Condensed Financial Statements reflect, in the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Intercompany transactions and accounts are eliminated in consolidation.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company incurs research and development costs related to new product development, which are expensed as incurred and included in Selling, general and administrative expenses</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the Company’s Consolidated and Condensed Statements of Operations. Research and development costs were $10.1 million and $9.6 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during the three months ended March 29, 2024 and March 31, 2023, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hese amounts do not include development and application engineering costs incurred in conjunction with fulfilling customer orders and executing customer projects, nor do they include costs related to securing third party product rights. The Company expects to continue making significant expenditures for research and development to maintain and improve its competitive positions.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim Consolidated and Condensed Financial Statements and the related notes should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”), filed with the SEC on February 29, 2024.</span></div> 2 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year ends December 31. The Company’s first quarter ends on the last business day of the 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span> week after the end of the prior quarter. As used herein, the first quarter results for 2024 and 2023 refer to the 13-week periods ended March 29, 2024 and March 31, 2023, respectively. 0.05 4000000 0.03 -118000000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated and Condensed Financial Statements included herein have been prepared by the Company pursuant to the rules and regulations of the Security and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in the financial statements prepared in accordance with the accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted pursuant to SEC rules and regulations; however the Company believes that the disclosures are adequate to make the information presented not misleading.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim Consolidated and Condensed Financial Statements and the related notes should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”), filed with the SEC on February 29, 2024.</span></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated and Condensed Financial Statements reflect, in the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Intercompany transactions and accounts are eliminated in consolidation.</span></div> 10100000 9600000 Discontinued Operations<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds certain asbestos-related contingencies and insurance coverages from divested businesses for which it does not have an interest in the ongoing operations. The Company has classified asbestos-related activity in its Consolidated and Condensed Statements of Operations as part of Loss from discontinued operations, net of taxes. This activity consists primarily of expected settlements, legal and administrative expenses associated with the above liabilities.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 29, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2023, respectively, loss from discontinued operations, net of taxes was $1.3 million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $0.9 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ee Note </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14, “Commitments and Contingencies” for further information.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cas</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h used in operating activities related to discontinued operations for the three months ended March 29, 2024 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2023 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3.7 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5.4 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively.</span></div> 1300000 900000 -3700000 -5400000 Acquisitions<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 26, 2024, the Company completed the acquisition of Sager S.A., a welding repair and maintenance product and service leader in South America, for $18.1 million, net of cash received.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 11, 2023, the Company completed the acquisition of Therapy Equipment Limited, a regional leader in oxygen regulators, for $18.7 million, net of cash received.</span></div> 18100000 18700000 Revenue<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides fabrication technology advanced equipment, consumables, gas control equipment, robotics and digital solutions. The Company’s products are utilized to solve challenges in a wide range of industries. Substantially all revenue is recognized at a point in time. The Company disaggregates its revenue into the following product groups:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.736%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:16.615%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.617%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214,860 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,219 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">474,884 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">483,781 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">689,744 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">684,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sales mix in the above table is relatively consistent across both reportable segments. The consumables product grouping generally has less production complexity and shorter production cycles than equipment products.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the nature of the business, the total amount of unsatisfied performance obligations with an original contract duration of greater than one year as of March 29, 2024 is immaterial. In some circumstances, customers are billed in advance of revenue recognition, resulting in contract liabilities. As of December 31, 2023 and December 31, 2022, total contract liabilities were $31.2 million and $25.9 million, respectively, and were included in Accrued liabilities on the Consolidated and Condensed Balance Sheets. During the three months ended March 29, 2024 and March 31, 2023, revenue recognized that was included in the contract liabilities balance at the beginning of the year was $16.2 million and $11.1 million, respectively. As of March 29, 2024 and March 31, 2023, total contract liabilities were $29.5 million and $28.3 million, respectively, and were included in Accrued liabilities on the Company’s Consolidated and Condensed Balance Sheets.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for Credit Losses</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the activity in the Company’s allowance for credit losses included within Trade receivables in the Consolidated and Condensed Balance Sheets is as follows:</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 29, 2024</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Charged to Expense, net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Write-Offs and Deductions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign<br/>Currency<br/>Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,477 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(439)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> The Company disaggregates its revenue into the following product groups:<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.736%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:16.615%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.617%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214,860 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,219 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">474,884 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">483,781 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">689,744 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">684,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 214860000 200219000 474884000 483781000 689744000 684000000 31200000 25900000 16200000 11100000 29500000 28300000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the activity in the Company’s allowance for credit losses included within Trade receivables in the Consolidated and Condensed Balance Sheets is as follows:</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 29, 2024</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Charged to Expense, net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Write-Offs and Deductions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign<br/>Currency<br/>Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,477 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(439)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 25477000 651000 439000 -265000 25424000 Earnings per Share from Continuing Operations<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has unvested share-based payment awards with a right to receive non-forfeitable dividends, which are considered participating securities. The Company allocates earnings to participating securities and computed earnings per share using the two-class method as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Computation of earnings per share from continuing operations – basic:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations attributable to ESAB Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,260 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,816 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: distributed and undistributed earnings allocated to nonvested shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations attributable to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,895 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,579 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average shares of Common stock outstanding – basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,346,121 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,146,348 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Income per share from continuing operations – basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.01 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Computation of earnings per share from continuing operations – diluted:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations attributable to common stockholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,895 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,579 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average shares of Common stock outstanding – basic</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,346,121 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,146,348 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net effect of potentially dilutive securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">641,836 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339,878 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average shares of Common stock outstanding – dilution</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,987,957 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,486,226 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net income per share from continuing operations – diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.00 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.54 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income from continuing operations attributable to ESAB Corporation for the respective periods is calculated using Net income from continuing operations, less Income attributable to noncontrolling interest, net of taxes, of $1.6 million for the three months ended March 29, 2024 and $1.3 million for the three months ended March 31, 2023.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Potentially dilutive securities include stock options, performance-based restricted stock units and non-performance-based restricted stock units.</span></div> The Company allocates earnings to participating securities and computed earnings per share using the two-class method as follows:<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Computation of earnings per share from continuing operations – basic:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations attributable to ESAB Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,260 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,816 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: distributed and undistributed earnings allocated to nonvested shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations attributable to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,895 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,579 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average shares of Common stock outstanding – basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,346,121 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,146,348 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Income per share from continuing operations – basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.01 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Computation of earnings per share from continuing operations – diluted:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations attributable to common stockholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,895 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,579 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average shares of Common stock outstanding – basic</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,346,121 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,146,348 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net effect of potentially dilutive securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">641,836 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339,878 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Weighted-average shares of Common stock outstanding – dilution</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,987,957 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,486,226 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net income per share from continuing operations – diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.00 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.54 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income from continuing operations attributable to ESAB Corporation for the respective periods is calculated using Net income from continuing operations, less Income attributable to noncontrolling interest, net of taxes, of $1.6 million for the three months ended March 29, 2024 and $1.3 million for the three months ended March 31, 2023.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Potentially dilutive securities include stock options, performance-based restricted stock units and non-performance-based restricted stock units.</span></div> 61260000 32816000 365000 237000 60895000 32579000 60346121 60146348 1.01 0.54 60895000 32579000 60346121 60146348 641836 339878 60987957 60486226 1.00 0.54 1600000 1300000 Income Taxes <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 29, 2024, Income from continuing operations before income taxes was $81.4 million, while Income tax expense was $18.5 million. The effective tax rate was 22.7% for the three months ended March 29, 2024. The effective tax rate differed from the 2024 U.S. federal statutory rate of 21.0% primarily due to withholding taxes.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2023, Income from continuing operations before income taxes was $71.2 million, while Income tax expense was $37.0 million. The effective tax rate was 52.0% for the three months ended March 31, 2023. The effective tax rate differed from the 2023 U.S. federal statutory rate of 21.0% primarily due to discrete tax expenses in 2023 for dividend withholding taxes and an increase in the liability for uncertain tax positions as discussed below, that do not recur in 2024.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2023, the Company changed its indefinite reinvestment assertion on certain undistributed earnings of the Company’s foreign subsidiaries, resulting in a total tax expense of $10.9 million, as of March 31, 2023 on such earnings that have not been indefinitely reinvested.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a liability for certain unrecognized income tax benefits for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority (“uncertain tax positions”). During the three months ended March 31, 2023, due to an adverse court ruling in a tax case in a foreign jurisdiction, the Company increased the related liability for uncertain tax positions by $9.4 million partially offset by changes in other positions.</span></div> 81400000 18500000 0.227 71200000 37000000 0.520 10900000 9400000 Inventories, Net<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:65.078%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,072 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,627 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,561 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244,580 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">455,342 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">444,724 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIFO reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,980)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for excess, slow-moving and obsolete inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(44,761)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(47,587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,601 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">392,858 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At March 29, 2024 and December 31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 26.0% a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nd 27.4% of total inventories, respectively, were valued using the LIFO method.</span></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:65.078%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,072 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,627 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,561 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244,580 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">455,342 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">444,724 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIFO reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,980)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for excess, slow-moving and obsolete inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(44,761)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(47,587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,601 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">392,858 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 153072000 156583000 48627000 43561000 253643000 244580000 455342000 444724000 4980000 4279000 44761000 47587000 405601000 392858000 0.260 0.274 Accrued and Other Liabilities<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued and Other liabilities in the Consolidated and Condensed Balance Sheets consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Noncurrent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Noncurrent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued taxes and deferred tax liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,727 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,214 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,681 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,662 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation and related benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,906 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,052 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,589 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asbestos liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,111 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223,829 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,908 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234,796 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,548 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,248 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-371"><span style="-sec-ix-hidden:f-372">Lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,936 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,995 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,794 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,609 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,936 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,606 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third-party commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,711 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,045 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,345 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">354 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,470 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,967 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,144 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,823 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292,903 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">521,011 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313,489 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">542,833 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued Warranty Liability</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated and Condensed Balance Sheets is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:63.907%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.030%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.031%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty liability, beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,606 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,946 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued warranty expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,457 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,393 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in estimates related to pre-existing warranties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">727 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">672 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of warranty service work performed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,647)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,678)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange translation effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(207)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">964 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty liability, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,936 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,297 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued Restructuring Liability</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s restructuring programs include a series of actions to reduce the structural costs of the Company. A summary of the activity in the Company’s restructuring liability included in Accrued and Other liabilities in the Consolidated and Condensed Balance Sheets is as follows:</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 29, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at Beginning of Period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Charges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at End of Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Restructuring and other related charges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Termination benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,595 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,320 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,507)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(352)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,056 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility closure costs and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,104</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">604 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,404)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,699 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,924 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,911)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,301 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes severance and other termination benefits, including outplacement services. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span>Includes the cost of relocating associates, relocating equipment, lease termination expense and other costs in connection with the closure and optimization of facilities and product lines. <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued and Other liabilities in the Consolidated and Condensed Balance Sheets consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Noncurrent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Noncurrent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued taxes and deferred tax liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,727 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,214 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,681 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,662 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation and related benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,906 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,052 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,589 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asbestos liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,111 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223,829 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,908 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234,796 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,548 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,248 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-371"><span style="-sec-ix-hidden:f-372">Lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,936 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,995 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,794 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,609 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,936 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,606 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third-party commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,711 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,045 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,345 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">354 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,470 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,967 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,144 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,823 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292,903 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">521,011 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313,489 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">542,833 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 44727000 144214000 45681000 144662000 75906000 50750000 97052000 52589000 34111000 223829000 32908000 234796000 29548000 0 31248000 0 22936000 73995000 22794000 76609000 12936000 0 12606000 0 11224000 0 18711000 0 4045000 256000 5345000 354000 57470000 27967000 47144000 33823000 292903000 521011000 313489000 542833000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated and Condensed Balance Sheets is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:63.907%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.030%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.031%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty liability, beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,606 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,946 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued warranty expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,457 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,393 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in estimates related to pre-existing warranties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">727 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">672 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of warranty service work performed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,647)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,678)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange translation effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(207)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">964 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty liability, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,936 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,297 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 12606000 12946000 2457000 1393000 727000 672000 2647000 2678000 207000 -964000 12936000 13297000 A summary of the activity in the Company’s restructuring liability included in Accrued and Other liabilities in the Consolidated and Condensed Balance Sheets is as follows:<div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 29, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at Beginning of Period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Charges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at End of Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Restructuring and other related charges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Termination benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,595 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,320 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,507)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(352)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,056 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility closure costs and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,104</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">604 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,404)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,699 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,924 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,911)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,301 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes severance and other termination benefits, including outplacement services. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span>Includes the cost of relocating associates, relocating equipment, lease termination expense and other costs in connection with the closure and optimization of facilities and product lines. 4595000 1320000 1507000 -352000 4056000 1104000 604000 1404000 -59000 245000 5699000 1924000 2911000 -411000 4301000 Benefit Plans<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various defined benefit plans and other post-retirement benefits plans, including health and life insurance, for certain eligible employees or former employees.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 29, 2024, the Company recognized a non-cash pension settlement loss of $12.2 million related to the transfer of plan assets to a third party as part of externalizing the risk associated with a foreign defined benefit plan. This amount is reflected in Pension settlement loss in the Consolidated and Condensed Statements of Operations.</span></div> -12200000 Debt<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.153%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">981,250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">987,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revolving credit facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">993,250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,019,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized deferred financing fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">992,798 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,018,057 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loans and Revolving Credit Facility</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 4, 2022, the Company entered into a credit agreement (as amended and restated from time-to-time, the “Credit Agreement”) in connection with the Separation. The Credit Agreement initially consisted of the following facilities:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $750 million revolving credit facility (the “Revolving Facility”) with a maturity date of April 4, 2027;</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A Term A-1 loan with an initial aggregate principal amount of $400 million (the “Term Loan A-1 Facility”), with a maturity date of April 4, 2027; and</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $600 million 364-day senior term loan facility (the “Term Loan A-2 Facility”) with a maturity date of April 3, 2023.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Facility contains a $300 million foreign currency sublimit and a $50 million swing line loan sub-facility.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 4, 2022, the Company drew down $1.2 billion available under the credit facilities consisting of (i) $200 million under the Revolving Facility, (ii) $400 million under the Term Loan A-1 Facility and (iii) $600 million under the Term Loan A-2 Facility. The Company used these proceeds to make payments to Enovis of $1.2 billion, which was used as part of the consideration for the contribution of certain assets and liabilities to the Company by Enovis in connection with the Separation.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 28, 2022, the Company amended and restated the Credit Agreement by entering into Amendment No. 2 to Credit Agreement (“Credit Agreement Amendment”). The Credit Agreement Amendment provides for a $600 million term loan facility (the “Term Loan A-3 Facility” and, together with the Term Loan A-1 Facility, the “Term Facilities”, and together with the Revolving Facility, the “Facilities”) with a maturity date of April 3, 2025 to refinance the Company’s existing Term Loan A-2 Facility. Also on June 28, 2022, the Company borrowed the entire $600 million under Term Loan A-3 Facility to fund the repayment of the Term Loan A-2 Facility.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As March 29, 2024, the Credit Agreement consisted of the following facilities:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $750 million revolving credit facility (the “Revolving Facility”) with a maturity date of April 4, 2027, of which $12 million was drawn;</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A Term A-1 loan with an aggregate principal amount of $393 million (the “Term Loan A-1 Facility”) with a maturity date of April 4, 2027; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"> A Term A-3 loan with an aggregate principal amount of $589 million (the “Term Loan A-3 Facility”) with a maturity date of April 3, 2025. Refer to Note 16, “Subsequent Events” for further information.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The draw-down and repayment related to these term facilities are presented net within the Consolidated and Condensed Statements of Cash Flows.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary covenants limiting the ability of the Company and its subsidiaries to, among other things, incur debt or liens, merge or consolidate with others, dispose of assets, make investments or pay dividends. In addition, the Credit Agreement contains financial covenants requiring the Company to maintain (i) a maximum total leverage ratio of not more than 4.00:1.00, with step-downs to, commencing with the fiscal quarter ending June 30, 2023, 3.75:1.00, and commencing with the fiscal quarter ending June 30, 2024, 3.50:1.00, and (ii) a minimum interest coverage ratio of 3.00:1.00. The Credit Agreement contains various events of default (including failure to comply with the covenants under the Credit Agreement and related agreements) and upon an event of default the lenders may, subject to various customary cure rights, require the immediate payment of all amounts outstanding under the Term Facilities and the Revolving Facility. Certain United States subsidiaries of the Company have agreed to guarantee the obligations of the Company under the Credit Agreement.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans made under the Term Facilities will bear interest, at the election of the Company, at either the base rate (as defined in the Credit Agreement) or at the term Secured Overnight Financing Rate (“SOFR”) rate plus an adjustment (as defined in the Credit Agreement), in each case, plus the applicable interest rate margin. Loans made under the Revolving Facility will bear interest, at the election of the Company, at either the base rate or, (i) in the case of loans denominated in dollars, the term SOFR rate plus an adjustment or the daily simple SOFR plus an adjustment, (ii) in the case of loans denominated in euros, the adjusted Euro Interbank Offered Rate (“EURIBOR”) rate and, (iii) in the case of loans denominated in sterling, Sterling Overnight Index </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Average (“SONIA”) plus an adjustment (as all such rates are defined in the Credit Agreement Amendment), in each case, plus the applicable interest rate margin. The applicable interest rate margin changes based upon the Company’s total leverage ratio (consolidated total debt divided by EBITDA, as defined in the credit agreement and ranging from 1.125% to 1.750% or in the case of the base rate margin, 0.125% to 0.750%). Each swing line loan denominated in dollars will bear interest at the base rate plus the applicable interest rate margin.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To manage exposures to currency exchange rates and interest rates arising in Long-term debt, the Company entered into interest rate and cross currency swap agreements during the year ended December 31, 2022. Refer to Note 11, “Derivatives” for additional information.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 29, 2024, the weighted-average interest rate of borrowings under the Credit Agreement was 5.09%, including the net impact from the interest rate and cross currency swaps and excluding accretion of deferred financing fees, and there was $738 million of borrowing capacity available under the Revolving Facility, subject to meeting financial covenants and other requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other Indebtedness </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the debt agreements discussed above, the Company also has the ability to incur approximately $77 million of indebtedness pursuant to certain uncommitted credit lines, consisting of an uncommitted credit line that the Company has used from time to time in the past for short-term working capital needs.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is party to letter of credit facilities with an aggregate capacity of $109.0 million. Total letters of credit of $28.3 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were outstanding as of March 29, 2024.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Financing Fees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had total deferred financing fees of $1.3 million included in its Consolidated Balance Sheet as of March 29, 2024, which will be charged to Interest expense and other, net, using the straight-line method. The costs associated with the Term Facilities will be amortized over the contractual term of the Term Facilities and the costs associated with the Revolving Facility will be amortized over the life of the Credit Agreement. Of the $1.3 million, $0.8 million of deferred financing fees relating to the Revolving Facility are included in Other assets and $0.5 million of deferred financing fees relating to the Term Facilities are recorded as a contra-liability within Long-term debt.</span></div> <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.153%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">981,250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">987,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revolving credit facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">993,250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,019,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized deferred financing fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">992,798 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,018,057 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 981250000 987500000 12000000 32000000 993250000 1019500000 452000 1443000 992798000 1018057000 750000000 400000000 600000000 P364D 300000000 50000000 1200000000 200000000 400000000 600000000 1200000000 600000000 600000000 750000000 12000000 393000000 589000000 4 3.75 3.5 3 0.01125 0.01750 0.00125 0.00750 0.0509 738000000 77000000 109000000 28300000 1300000 1300000 800000 500000 Derivatives<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative instruments to manage exposures to currency exchange rates and interest rates arising in connection with Long-term debt and the normal course of business. The Company has established policies and procedures that govern the risk management of these exposures. Both at inception and on an ongoing basis, the derivative instruments that qualify for hedge accounting are assessed as to their effectiveness, when applicable.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to the credit risk of counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. None of the concentrations of risk with an individual counterparty was considered significant as of March 29, 2024. The Company does not expect any counterparties to fail to meet their obligations. The Company records derivatives in the Consolidated and Condensed Balance Sheets at fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 14, 2022, the Company entered into two interest rate swap agreements to manage interest rate risk exposure. The aggregate notional amount of these contracts is $600 million and they mature in April 2025. These interest rate swap agreements utilized by the Company effectively modify the Company’s exposure to interest rate risk by converting a portion of the Company’s floating-rate debt to a fixed rate of 3.293%, plus a spread, thus reducing the impact of interest-rate changes on future interest expense. The applicable spread may vary between 1.125% to 1.750%, depending on the total leverage ratio of the Company. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the Company received $5.5 million to settle one of the interest rate swaps associated with the Company’s floating-rate debt. The termination of the interest rate swap related to the anticipated repayment of the Term A-3 Facility when </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">completed in April with the proceeds of the April 2024 $700 million Senior Note Offering. Refer to Note 16, “Subsequent Events” for further information. As this interest rate swap was designated as a cash flow hedge, $5.5 million was deferred in accumulated other comprehensive income (loss) (“AOCI”) and will be recognized in earnings over the period the originally forecasted hedged transaction impacts earnings. The remaining $300 million swap will continue to be hedged against the remaining floating-rate debt.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the remaining swap, the spread was 1.250% as of March 29, 2024. This agreement involves the receipt of floating-rate amounts in exchange for fixed-rate interest payments over the life of the agreement without an exchange of the underlying principal amount. This interest rate swap agreement is designated and qualifies as a cash flow hedge and as such, the gain or loss on the derivative instrument due to the change in fair value is reported as a component of AOCI and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is deemed to be ineffective, the change in fair value of the derivative is recognized directly in earnings. The Company </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">did not have any ineffectiveness related to the cash flow hedges during the three months ended March 29, 2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash inflows and outflows associated with the Company’s interest rate swap agreement designated as cash flow hedges are classified in cash flows from operating activities in the accompanying Consolidated and Condensed Statements of Cash Flows.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects a gain of $4.0 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, net of tax, r</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">elated to interest rate swap agreements to be reclassified from AOCI to earnings over the next 12 months as the hedged transactions are realized. The expected gain to be reclassified is based on current forward rates in active markets as of March 29, 2024.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of designated cash flow hedges on the Company’s Consolidated and Condensed Statements of Operations consisted of the following:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:26.425%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.665%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.670%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) recognized in the Consolidated and Condensed Statements of Operations:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense and other, net</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,722)</span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,977)</span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 22, 2022, the Company entered into two cross-currency swap agreements to partially hedge its net investment in its Euro-denominated subsidiaries against adverse movements in exchange rates between the U.S. Dollar and the Euro. In addition, the cross-currency swap agreements include provisions to exchange fixed-rate payments in U.S. Dollar for fixed-rate payments in Euro and are designated and qualify as a net investment hedge. These contracts have a Euro aggregate notional amount of approximately €270 million and a U.S. Dollar aggregate notional amount of $275 million at March 29, 2024, and they mature in April 2025.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the spot rate of these instruments are recorded in AOCI in equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCI. The Company uses the spot method of assessing hedge effectiveness and as such, the initial value of the hedge components excluded from the assessment of effectiveness is recognized in the Interest expense and other, net line item in the Consolidated and Condensed Statement of Operations under a systematic and rational method over the life of the cross-currency swap agreements. Any ineffective portions of net investment hedges are reclassified from AOCI into earnings during the period of change. The Com</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pany did not have any ineffectiveness related to net investment hedges during the three months ended March 29, 2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash inflows and outflows associated with the excluded components of the Company’s cross-currency swap agreements designated as net investment hedges are classified in operating activities in the accompanying Consolidated and Condensed Statements of Cash Flows.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of the excluded components of designated net investment hedges on the Company’s Consolidated and Condensed Statements of Operations consisted of the following:</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:26.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.665%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.523%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) recognized in the Consolidated and Condensed Statements of Operations:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap agreements</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense and other, net</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,179)</span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,201)</span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows the fair value of the derivatives recognized in the Consolidated Balance Sheet: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Designated as hedging instruments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Assets</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap agreements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,783 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,232 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,783 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,174 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,232 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,522 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedging Instruments </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain foreign currency contracts that are not designated as hedges. As of March 29, 2024 and December 31, 2023, the Company had foreign currency contracts related to purchases and sales with notional values of $267.2 million and $232.5 million, respectively. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows the fair value of derivative instruments not designated in a hedging relationship recognized in the Consolidated Balance Sheet: </span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Not designated as hedging instruments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-511">Accrued Liabilities</span></span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-512">Other Current Assets</span></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-513">Accrued Liabilities</span></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-514">Other Current Assets</span></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">431 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">596 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,088 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts in the table above as of March 29, 2024 reflect the fair value of the Company’s foreign currency contracts on a net basis where allowable under master netting agreements. Had these amounts been recognized on a gross basis, the impact would have been a $0.6 million increase in Other current assets with a corresponding increase in Accrued liabilities.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized the following in its Consolidated and Condensed Financial Statements related to its derivative instruments not designated in a hedging relationship: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:23.497%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.499%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized gains (losses)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized gains (losses)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,027 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:2pt;text-align:justify"><span><br/></span></div><div style="margin-top:2pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above gains or losses on foreign currency contracts are usually offset by foreign exchange exposure on cash and intercompany positions, all of which are recognized in Interest expense and other, net, in the Consolidated and Condensed Statements of Operations.</span></div> 2 600000000 0.03293 0.01125 0.01750 5500000 700000000 5500000 300000000 0.01250 4000000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of designated cash flow hedges on the Company’s Consolidated and Condensed Statements of Operations consisted of the following:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:26.425%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.665%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.670%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) recognized in the Consolidated and Condensed Statements of Operations:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense and other, net</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,722)</span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,977)</span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> -2722000 -1977000 2 270000000 275000000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of the excluded components of designated net investment hedges on the Company’s Consolidated and Condensed Statements of Operations consisted of the following:</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:26.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.665%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.523%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivative type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) recognized in the Consolidated and Condensed Statements of Operations:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap agreements</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense and other, net</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,179)</span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,201)</span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> -1179000 -1201000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows the fair value of the derivatives recognized in the Consolidated Balance Sheet: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Designated as hedging instruments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Assets</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap agreements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,783 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,232 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,783 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,174 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,232 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,522 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 15783000 0 22232000 0 0 5174000 0 9522000 15783000 5174000 22232000 9522000 267200000 232500000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows the fair value of derivative instruments not designated in a hedging relationship recognized in the Consolidated Balance Sheet: </span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Not designated as hedging instruments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-511">Accrued Liabilities</span></span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-512">Other Current Assets</span></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-513">Accrued Liabilities</span></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-514">Other Current Assets</span></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">431 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">596 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,088 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 431000 874000 596000 1088000 600000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized the following in its Consolidated and Condensed Financial Statements related to its derivative instruments not designated in a hedging relationship: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:23.497%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.499%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrealized gains (losses)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized gains (losses)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,027 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:2pt;text-align:justify"><span><br/></span></div><div style="margin-top:2pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above gains or losses on foreign currency contracts are usually offset by foreign exchange exposure on cash and intercompany positions, all of which are recognized in Interest expense and other, net, in the Consolidated and Condensed Statements of Operations.</span></div> -49000 143000 -394000 1027000 Fair Value Measurements<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of financial instruments, including Trade receivables and Accounts payable, approximate their fair values due to their short-term maturities. The estimated fair values may not represent actual values of the financial instruments that could be realized as of the balance sheet date or that will be realized in the future.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>One</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>Two</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>Three</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,968 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,968 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts - not designated as hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,457 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,457 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,281 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,281 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,968 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,912 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,880 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts - not designated as hedges</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,014 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,014 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,783 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,783 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,281 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,281 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,078 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,078 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:2pt;text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>One</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>Two</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>Three</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,027 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,027 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts - not designated as hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,261 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,261 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,488 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,488 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,027 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,271 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,298 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts - not designated as hedges</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,769 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,769 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap agreements </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,232 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,232 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,488 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,488 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,489 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,489 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of foreign currency contracts, cross currency swap agreements and interest rate swap agreements using Level Two inputs based on observable spot and forward rates in active markets. Additionally, the fair value of derivatives designated in hedging relationships includes a credit valuation adjustment to appropriately incorporate nonperformance risk for the Company and the respective counterparty. For the three months ended March 29, 2024, the impact of the credit valuation adjustment on the Company’s derivatives is immaterial. Refer to Note 11, “Derivatives” for additional information.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers in or out of Level One, Two or Three during the three months ended March 29, 2024.</span></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>One</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>Two</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>Three</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,968 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,968 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts - not designated as hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,457 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,457 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,281 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,281 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,968 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,912 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,880 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts - not designated as hedges</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,014 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,014 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,783 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,783 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,281 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,281 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,078 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,078 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:2pt;text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>One</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>Two</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Level<br/>Three</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,027 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,027 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts - not designated as hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,261 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,261 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swap agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,488 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,488 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,027 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,271 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,298 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts - not designated as hedges</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,769 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,769 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross currency swap agreements </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,232 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,232 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,488 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,488 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,489 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,489 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2968000 0 0 2968000 0 1457000 0 1457000 0 5174000 0 5174000 0 4281000 0 4281000 2968000 10912000 0 13880000 0 1014000 0 1014000 0 15783000 0 15783000 0 4281000 0 4281000 0 21078000 0 21078000 6027000 0 0 6027000 0 2261000 0 2261000 0 9522000 0 9522000 0 3488000 0 3488000 6027000 15271000 0 21298000 0 1769000 0 1769000 0 22232000 0 22232000 0 3488000 0 3488000 0 27489000 0 27489000 Equity<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the changes in the balances of each component of AOCI including reclassifications out of AOCI for the three months ended March 29, 2024 and March 31, 2023. All amounts are net of tax and noncontrolling interest, if any.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss Components</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrecognized Pension and Other Post-Retirement Benefit Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,805)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(554,622)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,215)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,370 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(624,272)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,265)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,995 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,027)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on long-term intra-entity foreign currency transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,996 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,996 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized loss on cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,269)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,995 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,920 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,111)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">629 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,907)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current period Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">872 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,269)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,995 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,013 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,389)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at March 29, 2024</span></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,933)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(584,891)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,220)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,383 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(647,661)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the three months ended March 29, 2024, the amount within Cash Flow Hedges is a component of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest expense and other, net. See Note 11, “Derivatives” for additional details.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.567%"><tr><td style="width:1.0%"></td><td style="width:40.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.101%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss Components</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrecognized Pension and Other Post-Retirement Benefit Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,847)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(613,907)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,336)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,102 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(674,988)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,276 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,086)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,082 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on long-term intra-entity foreign currency transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized loss on cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,051)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,051)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,777 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,086)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,051)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,530 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,530)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,251)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current period Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,777 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,086)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,581)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,279 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at March 31, 2023</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,678)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(570,130)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,422)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,521 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(636,709)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the three months ended March 31, 2023, the amount within Cash Flow Hedges is a component of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest expense and other, net. See Note 11, “Derivatives” for additional details.</span></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the changes in the balances of each component of AOCI including reclassifications out of AOCI for the three months ended March 29, 2024 and March 31, 2023. All amounts are net of tax and noncontrolling interest, if any.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss Components</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrecognized Pension and Other Post-Retirement Benefit Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,805)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(554,622)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,215)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,370 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(624,272)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,265)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,995 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,027)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on long-term intra-entity foreign currency transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,996 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,996 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized loss on cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,269)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,995 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,920 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,111)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">629 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,907)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current period Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">872 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,269)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,995 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,013 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,389)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at March 29, 2024</span></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,933)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(584,891)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,220)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,383 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(647,661)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the three months ended March 29, 2024, the amount within Cash Flow Hedges is a component of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest expense and other, net. See Note 11, “Derivatives” for additional details.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.567%"><tr><td style="width:1.0%"></td><td style="width:40.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.101%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss Components</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Unrecognized Pension and Other Post-Retirement Benefit Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,847)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(613,907)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,336)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,102 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(674,988)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,276 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,086)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,082 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on long-term intra-entity foreign currency transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized loss on cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,051)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,051)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,777 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,086)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,051)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,530 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,530)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,251)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current period Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,777 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,086)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,581)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,279 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at March 31, 2023</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,678)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(570,130)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,422)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,521 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(636,709)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the three months ended March 31, 2023, the amount within Cash Flow Hedges is a component of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest expense and other, net. See Note 11, “Derivatives” for additional details.</span></div> -59805000 -554622000 -17215000 7370000 -624272000 243000 -38265000 4995000 0 -33027000 0 7996000 0 0 7996000 0 0 0 3920000 3920000 -243000 30269000 -4995000 -3920000 -21111000 -629000 0 0 2907000 2278000 872000 -30269000 4995000 1013000 -23389000 -58933000 -584891000 -12220000 8383000 -647661000 -63847000 -613907000 -8336000 11102000 -674988000 2000 0 0 0 2000 -108000 31276000 -2086000 0 29082000 0 12501000 0 0 12501000 0 0 0 -2051000 -2051000 110000 -43777000 2086000 2051000 39530000 -279000 0 0 1530000 1251000 169000 43777000 -2086000 -3581000 38279000 -63678000 -570130000 -10422000 7521000 -636709000 Commitments and Contingencies <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asbestos Contingencies </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain entities that became subsidiaries of ESAB Corporation in connection with the Separation are the legal obligor, or owner, for certain asbestos obligations including long-term asbestos insurance assets, long-term asbestos insurance receivables, accrued asbestos liabilities, long-term asbestos liabilities, asbestos indemnity expenses, asbestos-related defense costs and asbestos insurance recoveries related to the asbestos obligations from the Former Parent’s other legacy industrial businesses. As a result, the Company holds certain asbestos-related contingencies and insurance coverages.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These subsidiaries are each one of many defendants in a large number of lawsuits that claim personal injury as a result of exposure to asbestos from products manufactured or used with components that are alleged to have contained asbestos. Such components were acquired from third-party suppliers, and were not manufactured by any of the Company’s, or Former Parent’s, subsidiaries, nor were the subsidiaries, producers or direct suppliers of asbestos. The manufactured products that are alleged to have contained or used asbestos generally were provided to meet the specifications of the subsidiaries’ customers, including the U.S. Navy. The subsidiaries settle asbestos claims for amounts the Company considers reasonable given the facts and circumstances of each claim. The annual average settlement payment per asbestos claimant has fluctuated during the past several years</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> while </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the number of cases has steadily declined. The Company expects such settlement value fluctuations to continue in the future based upon, among other things, the number and type of claims settled in a particular period and the jurisdictions in which such claims arise. To date, the majority of settled claims have been dismissed for no payment to plaintiffs.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified asbestos-related activity in Loss from discontinued operations, net of taxes in the Consolidated and Condensed Statements of Operations. This is consistent with the Former Parent’s classification on the basis that, pursuant to the purchase agreement from the Former Parent’s Fluid Handling business divestiture, the Former Parent retained its asbestos-related contingencies and insurance coverages. However, as the Former Parent did not retain an interest in the ongoing operations of the business subject to the contingencies, asbestos-related activity was classified as part of Loss from discontinued operations, net of taxes in the Condensed Consolidated Statements of Operations of the Former Parent.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has projected each subsidiary’s future asbestos-related liability costs with regard to pending and future unasserted claims based upon the Nicholson methodology. The Nicholson methodology is a standard approach used by experts and has been accepted by numerous courts. Consistent with the Former Parent, it is ESAB’s policy to record a liability for asbestos-related liability costs for the longest period of time that ESAB management can reasonably estimate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that it can reasonably estimate the asbestos-related liability for pending and future claims that will be resolved in the next 15 years and has recorded that liability as its best estimate. While it is reasonably possible that the subsidiaries will incur costs after this period, the Company does not believe the reasonably possible loss or a range of reasonably possible losses is estimable at the current time. Accordingly, no accrual has been recorded for any costs that may be paid after the next 15 years. Defense costs associated with asbestos-related liabilities as well as costs incurred related to efforts to recover insurance from the subsidiaries’ insurers are expensed as incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each subsidiary has separate insurance coverage acquired prior to Company ownership. The Company estimates the insurance assets for each subsidiary based upon the applicable policy language, expected recoveries and allocation methodologies, and law pertaining to the affected subsidiary’s insurance policies.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asbestos-related claims activity since December 31 is as follows:</span></div><div style="padding-left:20.25pt;padding-right:20.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.813%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Number of claims)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Claims unresolved, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,106 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Claims filed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,297 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">986 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Claims resolved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(749)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Claims unresolved, end of period</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,231 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,343 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Claims filed include all asbestos claims for which notification have been received or a file has been opened.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Consolidated Balance Sheet included the following amounts related to asbestos-related litigation:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.813%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term asbestos insurance asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213,323 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">221,489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term asbestos insurance receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,306 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,868 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued asbestos liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,111 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,908 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term asbestos liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223,829 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234,796 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in Other assets in the Consolidated Balance Sheets.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay, and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Consolidated Balance Sheets.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in Other liabilities in the Consolidated Balance Sheets.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management’s analyses are based on currently known facts and assumptions. Projecting future events, such as new claims to be filed each year, the average cost of resolving each claim, coverage issues among layers of insurers, the method in which losses will be allocated to the various insurance policies, interpretation of the effect on coverage of various policy terms and limits and their interrelationships, the continuing solvency of various insurance companies, the amount of remaining insurance available, as well as the numerous uncertainties inherent in asbestos litigation could cause the actual liabilities and insurance recoveries to be higher or lower than those projected or recorded that could materially affect the Company’s financial condition, results of operations or cash flow.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General Litigation</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various pending legal proceedings arising out of the ordinary course of the Company’s business. None of these legal proceedings is expected to have a material adverse effect on the financial condition, results of operations or cash flow of the Company. With respect to these proceedings, and the litigation and claims described in the preceding paragraphs, management of the Company believes that it will either prevail, has adequate insurance coverage or has established appropriate accruals to cover potential liabilities. Legal costs related to proceedings or claims are recorded when incurred. Other costs that management estimates may be paid related to the claims are accrued when the liability is considered probable and the amount can be reasonably estimated. There can be no assurance, however, as to the ultimate outcome of any of these matters, and if all or substantially all of these legal proceedings were to be determined adverse to the Company, there could be a material adverse effect on the financial condition, results of operations or cash flow of the Company.</span></div> P15Y P15Y <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asbestos-related claims activity since December 31 is as follows:</span></div><div style="padding-left:20.25pt;padding-right:20.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.813%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Number of claims)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Claims unresolved, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,106 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Claims filed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,297 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">986 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Claims resolved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(749)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Claims unresolved, end of period</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,231 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,343 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Claims filed include all asbestos claims for which notification have been received or a file has been opened.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants.</span></div> 13648 14106 1297 986 714 749 14231 14343 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Consolidated Balance Sheet included the following amounts related to asbestos-related litigation:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.813%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term asbestos insurance asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213,323 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">221,489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term asbestos insurance receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,306 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,868 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued asbestos liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,111 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,908 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term asbestos liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223,829 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234,796 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in Other assets in the Consolidated Balance Sheets.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay, and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Consolidated Balance Sheets.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in Other liabilities in the Consolidated Balance Sheets.</span></div> 213323000 221489000 18306000 17868000 34111000 32908000 223829000 234796000 Segment Information<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ESAB is a focused premier industrial compounder. ESAB provides its partners with fabrication technology, advanced equipment, consumables, gas control equipment, welding robotics and digital solutions.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America, and “EMEA &amp; APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s management evaluates the operating results of each of its reportable segments based upon Net sales and Adjusted EBITDA, which represents Net income from continuing operations excluding the impact of Income tax expense, Interest expense and other, net, Pension settlement (loss), Restructuring and other related charges, acquisition - amortization and other related charges and depreciation and other amortization</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pany’s segment results were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.686%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Net sales:</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296,047 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA &amp; APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393,697 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">392,431 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">689,744 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">684,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,098 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,442 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA &amp; APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,039 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,547 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,137 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,989 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following is a reconciliation of Net income from continuing operations to Adjusted EBITDA.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:54.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.715%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.717%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,903 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,504 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,024 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense and other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,091 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,510 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pension settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,155 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring and other related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,444 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition - amortization and other related charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,777 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,289 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and other amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,783 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,593 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,137 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,989 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to removal of interest expense, net included within the Interest expense and other, net line within the Consolidated and Condensed Statements of Operations.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.</span></div> 2 <div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pany’s segment results were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.686%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Net sales:</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296,047 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA &amp; APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393,697 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">392,431 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">689,744 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">684,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,098 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,442 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA &amp; APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,039 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,547 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,137 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,989 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following is a reconciliation of Net income from continuing operations to Adjusted EBITDA.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:54.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.715%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.717%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 29, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,903 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,504 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,024 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense and other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,091 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,510 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pension settlement loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,155 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring and other related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,444 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition - amortization and other related charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,777 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,289 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and other amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,783 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,593 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,137 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,989 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-2.8pt;vertical-align:baseline"> </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to removal of interest expense, net included within the Interest expense and other, net line within the Consolidated and Condensed Statements of Operations.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses.</span></div> 296047000 291569000 393697000 392431000 689744000 684000000 54098000 49442000 75039000 68547000 129137000 117989000 62903000 34129000 18504000 37024000 17091000 19510000 -12155000 0 1924000 9444000 7777000 9289000 8783000 8593000 129137000 117989000 Subsequent Events<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 9, 2024, the Company completed a $700.0 million Senior Note Offering (“the Offering”). The Offering has a contractual interest rate of 6.25% and expected maturity date of April 15, 2029. The Company used the net proceeds from the Offering to repay $588.8 million of borrowings under its Term Loan A-3 Facility and pay fees associated with the Offering. The Company intends to use the remaining proceeds received to repay borrowings under its Revolving Facility and other general corporate purposes. The Offering did not have any material changes to the required financial covenants for the Company.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dividend of $3.6 million included in Accrued liabilities in the Consolidated Balance Sheet at March 29, 2024 was paid on April 12, 2024 to stockholders of record as of March 29, 2024.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 30, 2024, the Company reached an agreement to acquire SUMIG Soluções para Solda e Corte Ltda, a South American light automation and equipment business for approximately $74 million of cash consideration. This acquisition is expected to be completed during the second half of 2024, subject to the receipt of applicable regulatory approvals and customary closing conditions.</span></div> 700000000 0.0625 588800000 3600000 74000000 false false false false